<html>
<head><meta http-equiv=Content-Type content="text/html; charset=UTF-8">
<style type="text/css">
<!--
span.cls_003{font-family:Arial,serif;font-size:8.0px;color:rgb(0,0,0);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_003{font-family:Arial,serif;font-size:8.0px;color:rgb(0,0,0);font-weight:normal;font-style:normal;text-decoration: none}
span.cls_004{font-family:Arial,serif;font-size:23.1px;color:rgb(43,60,131);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_004{font-family:Arial,serif;font-size:23.1px;color:rgb(43,60,131);font-weight:normal;font-style:normal;text-decoration: none}
span.cls_005{font-family:Arial,serif;font-size:13.1px;color:rgb(0,0,0);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_005{font-family:Arial,serif;font-size:13.1px;color:rgb(0,0,0);font-weight:normal;font-style:normal;text-decoration: none}
span.cls_006{font-family:Arial,serif;font-size:9.2px;color:rgb(0,0,0);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_006{font-family:Arial,serif;font-size:9.2px;color:rgb(0,0,0);font-weight:normal;font-style:normal;text-decoration: none}
span.cls_007{font-family:Arial,serif;font-size:5.4px;color:rgb(0,0,0);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_007{font-family:Arial,serif;font-size:5.4px;color:rgb(0,0,0);font-weight:normal;font-style:normal;text-decoration: none}
span.cls_008{font-family:Arial,serif;font-size:7.5px;color:rgb(0,0,0);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_008{font-family:Arial,serif;font-size:7.5px;color:rgb(0,0,0);font-weight:normal;font-style:normal;text-decoration: none}
span.cls_009{font-family:Arial,serif;font-size:8.2px;color:rgb(43,60,131);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_009{font-family:Arial,serif;font-size:8.2px;color:rgb(43,60,131);font-weight:normal;font-style:normal;text-decoration: none}
span.cls_010{font-family:Arial,serif;font-size:7.0px;color:rgb(0,0,0);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_010{font-family:Arial,serif;font-size:7.0px;color:rgb(0,0,0);font-weight:normal;font-style:normal;text-decoration: none}
span.cls_011{font-family:Arial,serif;font-size:9.1px;color:rgb(0,0,0);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_011{font-family:Arial,serif;font-size:9.1px;color:rgb(0,0,0);font-weight:normal;font-style:normal;text-decoration: none}
span.cls_012{font-family:Arial,serif;font-size:9.1px;color:rgb(139,185,48);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_012{font-family:Arial,serif;font-size:9.1px;color:rgb(139,185,48);font-weight:normal;font-style:normal;text-decoration: none}
span.cls_013{font-family:Arial,serif;font-size:10.1px;color:rgb(0,0,0);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_013{font-family:Arial,serif;font-size:10.1px;color:rgb(0,0,0);font-weight:normal;font-style:normal;text-decoration: none}
span.cls_014{font-family:Arial,serif;font-size:8.6px;color:rgb(0,0,0);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_014{font-family:Arial,serif;font-size:8.6px;color:rgb(0,0,0);font-weight:normal;font-style:normal;text-decoration: none}
span.cls_015{font-family:Arial,serif;font-size:10.6px;color:rgb(43,60,131);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_015{font-family:Arial,serif;font-size:10.6px;color:rgb(43,60,131);font-weight:normal;font-style:normal;text-decoration: none}
span.cls_016{font-family:Arial,serif;font-size:6.4px;color:rgb(0,0,0);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_016{font-family:Arial,serif;font-size:6.4px;color:rgb(0,0,0);font-weight:normal;font-style:normal;text-decoration: none}
span.cls_017{font-family:Arial,serif;font-size:15.1px;color:rgb(43,60,131);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_017{font-family:Arial,serif;font-size:15.1px;color:rgb(43,60,131);font-weight:normal;font-style:normal;text-decoration: none}
span.cls_018{font-family:Arial,serif;font-size:9.1px;color:rgb(0,0,255);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_018{font-family:Arial,serif;font-size:9.1px;color:rgb(0,0,255);font-weight:normal;font-style:normal;text-decoration: none}
span.cls_019{font-family:Arial,serif;font-size:8.6px;color:rgb(0,0,255);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_019{font-family:Arial,serif;font-size:8.6px;color:rgb(0,0,255);font-weight:normal;font-style:normal;text-decoration: none}
span.cls_002{font-family:Arial,serif;font-size:12.0px;color:rgb(125,161,54);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_002{font-family:Arial,serif;font-size:12.0px;color:rgb(125,161,54);font-weight:normal;font-style:normal;text-decoration: none}
span.cls_020{font-family:Arial,serif;font-size:9.1px;color:rgb(43,60,131);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_020{font-family:Arial,serif;font-size:9.1px;color:rgb(43,60,131);font-weight:normal;font-style:normal;text-decoration: none}
span.cls_022{font-family:Arial,serif;font-size:8.0px;color:rgb(0,0,255);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_022{font-family:Arial,serif;font-size:8.0px;color:rgb(0,0,255);font-weight:normal;font-style:normal;text-decoration: none}
span.cls_023{font-family:Arial,serif;font-size:6.1px;color:rgb(0,0,0);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_023{font-family:Arial,serif;font-size:6.1px;color:rgb(0,0,0);font-weight:normal;font-style:normal;text-decoration: none}
span.cls_024{font-family:Arial,serif;font-size:7.0px;color:rgb(46,72,123);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_024{font-family:Arial,serif;font-size:7.0px;color:rgb(46,72,123);font-weight:normal;font-style:normal;text-decoration: none}
span.cls_025{font-family:Arial,serif;font-size:7.0px;color:rgb(46,72,123);font-weight:bold;font-style:normal;text-decoration: none}
div.cls_025{font-family:Arial,serif;font-size:7.0px;color:rgb(46,72,123);font-weight:bold;font-style:normal;text-decoration: none}
span.cls_026{font-family:Arial,serif;font-size:7.5px;color:rgb(0,0,255);font-weight:normal;font-style:normal;text-decoration: none}
div.cls_026{font-family:Arial,serif;font-size:7.5px;color:rgb(0,0,255);font-weight:normal;font-style:normal;text-decoration: none}
-->
</style>
<script type="text/javascript" src="fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_id_fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_files/wz_jsgraphics.js"></script>
</head>
<body>
<div style="position:absolute;left:50%;margin-left:-306px;top:0px;width:612px;height:790px;border-style:outset;overflow:hidden">
<div style="position:absolute;left:0px;top:0px">
<img src="fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_id_fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_files/background01.jpg" width=612 height=790></div>
<div style="position:absolute;left:48.19px;top:27.19px" class="cls_003"><span class="cls_003">Human Reproduction Update, Vol.23, No.2 pp. 139-155, 2017</span></div>
<div style="position:absolute;left:48.19px;top:39.15px" class="cls_003"><span class="cls_003">Advanced Access publication on November 4, 2016</span></div>
<div style="position:absolute;left:222.12px;top:39.15px" class="cls_003"><span class="cls_003">doi:10.1093/humupd/dmw038</span></div>
<div style="position:absolute;left:150.18px;top:95.87px" class="cls_004"><span class="cls_004">Oocyte, embryo and blastocyst</span></div>
<div style="position:absolute;left:150.18px;top:122.86px" class="cls_004"><span class="cls_004">cryopreservation in ART: systematic</span></div>
<div style="position:absolute;left:150.18px;top:149.84px" class="cls_004"><span class="cls_004">review and meta-analysis comparing</span></div>
<div style="position:absolute;left:150.18px;top:176.88px" class="cls_004"><span class="cls_004">slow-freezing versus vitrification to</span></div>
<div style="position:absolute;left:150.18px;top:203.87px" class="cls_004"><span class="cls_004">produce evidence for the development</span></div>
<div style="position:absolute;left:150.18px;top:230.86px" class="cls_004"><span class="cls_004">of global guidance</span></div>
<div style="position:absolute;left:150.18px;top:270.01px" class="cls_005"><span class="cls_005">Laura Rienzi</span><span class="cls_006"><sup>1,*</sup></span><span class="cls_005">, Clarisa Gracia</span><span class="cls_006"><sup>2</sup></span><span class="cls_005">, Roberta Maggiulli</span><span class="cls_006"><sup>1</sup></span><span class="cls_005">,</span></div>
<div style="position:absolute;left:150.18px;top:287.01px" class="cls_005"><span class="cls_005">Andrew R. LaBarbera</span><span class="cls_006"><sup>3</sup></span><span class="cls_005">, Daniel J. Kaser</span><span class="cls_006"><sup>4</sup></span><span class="cls_005">, Filippo M. Ubaldi</span><span class="cls_006"><sup>1</sup></span><span class="cls_005">,</span></div>
<div style="position:absolute;left:150.18px;top:303.96px" class="cls_005"><span class="cls_005">Sheryl Vanderpoel</span><span class="cls_006"><sup>5,6</sup></span><span class="cls_005">, and Catherine Racowsky</span><span class="cls_006"><sup>4</sup></span></div>
<div style="position:absolute;left:150.18px;top:326.22px" class="cls_007"><span class="cls_007"><sup>1</sup></span><span class="cls_008">GENERA Centre for Reproductive Medicine, Clinica Valle Giulia, via de Notaris 2b, Rome, Italy</span><span class="cls_007"><sup>2</sup></span><span class="cls_008">Division of Reproductive Endocrinology</span></div>
<div style="position:absolute;left:150.18px;top:335.24px" class="cls_008"><span class="cls_008">and Infertility, Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA, USA</span><span class="cls_007"><sup>3</sup></span><span class="cls_008">American Society for</span></div>
<div style="position:absolute;left:150.18px;top:344.25px" class="cls_008"><span class="cls_008">Reproductive Medicine, Birmingham, Alabama 35216, USA</span><span class="cls_007"><sup>4</sup></span><span class="cls_008">Department of Obstetrics and Gynecology, Brigham and Women’s Hospital,</span></div>
<div style="position:absolute;left:150.18px;top:353.21px" class="cls_008"><span class="cls_008">Harvard Medical School, Boston, MA 02115, USA</span><span class="cls_007"><sup>5</sup></span><span class="cls_008">HRP (the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of</span></div>
<div style="position:absolute;left:150.18px;top:362.22px" class="cls_008"><span class="cls_008">Research, Development and Research Training in Human Reproduction), Geneva, Switzerland (at the time of the study)</span><span class="cls_007"><sup>6</sup></span><span class="cls_008">Population</span></div>
<div style="position:absolute;left:150.18px;top:372.38px" class="cls_008"><span class="cls_008">Council, Reproductive Health Programme, New York, USA</span></div>
<div style="position:absolute;left:150.18px;top:390.36px" class="cls_008"><span class="cls_008">*Correspondence address. E-mail: rienzi@generaroma.it</span></div>
<div style="position:absolute;left:150.18px;top:404.88px" class="cls_003"><span class="cls_003">Submitted on June 2, 2016; resubmitted on September 15, 2016; editorial decision on October 10, 2016; accepted on October 14, 2016</span></div>
<div style="position:absolute;left:150.18px;top:434.57px" class="cls_009"><span class="cls_009">TABLE OF CONTENTS</span></div>
<div style="position:absolute;left:150.18px;top:452.86px" class="cls_010"><span class="cls_010">•</span><span class="cls_011"> Introduction</span></div>
<div style="position:absolute;left:150.18px;top:464.82px" class="cls_010"><span class="cls_010">•</span><span class="cls_011"> Methods</span></div>
<div style="position:absolute;left:168.21px;top:476.84px" class="cls_012"><span class="cls_012">Oocyte cryopreservation: study eligibility criteria</span></div>
<div style="position:absolute;left:168.21px;top:488.86px" class="cls_012"><span class="cls_012">Oocyte cryopreservation: study search methods</span></div>
<div style="position:absolute;left:168.21px;top:500.82px" class="cls_012"><span class="cls_012">Oocyte cryopreservation: study descriptions</span></div>
<div style="position:absolute;left:168.21px;top:512.84px" class="cls_012"><span class="cls_012">Embryo cryopreservation: study eligibility criteria</span></div>
<div style="position:absolute;left:168.21px;top:524.86px" class="cls_012"><span class="cls_012">Embryo cryopreservation: study search methods</span></div>
<div style="position:absolute;left:168.21px;top:536.82px" class="cls_012"><span class="cls_012">Embryo cryopreservation: study descriptions</span></div>
<div style="position:absolute;left:168.21px;top:548.84px" class="cls_012"><span class="cls_012">Assessing the quality of each study</span></div>
<div style="position:absolute;left:168.21px;top:560.86px" class="cls_012"><span class="cls_012">Data synthesis and meta-analysis</span></div>
<div style="position:absolute;left:168.21px;top:572.82px" class="cls_012"><span class="cls_012">Assessment of the quality of the literature as a whole</span></div>
<div style="position:absolute;left:150.18px;top:584.84px" class="cls_010"><span class="cls_010">•</span><span class="cls_011"> Results</span></div>
<div style="position:absolute;left:168.21px;top:596.86px" class="cls_012"><span class="cls_012">Oocyte slow-freezing versus vitrification: clinical outcomes and oocyte cryosurvival</span></div>
<div style="position:absolute;left:168.21px;top:608.82px" class="cls_012"><span class="cls_012">Oocyte slow-freezing versus fresh oocytes: clinical outcomes</span></div>
<div style="position:absolute;left:168.21px;top:620.84px" class="cls_012"><span class="cls_012">Oocyte vitrification versus fresh oocytes: clinical outcomes</span></div>
<div style="position:absolute;left:168.21px;top:632.86px" class="cls_012"><span class="cls_012">Embryo slow-freezing versus vitrification</span></div>
<div style="position:absolute;left:150.18px;top:644.82px" class="cls_010"><span class="cls_010">•</span><span class="cls_011"> Discussion</span></div>
<div style="position:absolute;left:168.21px;top:656.84px" class="cls_012"><span class="cls_012">Contribution of cryopreservation to the cumulative LBR</span></div>
<div style="position:absolute;left:168.21px;top:668.86px" class="cls_012"><span class="cls_012">Embryo transfer policy and cryopreservation</span></div>
<div style="position:absolute;left:48.19px;top:709.02px" class="cls_010"><span class="cls_010">© The Author 2016. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology.</span></div>
<div style="position:absolute;left:48.19px;top:717.97px" class="cls_010"><span class="cls_010">This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (</span><A HREF="http://creativecommons.org/">http://creativecommons.org/</A> </div>
<div style="position:absolute;left:48.19px;top:726.99px" class="cls_010"><span class="cls_010">licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</span></div>
<div style="position:absolute;left:48.19px;top:736.00px" class="cls_010"><span class="cls_010">For commercial re-use, please contact journals.permissions@oup.com</span></div>
</div>
<div style="position:absolute;left:50%;margin-left:-306px;top:800px;width:612px;height:790px;border-style:outset;overflow:hidden">
<div style="position:absolute;left:0px;top:0px">
<img src="fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_id_fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_files/background02.jpg" width=612 height=790></div>
<div style="position:absolute;left:45.35px;top:25.13px" class="cls_013"><span class="cls_013">140</span></div>
<div style="position:absolute;left:525.71px;top:26.63px" class="cls_014"><span class="cls_014">Rienzi et al.</span></div>
<div style="position:absolute;left:165.37px;top:56.80px" class="cls_012"><span class="cls_012">IVF cycle segmentation</span></div>
<div style="position:absolute;left:165.37px;top:68.82px" class="cls_012"><span class="cls_012">Cryopreservation and enhanced embryo evaluation</span></div>
<div style="position:absolute;left:165.37px;top:80.79px" class="cls_012"><span class="cls_012">New possibilities related to oocyte cryopreservation</span></div>
<div style="position:absolute;left:165.37px;top:92.80px" class="cls_012"><span class="cls_012">Standardization of protocols and automation</span></div>
<div style="position:absolute;left:165.37px;top:104.82px" class="cls_012"><span class="cls_012">Obstetric and perinatal outcomes</span></div>
<div style="position:absolute;left:147.34px;top:116.79px" class="cls_010"><span class="cls_010">•</span><span class="cls_011"> Conclusions</span></div>
<div style="position:absolute;left:55.84px;top:158.26px" class="cls_009"><span class="cls_009">BACKGROUND</span><span class="cls_015">:</span><span class="cls_011"> Successful cryopreservation of oocytes and embryos is essential not only to maximize the safety and efficacy of ovarian</span></div>
<div style="position:absolute;left:55.84px;top:171.78px" class="cls_011"><span class="cls_011">stimulation cycles in an IVF treatment, but also to enable fertility preservation. Two cryopreservation methods are routinely used: slow-</span></div>
<div style="position:absolute;left:55.84px;top:183.74px" class="cls_011"><span class="cls_011">freezing or vitrification. Slow-freezing allows for freezing to occur at a sufficiently slow rate to permit adequate cellular dehydration while</span></div>
<div style="position:absolute;left:55.84px;top:195.76px" class="cls_011"><span class="cls_011">minimizing intracellular ice formation. Vitrification allows the solidification of the cell(s) and of the extracellular milieu into a glass-like state</span></div>
<div style="position:absolute;left:55.84px;top:207.78px" class="cls_011"><span class="cls_011">without the formation of ice.</span></div>
<div style="position:absolute;left:55.84px;top:221.24px" class="cls_009"><span class="cls_009">OBJECTIVE AND RATIONALE</span><span class="cls_015">:</span><span class="cls_011"> The objective of our study was to provide a systematic review and meta-analysis of clinical outcomes</span></div>
<div style="position:absolute;left:55.84px;top:234.76px" class="cls_011"><span class="cls_011">following slow-freezing/thawing versus vitrification/warming of oocytes and embryos and to inform the development of World Health</span></div>
<div style="position:absolute;left:55.84px;top:246.78px" class="cls_011"><span class="cls_011">Organization guidance on the most effective cryopreservation method.</span></div>
<div style="position:absolute;left:55.84px;top:260.25px" class="cls_009"><span class="cls_009">SEARCH METHODS</span><span class="cls_015">:</span><span class="cls_011"> A Medline search was performed from 1966 to 1 August 2016 using the following search terms: (Oocyte(s) [tiab]</span></div>
<div style="position:absolute;left:55.84px;top:273.77px" class="cls_011"><span class="cls_011">OR (Pronuclear[tiab] OR Embryo[tiab] OR Blastocyst[tiab]) AND (vitrification[tiab] OR freezing[tiab] OR freeze[tiab]) AND (pregnancy</span></div>
<div style="position:absolute;left:55.84px;top:285.73px" class="cls_011"><span class="cls_011">[tiab] OR birth[tiab] OR clinical[tiab]). Queries were limited to those involving humans. RCTs and cohort studies that were published in</span></div>
<div style="position:absolute;left:55.84px;top:297.75px" class="cls_011"><span class="cls_011">full-length were considered eligible. Each reference was reviewed for relevance and only primary evidence and relevant articles from the</span></div>
<div style="position:absolute;left:55.84px;top:309.77px" class="cls_011"><span class="cls_011">bibliographies of included articles were considered. References were included if they reported cryosurvival rate, clinical pregnancy rate</span></div>
<div style="position:absolute;left:55.84px;top:321.73px" class="cls_011"><span class="cls_011">(CPR), live-birth rate (LBR) or delivery rate for slow-frozen or vitrified human oocytes or embryos. A meta-analysis was performed using a</span></div>
<div style="position:absolute;left:55.84px;top:333.75px" class="cls_011"><span class="cls_011">random effects model to calculate relative risk ratios (RR) and 95% CI.</span></div>
<div style="position:absolute;left:55.84px;top:347.27px" class="cls_009"><span class="cls_009">OUTCOMES</span><span class="cls_015">:</span><span class="cls_011"> One RCT study comparing slow-freezing versus vitrification of oocytes was included. Vitrification was associated with</span></div>
<div style="position:absolute;left:55.84px;top:360.74px" class="cls_011"><span class="cls_011">increased ongoing CPR per cycle (RR = 2.81, 95% CI: 1.05-7.51; P = 0.039; 48 and 30 cycles, respectively, per transfer (RR = 1.81, 95%</span></div>
<div style="position:absolute;left:55.84px;top:372.75px" class="cls_011"><span class="cls_011">CI 0.71-4.67; P = 0.214; 47 and 19 transfers) and per warmed/thawed oocyte (RR = 1.14, 95% CI: 1.02-1.28; P = 0.018; 260 and 238</span></div>
<div style="position:absolute;left:55.84px;top:384.77px" class="cls_011"><span class="cls_011">oocytes). One RCT comparing vitrification versus fresh oocytes was analysed. In vitrification and fresh cycles, respectively, no evidence for</span></div>
<div style="position:absolute;left:55.84px;top:396.73px" class="cls_011"><span class="cls_011">a difference in ongoing CPR per randomized woman (RR = 1.03, 95% CI: 0.87-1.21; P = 0.744, 300 women in each group), per cycle</span></div>
<div style="position:absolute;left:55.84px;top:408.75px" class="cls_011"><span class="cls_011">(RR = 1.01, 95% CI: 0.86-1.18; P = 0.934; 267 versus 259 cycles) and per oocyte utilized (RR = 1.02, 95% CI: 0.82-1.26; P = 0.873;</span></div>
<div style="position:absolute;left:55.84px;top:420.77px" class="cls_011"><span class="cls_011">3286 versus 3185 oocytes) was reported. Findings were consistent with relevant cohort studies.</span></div>
<div style="position:absolute;left:64.85px;top:432.73px" class="cls_011"><span class="cls_011">Of the seven RCTs on embryo cryopreservation identified, three met the inclusion criteria (638 warming/thawing cycles at cleavage and</span></div>
<div style="position:absolute;left:55.84px;top:444.75px" class="cls_011"><span class="cls_011">blastocyst stage), none of which involved pronuclear-stage embryos. A higher CPR per cycle was noted with embryo vitrification compared</span></div>
<div style="position:absolute;left:55.84px;top:455.38px" class="cls_011"><span class="cls_011">with slow-freezing, though this was of borderline statistical significance (RR = 1.89, 95% CI: 1.00-3.59; P = 0.051; three RCTs; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011">  =</span></div>
<div style="position:absolute;left:55.84px;top:468.74px" class="cls_011"><span class="cls_011">71.9%). LBR per cycle was reported by one RCT performed with cleavage-stage embryos and was higher for vitrification (RR = 2.28; 95%</span></div>
<div style="position:absolute;left:55.84px;top:480.75px" class="cls_011"><span class="cls_011">CI: 1.17-4.44; P =</span></div>
<div style="position:absolute;left:128.80px;top:480.75px" class="cls_011"><span class="cls_011">0.016; 216 cycles; one RCT). A secondary analysis was performed focusing on embryo cryosurvival rate. Pooled data</span></div>
<div style="position:absolute;left:55.84px;top:492.77px" class="cls_011"><span class="cls_011">from seven RCTs (3615 embryos) revealed a significant improvement in embryo cryosurvival following vitrification as compared with slow-</span></div>
<div style="position:absolute;left:55.84px;top:503.40px" class="cls_011"><span class="cls_011">freezing (RR = 1.59, 95% CI: 1.30-1.93; P &lt; 0.001; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011"> = 93%).</span></div>
<div style="position:absolute;left:55.84px;top:518.26px" class="cls_009"><span class="cls_009">WIDER IMPLICATIONS</span><span class="cls_015">:</span><span class="cls_011"> Data from available RCTs suggest that vitrification/warming is superior to slow-freezing/thawing with regard</span></div>
<div style="position:absolute;left:55.84px;top:531.78px" class="cls_011"><span class="cls_011">to clinical outcomes (low quality of the evidence) and cryosurvival rates (moderate quality of the evidence) for oocytes, cleavage-stage</span></div>
<div style="position:absolute;left:55.84px;top:543.74px" class="cls_011"><span class="cls_011">embryos and blastocysts. The results were confirmed by cohort studies. The improvements obtained with the introduction of vitrification</span></div>
<div style="position:absolute;left:55.84px;top:555.76px" class="cls_011"><span class="cls_011">have several important clinical implications in ART. Based on this evidence, in particular regarding cryosurvival rates, laboratories that con-</span></div>
<div style="position:absolute;left:55.84px;top:567.78px" class="cls_011"><span class="cls_011">tinue to use slow-freezing should consider transitioning to the use of vitrification for cryopreservation.</span></div>
<div style="position:absolute;left:55.84px;top:585.75px" class="cls_011"><span class="cls_011">Key words: cryopreservation / vitrification / slow freezing / oocyte / embryo / blastocyst / World Health Organization</span></div>
<div style="position:absolute;left:314.65px;top:632.18px" class="cls_011"><span class="cls_011">countries, such as Switzerland, Finland, Netherlands, Sweden and</span></div>
<div style="position:absolute;left:45.35px;top:631.23px" class="cls_017"><span class="cls_017">Introduction</span></div>
<div style="position:absolute;left:314.65px;top:644.20px" class="cls_011"><span class="cls_011">Iceland, the proportion of cryopreserved embryo transfers is higher</span></div>
<div style="position:absolute;left:45.35px;top:655.20px" class="cls_011"><span class="cls_011">Cryopreservation of gametes and embryos is an essential aspect of</span></div>
<div style="position:absolute;left:314.65px;top:656.22px" class="cls_011"><span class="cls_011">than</span></div>
<div style="position:absolute;left:335.11px;top:656.22px" class="cls_011"><span class="cls_011">50% (</span><span class="cls_018">Kupka et al., 2016</span><span class="cls_011">). The observed differences among</span></div>
<div style="position:absolute;left:45.35px;top:667.22px" class="cls_011"><span class="cls_011">ART. Its widespread application has allowed increased safety and effi-</span></div>
<div style="position:absolute;left:314.65px;top:668.18px" class="cls_011"><span class="cls_011">European countries are mainly due to policies requiring lower trans-</span></div>
<div style="position:absolute;left:45.35px;top:679.24px" class="cls_011"><span class="cls_011">cacy of IVF treatments. The proportion of cryopreserved embryo</span></div>
<div style="position:absolute;left:314.65px;top:680.20px" class="cls_011"><span class="cls_011">fer order which, in turn, have led to more supernumerary embryos</span></div>
<div style="position:absolute;left:45.35px;top:691.20px" class="cls_011"><span class="cls_011">transfer cycles compared with fresh cycles is growing in Europe.</span></div>
<div style="position:absolute;left:314.65px;top:692.22px" class="cls_011"><span class="cls_011">available  for  cryopreservation</span></div>
<div style="position:absolute;left:432.17px;top:692.22px" class="cls_011"><span class="cls_011">(</span><span class="cls_018">Coetsier  and  Dhont,</span></div>
<div style="position:absolute;left:521.29px;top:692.22px" class="cls_018"><span class="cls_018">1998</span><span class="cls_011">).  The</span></div>
<div style="position:absolute;left:45.35px;top:703.22px" class="cls_011"><span class="cls_011">Overall it has been estimated that cryopreserved cycles contributed</span></div>
<div style="position:absolute;left:314.65px;top:704.18px" class="cls_011"><span class="cls_011">recent systematic application of cryopreservation for new indications</span></div>
<div style="position:absolute;left:45.35px;top:715.23px" class="cls_011"><span class="cls_011">to 32% of the transfers in 2011 compared to 28% in 2010. In some</span></div>
<div style="position:absolute;left:314.65px;top:716.20px" class="cls_011"><span class="cls_011">such as cycle segmentation (i.e. planned freeze all) (</span><span class="cls_018">Devroey et al., 2011</span><span class="cls_011">),</span></div>
</div>
<div style="position:absolute;left:50%;margin-left:-306px;top:1600px;width:612px;height:790px;border-style:outset;overflow:hidden">
<div style="position:absolute;left:0px;top:0px">
<img src="fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_id_fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_files/background03.jpg" width=612 height=790></div>
<div style="position:absolute;left:48.19px;top:26.63px" class="cls_014"><span class="cls_014">Slow-freezing versus vitrification in ART</span></div>
<div style="position:absolute;left:550.66px;top:25.13px" class="cls_013"><span class="cls_013">141</span></div>
<div style="position:absolute;left:48.19px;top:56.80px" class="cls_011"><span class="cls_011">oocyte banking (</span><span class="cls_018">Cobo et al.,</span></div>
<div style="position:absolute;left:166.22px;top:56.80px" class="cls_018"><span class="cls_018">2011a</span><span class="cls_011">,</span><span class="cls_018">2012</span><span class="cls_011">) and pre-implantation</span></div>
<div style="position:absolute;left:317.48px;top:56.80px" class="cls_011"><span class="cls_011">of other cryoprotectants such as glycerol have been investigated for</span></div>
<div style="position:absolute;left:48.19px;top:68.82px" class="cls_011"><span class="cls_011">genetic testing at the blastocyst stage (</span><span class="cls_018">Schoolcraft et al., 2011</span><span class="cls_011">) likely</span></div>
<div style="position:absolute;left:317.48px;top:68.82px" class="cls_011"><span class="cls_011">cryopreservation of oocytes, biopsied embryos and blastocysts (</span><span class="cls_018">Cohen</span></div>
<div style="position:absolute;left:48.19px;top:80.79px" class="cls_011"><span class="cls_011">will contribute, in our opinion, to a further increase in the proportion</span></div>
<div style="position:absolute;left:317.48px;top:80.79px" class="cls_018"><span class="cls_018">et al., 1985</span><span class="cls_011">;</span><span class="cls_018"> Fabbri et al., 2001</span><span class="cls_011">;</span><span class="cls_018"> Jericho et al., 2003</span><span class="cls_011">;</span><span class="cls_018"> Veeck et al., 2004</span><span class="cls_011">).</span></div>
<div style="position:absolute;left:48.19px;top:92.80px" class="cls_011"><span class="cls_011">of cryopreserved cycles in the near future.</span></div>
<div style="position:absolute;left:317.48px;top:92.80px" class="cls_011"><span class="cls_011">Detailed analysis of biological principles and development of various</span></div>
<div style="position:absolute;left:57.20px;top:104.82px" class="cls_011"><span class="cls_011">Embryo cryopreservation has, however, generated ethical, moral</span></div>
<div style="position:absolute;left:317.48px;top:104.82px" class="cls_011"><span class="cls_011">slow-freezing procedures have been described previously (</span><span class="cls_018">Leibo and</span></div>
<div style="position:absolute;left:48.19px;top:116.78px" class="cls_011"><span class="cls_011">and legal issues. Some countries have enacted specific laws that</span></div>
<div style="position:absolute;left:317.48px;top:116.79px" class="cls_018"><span class="cls_018">Songstaken, 2002</span><span class="cls_011">).</span></div>
<div style="position:absolute;left:48.19px;top:128.80px" class="cls_011"><span class="cls_011">restrict (e.g. Germany, Switzerland, Austria) or even forbid (Italy with</span></div>
<div style="position:absolute;left:326.49px;top:128.80px" class="cls_011"><span class="cls_011">In  contrast  to  slow-freezing,  vitrification  is  a  cryopreservation</span></div>
<div style="position:absolute;left:48.19px;top:140.82px" class="cls_011"><span class="cls_011">Law 40 in 2004) embryo cryopreservation. As an alternative and in</span></div>
<div style="position:absolute;left:317.48px;top:140.82px" class="cls_011"><span class="cls_011">method that allows solidification of the cell(s) and the extracellular</span></div>
<div style="position:absolute;left:48.19px;top:152.78px" class="cls_011"><span class="cls_011">accordance with the legal prohibition of embryo cryopreservation,</span></div>
<div style="position:absolute;left:317.48px;top:152.79px" class="cls_011"><span class="cls_011">milieu into a glass-like state without the formation of ice. The most</span></div>
<div style="position:absolute;left:48.19px;top:164.80px" class="cls_011"><span class="cls_011">oocyte cryopreservation had been introduced into routine practice in</span></div>
<div style="position:absolute;left:317.48px;top:164.80px" class="cls_011"><span class="cls_011">widely used vitrification method for mammalian embryos requires the</span></div>
<div style="position:absolute;left:48.19px;top:176.82px" class="cls_011"><span class="cls_011">Italy</span></div>
<div style="position:absolute;left:67.07px;top:176.82px" class="cls_011"><span class="cls_011">(</span><span class="cls_018">La Sala et al.,</span></div>
<div style="position:absolute;left:126.14px;top:176.82px" class="cls_018"><span class="cls_018">2006</span><span class="cls_011">;</span><span class="cls_018"> Borini et al.,</span></div>
<div style="position:absolute;left:201.37px;top:176.82px" class="cls_018"><span class="cls_018">2006a</span><span class="cls_011">,</span><span class="cls_018">b</span><span class="cls_011">,</span><span class="cls_018"> 2007</span><span class="cls_011">;</span><span class="cls_018"> Levi Setti,</span></div>
<div style="position:absolute;left:317.48px;top:176.82px" class="cls_011"><span class="cls_011">use of high initial concentrations of cryoprotectants, low volumes and</span></div>
<div style="position:absolute;left:48.19px;top:188.79px" class="cls_018"><span class="cls_018">2006</span><span class="cls_011">;</span><span class="cls_018"> De Santis et al., 2007</span><span class="cls_011">;</span><span class="cls_018"> Ubaldi et al., 2010</span><span class="cls_011">). Not until 2009 did</span></div>
<div style="position:absolute;left:317.48px;top:188.78px" class="cls_011"><span class="cls_011">ultra-rapid cooling-warming rates. This approach was first introduced</span></div>
<div style="position:absolute;left:48.19px;top:200.80px" class="cls_011"><span class="cls_011">the Italian Constitutional Court (151/2009) declare the constitution-</span></div>
<div style="position:absolute;left:317.48px;top:200.80px" class="cls_011"><span class="cls_011">in human embryology for cleavage-stage embryos (</span><span class="cls_018">Mukaida et al.,</span></div>
<div style="position:absolute;left:48.19px;top:212.82px" class="cls_011"><span class="cls_011">ality of embryo cryopreservation. Nevertheless, some couples are</span></div>
<div style="position:absolute;left:317.48px;top:212.82px" class="cls_018"><span class="cls_018">1998</span><span class="cls_011">) and then for oocytes (</span><span class="cls_018">Kuleshova et al., 1999</span><span class="cls_011">) and pronuclear-</span></div>
<div style="position:absolute;left:48.19px;top:224.79px" class="cls_011"><span class="cls_011">concerned  about  the  disposition  of  cryopreserved  embryos</span></div>
<div style="position:absolute;left:317.48px;top:224.79px" class="cls_011"><span class="cls_011">stage  embryos</span></div>
<div style="position:absolute;left:377.58px;top:224.79px" class="cls_011"><span class="cls_011">(</span><span class="cls_018">Jelinkova  et  al.,</span></div>
<div style="position:absolute;left:444.47px;top:224.79px" class="cls_018"><span class="cls_018">2002</span><span class="cls_011">;</span><span class="cls_018">  Selman  and  El-Danasouri,</span></div>
<div style="position:absolute;left:48.19px;top:236.80px" class="cls_011"><span class="cls_011">(</span><span class="cls_018">Nachtigall et al., 2010</span><span class="cls_011">) and therefore prefer to limit the number of</span></div>
<div style="position:absolute;left:317.48px;top:236.80px" class="cls_018"><span class="cls_018">2002</span><span class="cls_011">). In the last 15 years several vitrification protocols have been</span></div>
<div style="position:absolute;left:48.19px;top:248.82px" class="cls_011"><span class="cls_011">oocytes inseminated, with cryopreservation of the remainder (</span><span class="cls_018">Heng,</span></div>
<div style="position:absolute;left:317.48px;top:248.82px" class="cls_011"><span class="cls_011">described, which differ from one another in the type of cryoprotec-</span></div>
<div style="position:absolute;left:48.19px;top:260.79px" class="cls_018"><span class="cls_018">2007</span><span class="cls_011">). Oocyte cryopreservation also has emerged as an important</span></div>
<div style="position:absolute;left:317.48px;top:260.79px" class="cls_011"><span class="cls_011">tants (Ethylene glycol [EG] and/or DMSO and/or PROH and sucrose</span></div>
<div style="position:absolute;left:48.19px;top:272.80px" class="cls_011"><span class="cls_011">method for female fertility preservation for both medical and non-</span></div>
<div style="position:absolute;left:317.48px;top:272.80px" class="cls_011"><span class="cls_011">and/or  Ficoll  and/or  Trehalose),  equilibration  and  dilution  para-</span></div>
<div style="position:absolute;left:48.19px;top:284.82px" class="cls_011"><span class="cls_011">medical indications (reviewed in</span><span class="cls_018"> De Vos et al., 2014</span><span class="cls_011"> and</span><span class="cls_018"> Stoop et al.,</span></div>
<div style="position:absolute;left:317.48px;top:284.82px" class="cls_011"><span class="cls_011">meters, the carrier tools and the cooling, storage and warming meth-</span></div>
<div style="position:absolute;left:48.19px;top:296.79px" class="cls_018"><span class="cls_018">2014</span><span class="cls_011">).</span></div>
<div style="position:absolute;left:317.48px;top:296.78px" class="cls_011"><span class="cls_011">ods</span></div>
<div style="position:absolute;left:336.81px;top:296.78px" class="cls_011"><span class="cls_011">(reviewed  in</span><span class="cls_018">  Vajta  and  Nagy,</span></div>
<div style="position:absolute;left:462.50px;top:296.79px" class="cls_018"><span class="cls_018">2006</span><span class="cls_011">).  To  date  the  most</span></div>
<div style="position:absolute;left:57.20px;top:308.80px" class="cls_011"><span class="cls_011">Since the first pregnancy and delivery with cryopreserved embryos</span></div>
<div style="position:absolute;left:317.48px;top:308.80px" class="cls_011"><span class="cls_011">commonly used protocol for both oocyte and embryo vitrification</span></div>
<div style="position:absolute;left:48.19px;top:320.82px" class="cls_011"><span class="cls_011">(</span><span class="cls_018">Trounson and Mohr, 1983</span><span class="cls_011">;</span><span class="cls_018"> Zeilmaker et al., 1984</span><span class="cls_011">), various protocols</span></div>
<div style="position:absolute;left:317.48px;top:320.82px" class="cls_011"><span class="cls_011">involves the combination of 15% DMSO, 15% EG and 0.5 M sucrose</span></div>
<div style="position:absolute;left:48.19px;top:332.79px" class="cls_011"><span class="cls_011">have been introduced that differ from each other regarding the type</span></div>
<div style="position:absolute;left:317.48px;top:332.79px" class="cls_011"><span class="cls_011">in a minimum volume (≤1 µl) (</span><span class="cls_018">Kuwayama et al., 2005a</span><span class="cls_011">,</span><span class="cls_018">b</span><span class="cls_011">). Other fun-</span></div>
<div style="position:absolute;left:48.19px;top:344.80px" class="cls_011"><span class="cls_011">and  concentration  of  cryoprotectants,  equilibration  timing,  cooling</span></div>
<div style="position:absolute;left:317.48px;top:344.80px" class="cls_011"><span class="cls_011">damental aspects of the technique are related to the cooling and</span></div>
<div style="position:absolute;left:48.19px;top:356.82px" class="cls_011"><span class="cls_011">rates and cryopreservation devices used. Two principal approaches for</span></div>
<div style="position:absolute;left:317.48px;top:356.82px" class="cls_011"><span class="cls_011">storing method. At present most embryos and oocytes are vitrified</span></div>
<div style="position:absolute;left:48.19px;top:368.78px" class="cls_011"><span class="cls_011">cryopreservation have been adopted: slow-freezing and vitrification</span></div>
<div style="position:absolute;left:317.48px;top:368.79px" class="cls_011"><span class="cls_011">by exposing the sample to direct contact with liquid nitrogen (open</span></div>
<div style="position:absolute;left:48.19px;top:380.80px" class="cls_011"><span class="cls_011">(reviewed by</span><span class="cls_018"> Edgar and Gook, 2012</span><span class="cls_011">).</span></div>
<div style="position:absolute;left:317.48px;top:380.80px" class="cls_011"><span class="cls_011">system) to increase the cooling/warming rates and thus the efficiency</span></div>
<div style="position:absolute;left:57.20px;top:392.82px" class="cls_011"><span class="cls_011">Slow-freezing allows for cryopreservation to occur at a sufficiently</span></div>
<div style="position:absolute;left:317.48px;top:392.82px" class="cls_011"><span class="cls_011">of the procedure (</span><span class="cls_018">Vajta et al., 2015</span><span class="cls_011">). The ability to survive vitrification</span></div>
<div style="position:absolute;left:48.19px;top:404.79px" class="cls_011"><span class="cls_011">slow rate to permit adequate cellular dehydration while minimizing</span></div>
<div style="position:absolute;left:317.48px;top:404.79px" class="cls_011"><span class="cls_011">is in fact strictly dependent on the degree of cellular dehydration and</span></div>
<div style="position:absolute;left:48.19px;top:416.80px" class="cls_011"><span class="cls_011">intracellular ice formation. The first successful protocol applied in</span></div>
<div style="position:absolute;left:317.48px;top:416.80px" class="cls_011"><span class="cls_011">on the rate of warming, rather than on the type and concentration of</span></div>
<div style="position:absolute;left:48.19px;top:428.82px" class="cls_011"><span class="cls_011">1972 for mammalian embryo cryopreservation required a cooling</span></div>
<div style="position:absolute;left:317.48px;top:428.82px" class="cls_011"><span class="cls_011">cryoprotectants used (</span><span class="cls_018">Jin and Mazur, 2015</span><span class="cls_011">). High cryosurvival rates</span></div>
<div style="position:absolute;left:48.19px;top:440.78px" class="cls_011"><span class="cls_011">rate of</span></div>
<div style="position:absolute;left:78.52px;top:440.78px" class="cls_011"><span class="cls_011">~1°C/min to −70°C (</span><span class="cls_018">Whittingham et al., 1972</span><span class="cls_011">). Embryo</span></div>
<div style="position:absolute;left:317.48px;top:440.79px" class="cls_011"><span class="cls_011">of mouse oocytes and embryos have been recently obtained with the</span></div>
<div style="position:absolute;left:48.19px;top:452.80px" class="cls_011"><span class="cls_011">cooling performed this way is referred to as equilibrium freezing</span></div>
<div style="position:absolute;left:317.48px;top:452.80px" class="cls_011"><span class="cls_011">use of only non-permeating cryoprotectant and a relatively slow cool-</span></div>
<div style="position:absolute;left:48.19px;top:464.82px" class="cls_011"><span class="cls_011">(</span><span class="cls_018">Mazur, 1990</span><span class="cls_011">). Subsequently, slow-rate cooling was only applied to</span></div>
<div style="position:absolute;left:317.48px;top:464.82px" class="cls_011"><span class="cls_011">ing rate, but combined with an ultra-rapid warming (</span><span class="cls_018">Jin and Mazur,</span></div>
<div style="position:absolute;left:48.19px;top:476.79px" class="cls_011"><span class="cls_011">around −30°C (</span><span class="cls_018">Willadsen, 1977</span><span class="cls_011">). With this approach, intracellular</span></div>
<div style="position:absolute;left:317.48px;top:476.79px" class="cls_018"><span class="cls_018">2015</span><span class="cls_011">). This study also demonstrates that the osmotic withdrawal of a</span></div>
<div style="position:absolute;left:48.19px;top:488.80px" class="cls_011"><span class="cls_011">water content was converted into small intracellular ice crystals or</span></div>
<div style="position:absolute;left:317.48px;top:488.80px" class="cls_011"><span class="cls_011">very large proportion of intracellular water prior to cooling, and not</span></div>
<div style="position:absolute;left:48.19px;top:500.82px" class="cls_011"><span class="cls_011">into a glass. To avoid extensive crystallization, a very rapid warming</span></div>
<div style="position:absolute;left:317.48px;top:500.82px" class="cls_011"><span class="cls_011">the permeation of cryoprotectant in the cell, is the key for a success-</span></div>
<div style="position:absolute;left:48.19px;top:512.78px" class="cls_011"><span class="cls_011">was required.</span></div>
<div style="position:absolute;left:317.48px;top:512.78px" class="cls_011"><span class="cls_011">ful vitrification (</span><span class="cls_018">Jin and Mazur, 2015</span><span class="cls_011">).</span></div>
<div style="position:absolute;left:57.20px;top:524.80px" class="cls_011"><span class="cls_011">Although the first pregnancies with human cleavage-stage embryos</span></div>
<div style="position:absolute;left:326.49px;top:524.80px" class="cls_011"><span class="cls_011">To avoid potential contamination during open system vitrification,</span></div>
<div style="position:absolute;left:48.19px;top:536.82px" class="cls_011"><span class="cls_011">were obtained with the use of dimethylsulphoxide (DMSO) as the</span></div>
<div style="position:absolute;left:317.48px;top:536.82px" class="cls_011"><span class="cls_011">sterile liquid nitrogen can be used (</span><span class="cls_018">Vajta et al., 1998</span><span class="cls_011">;</span><span class="cls_018"> Parmegiani et al.,</span></div>
<div style="position:absolute;left:48.19px;top:548.78px" class="cls_011"><span class="cls_011">cryoprotectant</span></div>
<div style="position:absolute;left:106.47px;top:548.78px" class="cls_011"><span class="cls_011">(</span><span class="cls_018">Trounson and Mohr, 1983</span><span class="cls_011"> and</span><span class="cls_018"> Zeilmaker et al.,</span></div>
<div style="position:absolute;left:317.48px;top:548.79px" class="cls_018"><span class="cls_018">2009</span><span class="cls_011">). Alternatively, specific devices have been designed to avoid dir-</span></div>
<div style="position:absolute;left:48.19px;top:560.80px" class="cls_018"><span class="cls_018">1984</span><span class="cls_011">) this approach was rapidly replaced.</span></div>
<div style="position:absolute;left:317.48px;top:560.80px" class="cls_011"><span class="cls_011">ect contact of the samples with the nitrogen either during vitrification</span></div>
<div style="position:absolute;left:57.20px;top:572.82px" class="cls_011"><span class="cls_011">For nearly 20 years the protocol combining 1.5 M propylene glycol</span></div>
<div style="position:absolute;left:317.48px;top:572.82px" class="cls_011"><span class="cls_011">(closed system) and/or during storage (</span><span class="cls_018">Vajta et al., 1998</span><span class="cls_011">;</span><span class="cls_018"> Kuleshova</span></div>
<div style="position:absolute;left:48.19px;top:584.79px" class="cls_011"><span class="cls_011">(PROH) plus 0.1 M sucrose, as the permeable and non-permeable</span></div>
<div style="position:absolute;left:317.48px;top:584.79px" class="cls_018"><span class="cls_018">and Shaw 2000</span><span class="cls_011">;</span><span class="cls_018"> Isachenko et al., 2006</span><span class="cls_011">;</span><span class="cls_018"> Vanderzwalmen et al., 2009</span><span class="cls_011">;</span></div>
<div style="position:absolute;left:48.19px;top:596.80px" class="cls_011"><span class="cls_011">cryoprotectants, respectively, has been the most widely used (</span><span class="cls_018">Lassalle</span></div>
<div style="position:absolute;left:317.48px;top:596.80px" class="cls_018"><span class="cls_018">Abdelhafez et al., 2011</span><span class="cls_011">;</span><span class="cls_018"> Parmegiani, 2011</span><span class="cls_011">). Of note, not all closed sys-</span></div>
<div style="position:absolute;left:48.19px;top:608.82px" class="cls_018"><span class="cls_018">et al., 1985</span><span class="cls_011">;</span><span class="cls_018"> Testart et al., 1986</span><span class="cls_011">). The freezing curve adopted requires</span></div>
<div style="position:absolute;left:317.48px;top:608.82px" class="cls_011"><span class="cls_011">tems available on the market are completely free of any possible</span></div>
<div style="position:absolute;left:48.19px;top:620.79px" class="cls_011"><span class="cls_011">the use of a programmable freezing machine designed to provide</span></div>
<div style="position:absolute;left:317.48px;top:620.79px" class="cls_011"><span class="cls_011">sources of contamination (</span><span class="cls_018">Vajta et al., 2015</span><span class="cls_011">). On the other hand, a</span></div>
<div style="position:absolute;left:48.19px;top:632.80px" class="cls_011"><span class="cls_011">accurate and consistent cooling parameters. Briefly, the sample is</span></div>
<div style="position:absolute;left:317.48px;top:632.80px" class="cls_011"><span class="cls_011">lower degree of cooling/warming rate is generally associated with the</span></div>
<div style="position:absolute;left:48.19px;top:644.82px" class="cls_011"><span class="cls_011">exposed to a relatively rapid cooling rate of 2°C/min to around −7°C</span></div>
<div style="position:absolute;left:317.48px;top:644.82px" class="cls_011"><span class="cls_011">use of these systems. To date, neither open nor closed systems have</span></div>
<div style="position:absolute;left:48.19px;top:656.78px" class="cls_011"><span class="cls_011">followed by a manual seeding to induce ice crystal formation in the</span></div>
<div style="position:absolute;left:317.48px;top:656.78px" class="cls_011"><span class="cls_011">resulted in disease transmission during vitrification. However, to ensure</span></div>
<div style="position:absolute;left:48.19px;top:668.80px" class="cls_011"><span class="cls_011">solution. Then, a consistent slow cooling rate of 0.3-1.0°C/min is</span></div>
<div style="position:absolute;left:317.48px;top:668.80px" class="cls_011"><span class="cls_011">biosafety during cryopreservation, the use of sterile approaches is</span></div>
<div style="position:absolute;left:48.19px;top:680.82px" class="cls_011"><span class="cls_011">applied before the freezing device is plunged into liquid nitrogen after</span></div>
<div style="position:absolute;left:317.48px;top:680.82px" class="cls_011"><span class="cls_011">recommended (</span><span class="cls_018">Argyle et al., 2016</span><span class="cls_011">), providing that adequate cooling</span></div>
<div style="position:absolute;left:48.19px;top:692.78px" class="cls_011"><span class="cls_011">having  reached  temperatures  around</span></div>
<div style="position:absolute;left:196.16px;top:692.78px" class="cls_011"><span class="cls_011">−40</span></div>
<div style="position:absolute;left:217.47px;top:692.78px" class="cls_011"><span class="cls_011">to</span></div>
<div style="position:absolute;left:231.48px;top:692.78px" class="cls_011"><span class="cls_011">−70°C  using  the</span></div>
<div style="position:absolute;left:317.48px;top:692.79px" class="cls_011"><span class="cls_011">and, particularly, warming rates are still guaranteed.</span></div>
<div style="position:absolute;left:48.19px;top:704.80px" class="cls_011"><span class="cls_011">approach of</span><span class="cls_018"> Trounson and Mohr (1983)</span><span class="cls_011"> or</span><span class="cls_018"> Lassale et al., (1985)</span><span class="cls_011">,</span></div>
<div style="position:absolute;left:326.49px;top:704.80px" class="cls_011"><span class="cls_011">The objective of the present study was to compare slow-freezing/</span></div>
<div style="position:absolute;left:48.19px;top:716.82px" class="cls_011"><span class="cls_011">respectively. Modifications to the concentration of sucrose and the use</span></div>
<div style="position:absolute;left:317.48px;top:716.82px" class="cls_011"><span class="cls_011">thawing versus vitrification/warming for cryopreservation of oocytes,</span></div>
</div>
<div style="position:absolute;left:50%;margin-left:-306px;top:2400px;width:612px;height:790px;border-style:outset;overflow:hidden">
<div style="position:absolute;left:0px;top:0px">
<img src="fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_id_fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_files/background04.jpg" width=612 height=790></div>
<div style="position:absolute;left:45.35px;top:25.13px" class="cls_013"><span class="cls_013">142</span></div>
<div style="position:absolute;left:525.71px;top:26.63px" class="cls_014"><span class="cls_014">Rienzi et al.</span></div>
<div style="position:absolute;left:45.35px;top:56.80px" class="cls_011"><span class="cls_011">embryos and blastocysts. RCTs and relevant observational cohort</span></div>
<div style="position:absolute;left:323.15px;top:56.96px" class="cls_014"><span class="cls_014">A secondary analysis was performed focusing on oocyte cryosurvival</span></div>
<div style="position:absolute;left:45.35px;top:68.82px" class="cls_011"><span class="cls_011">studies were included in this systematic review and meta-analysis.</span></div>
<div style="position:absolute;left:314.65px;top:67.96px" class="cls_014"><span class="cls_014">rate. One RCT (</span><span class="cls_019">Smith et al., 2010</span><span class="cls_014">), two RCTs where sibling oocytes</span></div>
<div style="position:absolute;left:54.37px;top:80.79px" class="cls_011"><span class="cls_011">This study was performed to support a prioritized clinical question</span></div>
<div style="position:absolute;left:314.64px;top:78.96px" class="cls_014"><span class="cls_014">were randomized, rather than patients, (</span><span class="cls_019">Paffoni et al., 2008</span><span class="cls_014">;</span><span class="cls_019"> Cao et al.,</span></div>
<div style="position:absolute;left:314.64px;top:89.96px" class="cls_019"><span class="cls_019">2009</span><span class="cls_014">) and three cohort studies (</span><span class="cls_019">Fadini et al., 2009</span><span class="cls_014">;</span><span class="cls_019"> Grifo and Noyes,</span></div>
<div style="position:absolute;left:45.35px;top:92.80px" class="cls_011"><span class="cls_011">and to provide a review of the evidence for debate and discussion</span></div>
<div style="position:absolute;left:314.64px;top:100.96px" class="cls_019"><span class="cls_019">2010</span><span class="cls_014">;</span><span class="cls_019"> Levi Setti et al., 2016</span><span class="cls_014">) were included.</span></div>
<div style="position:absolute;left:45.35px;top:104.82px" class="cls_011"><span class="cls_011">during the consultation for the development of the World Health</span></div>
<div style="position:absolute;left:45.35px;top:116.78px" class="cls_011"><span class="cls_011">Organization (WHO) global guidelines: ‘Addressing evidence-based</span></div>
<div style="position:absolute;left:314.65px;top:124.29px" class="cls_013"><span class="cls_013">Slow-frozen versus fresh oocytes: clinical outcomes</span></div>
<div style="position:absolute;left:45.35px;top:128.80px" class="cls_011"><span class="cls_011">guidance on infertility diagnosis, management and treatment.’</span></div>
<div style="position:absolute;left:314.65px;top:137.81px" class="cls_014"><span class="cls_014">No  RCTs  were  identified  comparing  outcomes  following  transfer  of</span></div>
<div style="position:absolute;left:314.65px;top:148.81px" class="cls_014"><span class="cls_014">embryos from oocytes that were either slow-frozen or fresh. Five cohort</span></div>
<div style="position:absolute;left:314.65px;top:159.81px" class="cls_014"><span class="cls_014">studies  were  identified  comparing  outcomes  following  transfer  of</span></div>
<div style="position:absolute;left:45.35px;top:158.12px" class="cls_017"><span class="cls_017">Methods</span></div>
<div style="position:absolute;left:314.65px;top:170.80px" class="cls_014"><span class="cls_014">embryos derived from fresh or slow-frozen/thawed oocytes (</span><span class="cls_019">Chamayou</span></div>
<div style="position:absolute;left:314.64px;top:181.80px" class="cls_019"><span class="cls_019">et al., 2006</span><span class="cls_014">;</span><span class="cls_019"> Levi Setti et al., 2006</span><span class="cls_014">;</span><span class="cls_019"> Borini et al., 2007</span><span class="cls_014">;</span><span class="cls_019"> Borini et al., 2010</span><span class="cls_014">;</span></div>
<div style="position:absolute;left:45.35px;top:184.14px" class="cls_002"><span class="cls_002">Oocyte cryopreservation: study eligibility</span></div>
<div style="position:absolute;left:314.65px;top:192.80px" class="cls_019"><span class="cls_019">Virant-Klun et al., 2011</span><span class="cls_014">).</span></div>
<div style="position:absolute;left:45.35px;top:198.14px" class="cls_002"><span class="cls_002">criteria</span></div>
<div style="position:absolute;left:45.35px;top:215.65px" class="cls_014"><span class="cls_014">RCTs and well-designed cohort or case-control studies were included</span></div>
<div style="position:absolute;left:314.65px;top:216.13px" class="cls_013"><span class="cls_013">Vitrified versus fresh oocytes: clinical outcomes</span></div>
<div style="position:absolute;left:45.35px;top:226.65px" class="cls_014"><span class="cls_014">that  compared  outcomes  following  slow-freeze  versus  vitrification  of</span></div>
<div style="position:absolute;left:314.65px;top:229.65px" class="cls_014"><span class="cls_014">One RCT was identified that randomized 600 donor recipients to trans-</span></div>
<div style="position:absolute;left:45.35px;top:237.64px" class="cls_014"><span class="cls_014">mature i.e. metaphase II (MII) oocytes from women undergoing ART.</span></div>
<div style="position:absolute;left:314.64px;top:240.65px" class="cls_014"><span class="cls_014">fer of embryos either from fresh or vitrified/warmed oocytes (</span><span class="cls_019">Cobo</span></div>
<div style="position:absolute;left:45.35px;top:248.64px" class="cls_014"><span class="cls_014">Given the paucity of studies making direct comparisons between the two</span></div>
<div style="position:absolute;left:314.64px;top:251.65px" class="cls_019"><span class="cls_019">et  al.,</span></div>
<div style="position:absolute;left:340.16px;top:251.65px" class="cls_019"><span class="cls_019">2010</span><span class="cls_014">).  Characteristics  of  this  study  are  described  in  Table</span><span class="cls_019">  I</span><span class="cls_014">.</span></div>
<div style="position:absolute;left:45.35px;top:259.64px" class="cls_014"><span class="cls_014">cryopreservation methods, studies comparing slow-freeze or vitrification</span></div>
<div style="position:absolute;left:314.64px;top:262.65px" class="cls_014"><span class="cls_014">Ongoing clinical pregnancy at 10-11 weeks of gestation was reported;</span></div>
<div style="position:absolute;left:45.35px;top:270.64px" class="cls_014"><span class="cls_014">to fresh oocytes (control group) were also included. Only trials reported</span></div>
<div style="position:absolute;left:314.64px;top:273.64px" class="cls_014"><span class="cls_014">however, live-birth data were not reported.</span></div>
<div style="position:absolute;left:45.35px;top:281.64px" class="cls_014"><span class="cls_014">in peer-reviewed full publications involving MII oocyte cryopreservation</span></div>
<div style="position:absolute;left:323.15px;top:284.64px" class="cls_014"><span class="cls_014">Thirteen other studies were identified: five randomized sibling oocytes,</span></div>
<div style="position:absolute;left:45.35px;top:292.64px" class="cls_014"><span class="cls_014">were included; abstracts were excluded. Data from these studies were</span></div>
<div style="position:absolute;left:314.64px;top:295.64px" class="cls_014"><span class="cls_014">rather than patients, to vitrification versus fresh treatments (</span><span class="cls_019">Cobo et al.,</span></div>
<div style="position:absolute;left:45.35px;top:303.63px" class="cls_014"><span class="cls_014">used to assess the following outcomes: Clinical pregnancy rate (CPR),</span></div>
<div style="position:absolute;left:314.65px;top:306.64px" class="cls_019"><span class="cls_019">2008</span><span class="cls_014">;</span><span class="cls_019"> Rienzi et al.,</span></div>
<div style="position:absolute;left:386.59px;top:306.64px" class="cls_019"><span class="cls_019">2010</span><span class="cls_014">;</span><span class="cls_019"> Parmegiani et al.,</span></div>
<div style="position:absolute;left:475.09px;top:306.64px" class="cls_019"><span class="cls_019">2011</span><span class="cls_014">;</span><span class="cls_019"> Siano et al.,</span></div>
<div style="position:absolute;left:545.05px;top:306.64px" class="cls_019"><span class="cls_019">2013</span><span class="cls_014">;</span></div>
<div style="position:absolute;left:45.35px;top:314.63px" class="cls_014"><span class="cls_014">live-birth rate (LBR) and oocyte cryosurvival rate when reported.</span></div>
<div style="position:absolute;left:314.65px;top:317.64px" class="cls_019"><span class="cls_019">Forman et al., 2012</span><span class="cls_014">), and eight cohort studies (</span><span class="cls_019">Antinori et al., 2007</span><span class="cls_014">;</span><span class="cls_019"> Nagy</span></div>
<div style="position:absolute;left:314.64px;top:328.64px" class="cls_019"><span class="cls_019">et al., 2009</span><span class="cls_014">;</span><span class="cls_019"> Almodin et al., 2010</span><span class="cls_014">;</span><span class="cls_019"> Ubaldi et al., 2010</span><span class="cls_014">;</span><span class="cls_019"> Garcia et al., 2011</span><span class="cls_014">;</span></div>
<div style="position:absolute;left:314.65px;top:339.64px" class="cls_019"><span class="cls_019">Trokoudes et al., 2011</span><span class="cls_014">;</span><span class="cls_019"> Sole et al., 2013</span><span class="cls_014">;</span><span class="cls_019"> Doyle et al., 2016</span><span class="cls_014">). Three sibling</span></div>
<div style="position:absolute;left:45.35px;top:346.45px" class="cls_002"><span class="cls_002">Oocyte cryopreservation: study search</span></div>
<div style="position:absolute;left:314.64px;top:350.63px" class="cls_014"><span class="cls_014">oocyte RCTs (</span><span class="cls_019">Cobo et al., 2008</span><span class="cls_014">;</span><span class="cls_019"> Siano et al., 2013</span><span class="cls_014">;</span><span class="cls_019"> Forman et al., 2012</span><span class="cls_014">)</span></div>
<div style="position:absolute;left:45.35px;top:360.46px" class="cls_002"><span class="cls_002">methods</span></div>
<div style="position:absolute;left:314.64px;top:361.63px" class="cls_014"><span class="cls_014">and two cohort studies (</span><span class="cls_019">Nagy et al., 2009</span><span class="cls_014"> and</span><span class="cls_019"> Doyle et al., 2016</span><span class="cls_014">) were</span></div>
<div style="position:absolute;left:314.64px;top:372.63px" class="cls_014"><span class="cls_014">excluded from analysis due to study design (</span><span class="cls_019">Forman et al., 2012</span><span class="cls_014">) or data</span></div>
<div style="position:absolute;left:45.35px;top:377.96px" class="cls_014"><span class="cls_014">The searches for relevant studies were last performed and completed on 1</span></div>
<div style="position:absolute;left:314.64px;top:383.63px" class="cls_014"><span class="cls_014">reporting issues (</span><span class="cls_019">Cobo et al., 2008</span><span class="cls_014">;</span><span class="cls_019"> Nagy et al., 2009</span><span class="cls_014">;</span><span class="cls_019"> Siano et al., 2013</span><span class="cls_014">;</span></div>
<div style="position:absolute;left:45.35px;top:388.96px" class="cls_014"><span class="cls_014">August 2016 by two review authors (AL, RM) using the following search</span></div>
<div style="position:absolute;left:314.65px;top:394.63px" class="cls_019"><span class="cls_019">Doyle et al., 2016</span><span class="cls_014">).</span></div>
<div style="position:absolute;left:45.35px;top:399.96px" class="cls_014"><span class="cls_014">terms:</span></div>
<div style="position:absolute;left:71.21px;top:399.96px" class="cls_014"><span class="cls_014">(oocyte(s)</span></div>
<div style="position:absolute;left:109.81px;top:399.96px" class="cls_014"><span class="cls_014">[tiab]) AND (vitrification[tiab] OR freezing[tiab]  OR</span></div>
<div style="position:absolute;left:323.15px;top:405.63px" class="cls_014"><span class="cls_014">The remaining eight studies were grouped together for comparison of</span></div>
<div style="position:absolute;left:45.35px;top:410.95px" class="cls_014"><span class="cls_014">freeze[tiab]) AND (embryo quality[tiab] OR survival[tiab] OR pregnancy</span></div>
<div style="position:absolute;left:314.64px;top:416.62px" class="cls_014"><span class="cls_014">clinical outcomes following transfer of embryos arising from oocytes that</span></div>
<div style="position:absolute;left:45.35px;top:421.95px" class="cls_014"><span class="cls_014">[tiab] OR birth[tiab]). The search was limited to human studies. Articles</span></div>
<div style="position:absolute;left:314.64px;top:427.62px" class="cls_014"><span class="cls_014">were exclusively either vitrified or fresh. Five meta-analyses (</span><span class="cls_019">Oktay et al.,</span></div>
<div style="position:absolute;left:45.35px;top:432.95px" class="cls_014"><span class="cls_014">were also identified via snowball sampling by hand-searching references</span></div>
<div style="position:absolute;left:314.65px;top:438.62px" class="cls_019"><span class="cls_019">2006</span><span class="cls_014">;</span><span class="cls_019"> Cobo et al., 2011b</span><span class="cls_014">;</span><span class="cls_019"> Cil et al., 2013</span><span class="cls_014">;</span><span class="cls_019"> Glujovsky et al., 2014</span><span class="cls_014">;</span><span class="cls_019"> Potdar</span></div>
<div style="position:absolute;left:45.36px;top:443.95px" class="cls_014"><span class="cls_014">from systematic reviews. The search returned 806 records, of which 88</span></div>
<div style="position:absolute;left:314.64px;top:449.62px" class="cls_019"><span class="cls_019">et al., 2014</span><span class="cls_014">) focusing on oocyte cryopreservation were reviewed.</span></div>
<div style="position:absolute;left:45.36px;top:454.95px" class="cls_014"><span class="cls_014">were screened manually for relevance. The information about potentially</span></div>
<div style="position:absolute;left:45.36px;top:465.95px" class="cls_014"><span class="cls_014">eligible studies was reported in a table describing the characteristics of the</span></div>
<div style="position:absolute;left:45.36px;top:477.00px" class="cls_014"><span class="cls_014">studies for assessing the reliability of the results. Full texts of potentially eli-</span></div>
<div style="position:absolute;left:314.65px;top:480.99px" class="cls_002"><span class="cls_002">Embryo cryopreservation: study eligibility</span></div>
<div style="position:absolute;left:45.36px;top:488.00px" class="cls_014"><span class="cls_014">gible studies were obtained and examined independently by the two differ-</span></div>
<div style="position:absolute;left:45.36px;top:499.00px" class="cls_014"><span class="cls_014">ent  authors;  disagreements  as  to  study  eligibility  were  resolved  by</span></div>
<div style="position:absolute;left:314.65px;top:494.99px" class="cls_002"><span class="cls_002">criteria</span></div>
<div style="position:absolute;left:45.36px;top:509.99px" class="cls_014"><span class="cls_014">discussion (all authors). A total of 20 references were included (Fig.</span><span class="cls_019"> 1</span><span class="cls_014">a).</span></div>
<div style="position:absolute;left:314.65px;top:512.49px" class="cls_014"><span class="cls_014">RCTs and observational cohort studies were included that compared</span></div>
<div style="position:absolute;left:314.65px;top:523.49px" class="cls_014"><span class="cls_014">slow-freeze  to  vitrification  of  pronuclear  embryos,  cleavage-stage</span></div>
<div style="position:absolute;left:314.65px;top:534.49px" class="cls_014"><span class="cls_014">embryos  or  blastocysts  from  women  undergoing  ART.  Only  trials</span></div>
<div style="position:absolute;left:45.35px;top:541.82px" class="cls_002"><span class="cls_002">Oocyte cryopreservation: study descriptions</span></div>
<div style="position:absolute;left:314.65px;top:545.49px" class="cls_014"><span class="cls_014">reported in peer-reviewed full publications were included; abstracts were</span></div>
<div style="position:absolute;left:314.65px;top:556.48px" class="cls_014"><span class="cls_014">excluded. The following outcomes were assessed: CPR, LBR and embryo</span></div>
<div style="position:absolute;left:45.35px;top:560.83px" class="cls_013"><span class="cls_013">Slow-frozen versus vitrified oocytes: clinical outcomes and</span></div>
<div style="position:absolute;left:314.65px;top:567.48px" class="cls_014"><span class="cls_014">cryosurvival rate, when reported.</span></div>
<div style="position:absolute;left:45.35px;top:572.79px" class="cls_013"><span class="cls_013">cryosurvival</span></div>
<div style="position:absolute;left:45.35px;top:586.31px" class="cls_014"><span class="cls_014">One RCT was identified that randomized women to have an embryo</span></div>
<div style="position:absolute;left:45.35px;top:597.30px" class="cls_014"><span class="cls_014">transfer from MII oocytes that were either slow-frozen or vitrified (</span><span class="cls_019">Smith</span></div>
<div style="position:absolute;left:314.65px;top:598.79px" class="cls_002"><span class="cls_002">Embryo cryopreservation: study search</span></div>
<div style="position:absolute;left:45.35px;top:608.30px" class="cls_019"><span class="cls_019">et al., 2010</span><span class="cls_014">). Characteristics of this study are described in Table</span><span class="cls_019"> I</span><span class="cls_014">. A total</span></div>
<div style="position:absolute;left:314.65px;top:612.80px" class="cls_002"><span class="cls_002">methods</span></div>
<div style="position:absolute;left:45.35px;top:619.30px" class="cls_014"><span class="cls_014">of 230 patients with more than nine MII oocytes retrieved were allocated</span></div>
<div style="position:absolute;left:45.35px;top:630.30px" class="cls_014"><span class="cls_014">by random number generator to either slow-freezing or vitrification. This</span></div>
<div style="position:absolute;left:314.65px;top:630.30px" class="cls_014"><span class="cls_014">The searches for relevant studies were last performed and completed on</span></div>
<div style="position:absolute;left:45.35px;top:641.30px" class="cls_014"><span class="cls_014">results in 30 cases of oocyte thawing and 48 cases of warming (average</span></div>
<div style="position:absolute;left:314.65px;top:641.30px" class="cls_014"><span class="cls_014">August first 2016 using the following search terms: (Pronuclear[tiab] OR</span></div>
<div style="position:absolute;left:45.35px;top:652.30px" class="cls_014"><span class="cls_014">ages at oocyte retrieval: 32 ± 1 and 31 ± 1 years (mean + SD), respect-</span></div>
<div style="position:absolute;left:314.65px;top:652.30px" class="cls_014"><span class="cls_014">Embryo[tiab] OR Blastocyst[tiab]) AND (vitrification[tiab] OR freezing</span></div>
<div style="position:absolute;left:45.35px;top:663.29px" class="cls_014"><span class="cls_014">ively). LBRs were not reported. Ongoing CPRs were reported but not</span></div>
<div style="position:absolute;left:314.65px;top:663.29px" class="cls_014"><span class="cls_014">[tiab] OR freeze[tiab]) AND (pregnancy[tiab] OR birth[tiab] OR clinical</span></div>
<div style="position:absolute;left:45.35px;top:674.29px" class="cls_014"><span class="cls_014">defined by minimum gestational age.</span></div>
<div style="position:absolute;left:314.65px;top:674.29px" class="cls_014"><span class="cls_014">[tiab]). The search was limited to human studies. Articles were also iden-</span></div>
<div style="position:absolute;left:53.86px;top:685.29px" class="cls_014"><span class="cls_014">Two cohort studies were identified that compared CPRs from slow-</span></div>
<div style="position:absolute;left:314.65px;top:685.29px" class="cls_014"><span class="cls_014">tified by hand searching references from systematic reviews. The search</span></div>
<div style="position:absolute;left:45.35px;top:696.29px" class="cls_014"><span class="cls_014">frozen versus vitrified autologous oocytes (</span><span class="cls_019">Fadini et al., 2009</span><span class="cls_014">;</span><span class="cls_019"> Levi Setti</span></div>
<div style="position:absolute;left:314.65px;top:696.29px" class="cls_014"><span class="cls_014">returned 917 records, of which 587 were screened manually for rele-</span></div>
<div style="position:absolute;left:45.35px;top:707.29px" class="cls_019"><span class="cls_019">et al., 2014</span><span class="cls_014">). Oocyte cryopreservation was performed in these studies in</span></div>
<div style="position:absolute;left:314.65px;top:707.29px" class="cls_014"><span class="cls_014">vance. Full texts of potentially eligible studies were obtained and exam-</span></div>
<div style="position:absolute;left:45.35px;top:718.29px" class="cls_014"><span class="cls_014">an unselected population of infertile patients due to law restrictions (Law</span></div>
<div style="position:absolute;left:314.65px;top:718.29px" class="cls_014"><span class="cls_014">ined independently by two different authors (RM, DK); disagreements as</span></div>
<div style="position:absolute;left:45.35px;top:729.29px" class="cls_014"><span class="cls_014">40, 2004, Italy).</span></div>
<div style="position:absolute;left:314.65px;top:729.28px" class="cls_014"><span class="cls_014">to study eligibility were resolved by discussion (all Authors). A total of 20</span></div>
</div>
<div style="position:absolute;left:50%;margin-left:-306px;top:3200px;width:612px;height:790px;border-style:outset;overflow:hidden">
<div style="position:absolute;left:0px;top:0px">
<img src="fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_id_fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_files/background05.jpg" width=612 height=790></div>
<div style="position:absolute;left:48.19px;top:26.63px" class="cls_014"><span class="cls_014">Slow-freezing versus vitrification in ART</span></div>
<div style="position:absolute;left:550.66px;top:25.13px" class="cls_013"><span class="cls_013">143</span></div>
<div style="position:absolute;left:56.18px;top:526.68px" class="cls_020"><span class="cls_020">Figure 1</span><span class="cls_014"> Flow charts for a systematic review and meta-analysis comparing slow-freezing versus vitrification of oocytes, embryos and blastocysts in</span></div>
<div style="position:absolute;left:56.18px;top:538.17px" class="cls_014"><span class="cls_014">ART. (a) search for relevant studies for oocytes slow-freezing and vitrification (b) search for relevant studies for pronuclear, cleavage-stage embryo</span></div>
<div style="position:absolute;left:56.18px;top:549.17px" class="cls_014"><span class="cls_014">and blastocyst slow-freezing and vitrification.</span></div>
<div style="position:absolute;left:48.19px;top:596.96px" class="cls_014"><span class="cls_014">studies were included for this analysis, comparing outcomes following</span></div>
<div style="position:absolute;left:317.48px;top:596.96px" class="cls_014"><span class="cls_014">clinical outcomes were incomplete. Moreover, a meta-analysis (</span><span class="cls_019">AbdelHafez</span></div>
<div style="position:absolute;left:48.19px;top:607.96px" class="cls_014"><span class="cls_014">transfer of vitrified versus slow-frozen embryos (Fig.</span><span class="cls_019"> 1</span><span class="cls_014">b).</span></div>
<div style="position:absolute;left:317.48px;top:607.96px" class="cls_019"><span class="cls_019">et al.,</span></div>
<div style="position:absolute;left:341.18px;top:607.96px" class="cls_019"><span class="cls_019">2010</span><span class="cls_014">) focusing on clinical outcomes was reviewed. None of the</span></div>
<div style="position:absolute;left:317.48px;top:618.96px" class="cls_014"><span class="cls_014">included studies compared cryopreservation techniques at the pronuclear-</span></div>
<div style="position:absolute;left:317.48px;top:629.96px" class="cls_014"><span class="cls_014">stage. Two of the included RCTs were performed at the cleavage-stage</span></div>
<div style="position:absolute;left:317.48px;top:640.96px" class="cls_014"><span class="cls_014">(</span><span class="cls_019">Rama Raju et al., 2005</span><span class="cls_014">;</span><span class="cls_019"> Debrock et al., 2015</span><span class="cls_014">) and one at blastocyst stage</span></div>
<div style="position:absolute;left:48.19px;top:641.82px" class="cls_002"><span class="cls_002">Embryo cryopreservation: study descriptions</span></div>
<div style="position:absolute;left:317.48px;top:651.96px" class="cls_014"><span class="cls_014">(</span><span class="cls_019">Kim et al., 2000</span><span class="cls_014">). The primary outcome measures chosen were CPR</span></div>
<div style="position:absolute;left:48.19px;top:660.83px" class="cls_013"><span class="cls_013">Vitrified versus slow-frozen embryos: clinical outcomes</span></div>
<div style="position:absolute;left:317.48px;top:662.95px" class="cls_014"><span class="cls_014">and LBRs.</span></div>
<div style="position:absolute;left:48.19px;top:674.29px" class="cls_014"><span class="cls_014">Only one well-designed RCT comparing clinical outcomes following vitrifica-</span></div>
<div style="position:absolute;left:325.98px;top:673.95px" class="cls_014"><span class="cls_014">Eleven  observational  studies  reporting  clinical  pregnancy  per  cycle</span></div>
<div style="position:absolute;left:48.19px;top:685.29px" class="cls_014"><span class="cls_014">tion versus slow-freezing between randomized women rather than embryos</span></div>
<div style="position:absolute;left:317.48px;top:684.95px" class="cls_014"><span class="cls_014">and/or per transfer of embryos at different stages of development were</span></div>
<div style="position:absolute;left:48.19px;top:696.29px" class="cls_014"><span class="cls_014">was identified (</span><span class="cls_019">Debrock et al., 2015</span><span class="cls_014">). Two RCTs (</span><span class="cls_019">Rama Raju et al., 2005</span></div>
<div style="position:absolute;left:317.48px;top:695.95px" class="cls_014"><span class="cls_014">pooled and analyzed (</span><span class="cls_019">Kuwayama et al., 2005a</span><span class="cls_014">,</span><span class="cls_019">b</span><span class="cls_014">;</span><span class="cls_019"> Stehilk et al., 2005</span><span class="cls_014">;</span></div>
<div style="position:absolute;left:48.19px;top:707.29px" class="cls_014"><span class="cls_014">and</span><span class="cls_019"> Kim et al., 2000</span><span class="cls_014">) comparing clinical outcomes between randomized</span></div>
<div style="position:absolute;left:317.48px;top:706.95px" class="cls_019"><span class="cls_019">Liebermann and Tucker, 2006</span><span class="cls_014">;</span><span class="cls_019"> Rezazadeh Valojerdi et al., 2009</span><span class="cls_014">;</span><span class="cls_019"> Wilding</span></div>
<div style="position:absolute;left:48.19px;top:718.29px" class="cls_014"><span class="cls_014">embryos were also included. Characteristics of these studies are described</span></div>
<div style="position:absolute;left:317.48px;top:717.95px" class="cls_019"><span class="cls_019">et al., 2010</span><span class="cls_014">;</span><span class="cls_019"> Sifer et al., 2012</span><span class="cls_014">;</span><span class="cls_019"> Wang et al., 2012</span><span class="cls_014">;</span><span class="cls_019"> Van Landuyt et al., 2013</span></div>
<div style="position:absolute;left:48.19px;top:729.29px" class="cls_014"><span class="cls_014">in Table</span><span class="cls_019"> I</span><span class="cls_014">. One additional RCT (</span><span class="cls_019">Bernal et al., 2008</span><span class="cls_014">) was excluded because</span></div>
<div style="position:absolute;left:317.48px;top:729.00px" class="cls_014"><span class="cls_014">and</span><span class="cls_019">  Liu  et  al.,</span></div>
<div style="position:absolute;left:375.14px;top:729.00px" class="cls_019"><span class="cls_019">2013</span><span class="cls_014">;</span><span class="cls_019">  Zhu  et  al.,</span></div>
<div style="position:absolute;left:443.57px;top:729.00px" class="cls_019"><span class="cls_019">2015</span><span class="cls_014">;</span><span class="cls_019">  Kaartinen  et  al.,</span></div>
<div style="position:absolute;left:530.36px;top:729.00px" class="cls_019"><span class="cls_019">2016</span><span class="cls_014">).  An</span></div>
</div>
<div style="position:absolute;left:50%;margin-left:-395px;top:4000px;width:790px;height:612px;border-style:outset;overflow:hidden">
<div style="position:absolute;left:0px;top:0px">
<img src="fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_id_fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_files/background06.jpg" width=790 height=612></div>
<div style="position:absolute;left:62.65px;top:50.75px" class="cls_020"><span class="cls_020">Table I</span><span class="cls_011"> Characteristics of the included RCTs comparing reproductive outcomes of slow-freezing versus vitrification.</span></div>
<div style="position:absolute;left:59.64px;top:72.22px" class="cls_003"><span class="cls_003">Authors</span></div>
<div style="position:absolute;left:106.36px;top:72.22px" class="cls_003"><span class="cls_003">Location  Study design   Cryopreservation protocols</span></div>
<div style="position:absolute;left:316.52px;top:72.22px" class="cls_003"><span class="cls_003">Study</span></div>
<div style="position:absolute;left:357.22px;top:72.22px" class="cls_003"><span class="cls_003">N°</span></div>
<div style="position:absolute;left:390.84px;top:72.22px" class="cls_003"><span class="cls_003">Control    N°</span></div>
<div style="position:absolute;left:465.84px;top:72.22px" class="cls_003"><span class="cls_003">Outcomes    Risk of bias</span></div>
<div style="position:absolute;left:655.06px;top:72.22px" class="cls_003"><span class="cls_003">Journal: Impact</span></div>
<div style="position:absolute;left:59.64px;top:82.25px" class="cls_003"><span class="cls_003">(year)</span></div>
<div style="position:absolute;left:316.52px;top:82.25px" class="cls_003"><span class="cls_003">group</span></div>
<div style="position:absolute;left:390.84px;top:82.25px" class="cls_003"><span class="cls_003">group</span></div>
<div style="position:absolute;left:655.08px;top:82.25px" class="cls_003"><span class="cls_003">factor</span></div>
<div style="position:absolute;left:63.89px;top:98.81px" class="cls_022"><span class="cls_022">Balaban</span></div>
<div style="position:absolute;left:106.36px;top:98.81px" class="cls_003"><span class="cls_003">Turkey</span></div>
<div style="position:absolute;left:144.57px;top:98.81px" class="cls_003"><span class="cls_003">Randomization</span></div>
<div style="position:absolute;left:199.96px;top:98.81px" class="cls_003"><span class="cls_003">Vitrification 16%PrOH + 16%</span></div>
<div style="position:absolute;left:316.52px;top:98.81px" class="cls_003"><span class="cls_003">Cleavage</span></div>
<div style="position:absolute;left:357.22px;top:98.81px" class="cls_003"><span class="cls_003">234</span></div>
<div style="position:absolute;left:390.84px;top:98.81px" class="cls_003"><span class="cls_003">Cleavage</span></div>
<div style="position:absolute;left:432.28px;top:98.81px" class="cls_003"><span class="cls_003">232</span></div>
<div style="position:absolute;left:465.84px;top:98.81px" class="cls_003"><span class="cls_003">cryosurvival</span></div>
<div style="position:absolute;left:517.21px;top:98.81px" class="cls_003"><span class="cls_003">Serious risk of bias due to randomization</span></div>
<div style="position:absolute;left:655.08px;top:98.81px" class="cls_003"><span class="cls_003">Human</span></div>
<div style="position:absolute;left:63.89px;top:108.79px" class="cls_022"><span class="cls_022">et al.</span></div>
<div style="position:absolute;left:144.57px;top:108.79px" class="cls_003"><span class="cls_003">of embryos</span></div>
<div style="position:absolute;left:199.96px;top:108.79px" class="cls_003"><span class="cls_003">EG + 0.65 M sucrose + 10 mg/ml</span></div>
<div style="position:absolute;left:316.52px;top:108.79px" class="cls_003"><span class="cls_003">stage</span></div>
<div style="position:absolute;left:357.22px;top:108.79px" class="cls_003"><span class="cls_003">embryos</span></div>
<div style="position:absolute;left:390.84px;top:108.79px" class="cls_003"><span class="cls_003">stage slow-</span></div>
<div style="position:absolute;left:432.28px;top:108.79px" class="cls_003"><span class="cls_003">embryos</span></div>
<div style="position:absolute;left:465.84px;top:108.79px" class="cls_003"><span class="cls_003">rate,</span></div>
<div style="position:absolute;left:517.21px;top:108.79px" class="cls_003"><span class="cls_003">method, concealment of allocation,</span></div>
<div style="position:absolute;left:655.08px;top:108.79px" class="cls_003"><span class="cls_003">Reproduction:</span></div>
<div style="position:absolute;left:63.89px;top:118.82px" class="cls_022"><span class="cls_022">(2008)</span></div>
<div style="position:absolute;left:199.96px;top:118.82px" class="cls_003"><span class="cls_003">Ficoll- open system</span></div>
<div style="position:absolute;left:316.52px;top:118.82px" class="cls_003"><span class="cls_003">vitrification</span></div>
<div style="position:absolute;left:390.84px;top:118.82px" class="cls_003"><span class="cls_003">freezing</span></div>
<div style="position:absolute;left:465.84px;top:118.82px" class="cls_003"><span class="cls_003">blastocyct</span></div>
<div style="position:absolute;left:517.21px;top:118.82px" class="cls_003"><span class="cls_003">blinding</span></div>
<div style="position:absolute;left:655.08px;top:118.82px" class="cls_003"><span class="cls_003">4.621</span></div>
<div style="position:absolute;left:199.96px;top:128.80px" class="cls_003"><span class="cls_003">Slow-freezing: 1.5 M PROH-0.1 M</span></div>
<div style="position:absolute;left:465.84px;top:128.80px" class="cls_003"><span class="cls_003">formation</span></div>
<div style="position:absolute;left:199.96px;top:138.84px" class="cls_003"><span class="cls_003">Sucrose</span></div>
<div style="position:absolute;left:63.89px;top:151.82px" class="cls_022"><span class="cls_022">Cao et al.</span></div>
<div style="position:absolute;left:106.36px;top:151.82px" class="cls_003"><span class="cls_003">China</span></div>
<div style="position:absolute;left:144.57px;top:151.82px" class="cls_003"><span class="cls_003">Randomization</span></div>
<div style="position:absolute;left:199.96px;top:151.82px" class="cls_003"><span class="cls_003">Vitrification 15% EG + 15%</span></div>
<div style="position:absolute;left:316.52px;top:151.82px" class="cls_003"><span class="cls_003">Oocyte</span></div>
<div style="position:absolute;left:357.22px;top:151.82px" class="cls_003"><span class="cls_003">292</span></div>
<div style="position:absolute;left:390.84px;top:151.82px" class="cls_003"><span class="cls_003">Oocyte</span></div>
<div style="position:absolute;left:432.28px;top:151.82px" class="cls_003"><span class="cls_003">123</span></div>
<div style="position:absolute;left:465.84px;top:151.82px" class="cls_003"><span class="cls_003">cryosurvival</span></div>
<div style="position:absolute;left:517.21px;top:151.82px" class="cls_003"><span class="cls_003">Serious risk of bias due to randomization</span></div>
<div style="position:absolute;left:655.08px;top:151.82px" class="cls_003"><span class="cls_003">Seminars in</span></div>
<div style="position:absolute;left:63.89px;top:161.80px" class="cls_022"><span class="cls_022">(2009)</span></div>
<div style="position:absolute;left:144.57px;top:161.80px" class="cls_003"><span class="cls_003">of sibling</span></div>
<div style="position:absolute;left:199.96px;top:161.80px" class="cls_003"><span class="cls_003">PROH + 0.5 M sucrose - open</span></div>
<div style="position:absolute;left:316.52px;top:161.80px" class="cls_003"><span class="cls_003">vitrificaiton</span></div>
<div style="position:absolute;left:357.22px;top:161.80px" class="cls_003"><span class="cls_003">oocytes</span></div>
<div style="position:absolute;left:390.84px;top:161.80px" class="cls_003"><span class="cls_003">slow-</span></div>
<div style="position:absolute;left:432.28px;top:161.80px" class="cls_003"><span class="cls_003">oocytes</span></div>
<div style="position:absolute;left:465.84px;top:161.80px" class="cls_003"><span class="cls_003">rate</span></div>
<div style="position:absolute;left:517.21px;top:161.80px" class="cls_003"><span class="cls_003">method, concealment of allocation,</span></div>
<div style="position:absolute;left:655.08px;top:161.80px" class="cls_003"><span class="cls_003">Reproductive</span></div>
<div style="position:absolute;left:144.57px;top:171.77px" class="cls_003"><span class="cls_003">oocytes</span></div>
<div style="position:absolute;left:199.96px;top:171.77px" class="cls_003"><span class="cls_003">system</span></div>
<div style="position:absolute;left:390.84px;top:171.78px" class="cls_003"><span class="cls_003">freezing</span></div>
<div style="position:absolute;left:517.21px;top:171.78px" class="cls_003"><span class="cls_003">blinding</span></div>
<div style="position:absolute;left:655.08px;top:171.78px" class="cls_003"><span class="cls_003">Medicine: 2.113</span></div>
<div style="position:absolute;left:199.96px;top:181.81px" class="cls_003"><span class="cls_003">Slow-freezing: 1.5 M</span></div>
<div style="position:absolute;left:199.96px;top:191.79px" class="cls_003"><span class="cls_003">PROH + 0.3 M sucrose</span></div>
<div style="position:absolute;left:63.89px;top:204.77px" class="cls_022"><span class="cls_022">Cobo et al.</span></div>
<div style="position:absolute;left:106.36px;top:204.77px" class="cls_003"><span class="cls_003">Spain</span></div>
<div style="position:absolute;left:144.57px;top:204.77px" class="cls_003"><span class="cls_003">Randomization</span></div>
<div style="position:absolute;left:199.96px;top:204.77px" class="cls_003"><span class="cls_003">Vitrification 15% EG + 15%</span></div>
<div style="position:absolute;left:316.52px;top:204.77px" class="cls_003"><span class="cls_003">Oocyte</span></div>
<div style="position:absolute;left:357.22px;top:204.77px" class="cls_003"><span class="cls_003">295</span></div>
<div style="position:absolute;left:390.84px;top:204.77px" class="cls_003"><span class="cls_003">Oocyte</span></div>
<div style="position:absolute;left:432.28px;top:204.77px" class="cls_003"><span class="cls_003">289</span></div>
<div style="position:absolute;left:465.84px;top:204.77px" class="cls_003"><span class="cls_003">CPR,</span></div>
<div style="position:absolute;left:517.21px;top:204.77px" class="cls_003"><span class="cls_003">No serious risk of bias</span></div>
<div style="position:absolute;left:655.08px;top:204.77px" class="cls_003"><span class="cls_003">Human</span></div>
<div style="position:absolute;left:63.89px;top:214.80px" class="cls_022"><span class="cls_022">(2010)</span></div>
<div style="position:absolute;left:144.57px;top:214.80px" class="cls_003"><span class="cls_003">of patients</span></div>
<div style="position:absolute;left:199.96px;top:214.80px" class="cls_003"><span class="cls_003">DMSO + 0.5 M sucrose - open</span></div>
<div style="position:absolute;left:316.52px;top:214.80px" class="cls_003"><span class="cls_003">vitrification</span></div>
<div style="position:absolute;left:357.22px;top:214.80px" class="cls_003"><span class="cls_003">cycles</span></div>
<div style="position:absolute;left:390.84px;top:214.80px" class="cls_003"><span class="cls_003">fresh</span></div>
<div style="position:absolute;left:432.28px;top:214.80px" class="cls_003"><span class="cls_003">cycles</span></div>
<div style="position:absolute;left:465.84px;top:214.80px" class="cls_003"><span class="cls_003">cryosurvival</span></div>
<div style="position:absolute;left:655.08px;top:214.80px" class="cls_003"><span class="cls_003">Reproduction:</span></div>
<div style="position:absolute;left:199.96px;top:224.78px" class="cls_003"><span class="cls_003">system</span></div>
<div style="position:absolute;left:465.84px;top:224.78px" class="cls_003"><span class="cls_003">rate</span></div>
<div style="position:absolute;left:655.08px;top:224.78px" class="cls_003"><span class="cls_003">4.621</span></div>
<div style="position:absolute;left:63.89px;top:237.76px" class="cls_022"><span class="cls_022">Debrock</span></div>
<div style="position:absolute;left:106.36px;top:237.76px" class="cls_003"><span class="cls_003">Belgium</span></div>
<div style="position:absolute;left:144.57px;top:237.76px" class="cls_003"><span class="cls_003">Randomization</span></div>
<div style="position:absolute;left:199.96px;top:237.76px" class="cls_003"><span class="cls_003">Vitrification 15% EG + 15%</span></div>
<div style="position:absolute;left:316.52px;top:237.76px" class="cls_003"><span class="cls_003">Cleavage</span></div>
<div style="position:absolute;left:357.22px;top:237.76px" class="cls_003"><span class="cls_003">121</span></div>
<div style="position:absolute;left:390.84px;top:237.76px" class="cls_003"><span class="cls_003">Cleavage</span></div>
<div style="position:absolute;left:432.28px;top:237.76px" class="cls_003"><span class="cls_003">85</span></div>
<div style="position:absolute;left:465.84px;top:237.76px" class="cls_003"><span class="cls_003">CPR, LBR,</span></div>
<div style="position:absolute;left:517.21px;top:237.76px" class="cls_003"><span class="cls_003">No serious risk of bias</span></div>
<div style="position:absolute;left:655.08px;top:237.76px" class="cls_003"><span class="cls_003">Human</span></div>
<div style="position:absolute;left:63.89px;top:247.80px" class="cls_022"><span class="cls_022">et al.</span></div>
<div style="position:absolute;left:144.57px;top:247.80px" class="cls_003"><span class="cls_003">of patients</span></div>
<div style="position:absolute;left:199.96px;top:247.80px" class="cls_003"><span class="cls_003">DMSO + 0.5 M sucrose - closed</span></div>
<div style="position:absolute;left:316.52px;top:247.80px" class="cls_003"><span class="cls_003">stage</span></div>
<div style="position:absolute;left:357.22px;top:247.80px" class="cls_003"><span class="cls_003">cycles</span></div>
<div style="position:absolute;left:390.84px;top:247.80px" class="cls_003"><span class="cls_003">stage slow-</span></div>
<div style="position:absolute;left:432.28px;top:247.80px" class="cls_003"><span class="cls_003">cycles</span></div>
<div style="position:absolute;left:465.84px;top:247.80px" class="cls_003"><span class="cls_003">cryosurvival</span></div>
<div style="position:absolute;left:655.08px;top:247.80px" class="cls_003"><span class="cls_003">Reproduction:</span></div>
<div style="position:absolute;left:63.89px;top:257.78px" class="cls_022"><span class="cls_022">(2015)</span></div>
<div style="position:absolute;left:199.96px;top:257.78px" class="cls_003"><span class="cls_003">system</span></div>
<div style="position:absolute;left:316.52px;top:257.78px" class="cls_003"><span class="cls_003">vitrification</span></div>
<div style="position:absolute;left:390.84px;top:257.78px" class="cls_003"><span class="cls_003">freezing</span></div>
<div style="position:absolute;left:432.28px;top:257.78px" class="cls_003"><span class="cls_003">200</span></div>
<div style="position:absolute;left:465.84px;top:257.78px" class="cls_003"><span class="cls_003">rate</span></div>
<div style="position:absolute;left:655.08px;top:257.78px" class="cls_003"><span class="cls_003">4.621</span></div>
<div style="position:absolute;left:199.96px;top:267.75px" class="cls_003"><span class="cls_003">Slow-freezing: 1.5 M PROH −</span></div>
<div style="position:absolute;left:357.22px;top:267.75px" class="cls_003"><span class="cls_003">217</span></div>
<div style="position:absolute;left:432.28px;top:267.75px" class="cls_003"><span class="cls_003">embryos</span></div>
<div style="position:absolute;left:199.96px;top:277.79px" class="cls_003"><span class="cls_003">0.1 M Sucrose</span></div>
<div style="position:absolute;left:357.22px;top:277.79px" class="cls_003"><span class="cls_003">embryos</span></div>
<div style="position:absolute;left:63.89px;top:290.77px" class="cls_022"><span class="cls_022">Fasano</span></div>
<div style="position:absolute;left:106.36px;top:290.77px" class="cls_003"><span class="cls_003">Belgium</span></div>
<div style="position:absolute;left:144.57px;top:290.77px" class="cls_003"><span class="cls_003">Randomization</span></div>
<div style="position:absolute;left:199.96px;top:290.77px" class="cls_003"><span class="cls_003">Vitrification 20% EG + 15%</span></div>
<div style="position:absolute;left:316.52px;top:290.77px" class="cls_003"><span class="cls_003">Cleavage</span></div>
<div style="position:absolute;left:357.22px;top:290.77px" class="cls_003"><span class="cls_003">516</span></div>
<div style="position:absolute;left:390.84px;top:290.77px" class="cls_003"><span class="cls_003">Cleavage</span></div>
<div style="position:absolute;left:432.28px;top:290.77px" class="cls_003"><span class="cls_003">260</span></div>
<div style="position:absolute;left:465.84px;top:290.77px" class="cls_003"><span class="cls_003">CPR, LBR,</span></div>
<div style="position:absolute;left:517.21px;top:290.77px" class="cls_003"><span class="cls_003">Serious risk of bias due to randomization</span></div>
<div style="position:absolute;left:655.08px;top:290.77px" class="cls_003"><span class="cls_003">Journal of Assisted</span></div>
<div style="position:absolute;left:63.89px;top:300.75px" class="cls_022"><span class="cls_022">et al.</span></div>
<div style="position:absolute;left:144.57px;top:300.75px" class="cls_003"><span class="cls_003">of embryos</span></div>
<div style="position:absolute;left:199.96px;top:300.75px" class="cls_003"><span class="cls_003">DMSO + 0.5 M sucrose - closed</span></div>
<div style="position:absolute;left:316.52px;top:300.75px" class="cls_003"><span class="cls_003">stage</span></div>
<div style="position:absolute;left:357.22px;top:300.75px" class="cls_003"><span class="cls_003">cycles</span></div>
<div style="position:absolute;left:390.84px;top:300.75px" class="cls_003"><span class="cls_003">stage slow-</span></div>
<div style="position:absolute;left:432.28px;top:300.75px" class="cls_003"><span class="cls_003">cycles</span></div>
<div style="position:absolute;left:465.84px;top:300.75px" class="cls_003"><span class="cls_003">cryosurvival</span></div>
<div style="position:absolute;left:517.21px;top:300.75px" class="cls_003"><span class="cls_003">method, concealment of allocation, and</span></div>
<div style="position:absolute;left:655.08px;top:300.75px" class="cls_003"><span class="cls_003">Reproduction and</span></div>
<div style="position:absolute;left:63.89px;top:310.78px" class="cls_022"><span class="cls_022">(2014)</span></div>
<div style="position:absolute;left:199.96px;top:310.78px" class="cls_003"><span class="cls_003">system</span></div>
<div style="position:absolute;left:316.52px;top:310.78px" class="cls_003"><span class="cls_003">vitrification</span></div>
<div style="position:absolute;left:357.22px;top:310.78px" class="cls_003"><span class="cls_003">660</span></div>
<div style="position:absolute;left:390.84px;top:310.78px" class="cls_003"><span class="cls_003">freezing</span></div>
<div style="position:absolute;left:432.28px;top:310.78px" class="cls_003"><span class="cls_003">395</span></div>
<div style="position:absolute;left:465.84px;top:310.78px" class="cls_003"><span class="cls_003">rate</span></div>
<div style="position:absolute;left:517.21px;top:310.78px" class="cls_003"><span class="cls_003">blinding</span></div>
<div style="position:absolute;left:655.08px;top:310.78px" class="cls_003"><span class="cls_003">Genetics: 1.772</span></div>
<div style="position:absolute;left:199.95px;top:320.76px" class="cls_003"><span class="cls_003">Slow-freezing: 1.5 M PROH −</span></div>
<div style="position:absolute;left:357.22px;top:320.76px" class="cls_003"><span class="cls_003">embryos</span></div>
<div style="position:absolute;left:432.28px;top:320.76px" class="cls_003"><span class="cls_003">embryos</span></div>
<div style="position:absolute;left:199.95px;top:330.74px" class="cls_003"><span class="cls_003">0.1 M Sucrose</span></div>
<div style="position:absolute;left:63.89px;top:343.78px" class="cls_022"><span class="cls_022">Huang</span></div>
<div style="position:absolute;left:106.36px;top:343.78px" class="cls_003"><span class="cls_003">Taiwan</span></div>
<div style="position:absolute;left:144.60px;top:343.78px" class="cls_003"><span class="cls_003">Randomization</span></div>
<div style="position:absolute;left:199.96px;top:343.78px" class="cls_003"><span class="cls_003">Vitrification 20% EG + 20%</span></div>
<div style="position:absolute;left:316.52px;top:343.78px" class="cls_003"><span class="cls_003">Blastocyst</span></div>
<div style="position:absolute;left:357.22px;top:343.78px" class="cls_003"><span class="cls_003">81</span></div>
<div style="position:absolute;left:390.84px;top:343.78px" class="cls_003"><span class="cls_003">Blastocyst</span></div>
<div style="position:absolute;left:432.28px;top:343.78px" class="cls_003"><span class="cls_003">72</span></div>
<div style="position:absolute;left:465.85px;top:343.78px" class="cls_003"><span class="cls_003">cryosurvial</span></div>
<div style="position:absolute;left:517.21px;top:343.78px" class="cls_003"><span class="cls_003">Serious risk of bias due to randomization</span></div>
<div style="position:absolute;left:655.09px;top:343.78px" class="cls_003"><span class="cls_003">Human</span></div>
<div style="position:absolute;left:63.89px;top:353.76px" class="cls_022"><span class="cls_022">et al.</span></div>
<div style="position:absolute;left:144.57px;top:353.76px" class="cls_003"><span class="cls_003">of embryos</span></div>
<div style="position:absolute;left:199.96px;top:353.76px" class="cls_003"><span class="cls_003">DMSO and 0.5 M sucrose - open</span></div>
<div style="position:absolute;left:316.52px;top:353.76px" class="cls_003"><span class="cls_003">vitrification</span></div>
<div style="position:absolute;left:357.22px;top:353.76px" class="cls_003"><span class="cls_003">embryos</span></div>
<div style="position:absolute;left:390.84px;top:353.76px" class="cls_003"><span class="cls_003">slow-</span></div>
<div style="position:absolute;left:432.28px;top:353.76px" class="cls_003"><span class="cls_003">embryos</span></div>
<div style="position:absolute;left:465.85px;top:353.76px" class="cls_003"><span class="cls_003">rate</span></div>
<div style="position:absolute;left:517.21px;top:353.76px" class="cls_003"><span class="cls_003">method, concealment of allocation,</span></div>
<div style="position:absolute;left:655.09px;top:353.76px" class="cls_003"><span class="cls_003">Reproduction:</span></div>
<div style="position:absolute;left:63.89px;top:363.74px" class="cls_022"><span class="cls_022">(2005)</span></div>
<div style="position:absolute;left:199.96px;top:363.74px" class="cls_003"><span class="cls_003">system</span></div>
<div style="position:absolute;left:390.84px;top:363.74px" class="cls_003"><span class="cls_003">freezing</span></div>
<div style="position:absolute;left:517.21px;top:363.74px" class="cls_003"><span class="cls_003">blinding</span></div>
<div style="position:absolute;left:655.09px;top:363.74px" class="cls_003"><span class="cls_003">4.621</span></div>
<div style="position:absolute;left:199.96px;top:373.77px" class="cls_003"><span class="cls_003">Slow-freezing: 5% glycerol + 9%</span></div>
<div style="position:absolute;left:199.96px;top:383.75px" class="cls_003"><span class="cls_003">glycerol 0.2 M sucrose</span></div>
<div style="position:absolute;left:63.89px;top:396.73px" class="cls_022"><span class="cls_022">Kim et al.</span></div>
<div style="position:absolute;left:106.36px;top:396.73px" class="cls_003"><span class="cls_003">USA</span></div>
<div style="position:absolute;left:144.57px;top:396.73px" class="cls_003"><span class="cls_003">Randomization</span></div>
<div style="position:absolute;left:199.96px;top:396.73px" class="cls_003"><span class="cls_003">Vitrification 5.5 M EG + 1 M</span></div>
<div style="position:absolute;left:316.52px;top:396.73px" class="cls_003"><span class="cls_003">Blastocyst</span></div>
<div style="position:absolute;left:357.22px;top:396.73px" class="cls_003"><span class="cls_003">42</span></div>
<div style="position:absolute;left:390.84px;top:396.73px" class="cls_003"><span class="cls_003">Blastocyst</span></div>
<div style="position:absolute;left:432.28px;top:396.73px" class="cls_003"><span class="cls_003">216</span></div>
<div style="position:absolute;left:465.85px;top:396.73px" class="cls_003"><span class="cls_003">CPR,</span></div>
<div style="position:absolute;left:517.21px;top:396.73px" class="cls_003"><span class="cls_003">Unclear risk of bias related to random</span></div>
<div style="position:absolute;left:655.09px;top:396.73px" class="cls_003"><span class="cls_003">Fertility and</span></div>
<div style="position:absolute;left:63.89px;top:406.76px" class="cls_022"><span class="cls_022">(2000)</span></div>
<div style="position:absolute;left:144.57px;top:406.76px" class="cls_003"><span class="cls_003">of embryos</span></div>
<div style="position:absolute;left:199.96px;top:406.76px" class="cls_003"><span class="cls_003">sucrose</span></div>
<div style="position:absolute;left:316.52px;top:406.76px" class="cls_003"><span class="cls_003">vitrification</span></div>
<div style="position:absolute;left:357.22px;top:406.76px" class="cls_003"><span class="cls_003">cycles</span></div>
<div style="position:absolute;left:390.84px;top:406.76px" class="cls_003"><span class="cls_003">slow-</span></div>
<div style="position:absolute;left:432.28px;top:406.76px" class="cls_003"><span class="cls_003">cycles</span></div>
<div style="position:absolute;left:465.85px;top:406.76px" class="cls_003"><span class="cls_003">cryosurvival</span></div>
<div style="position:absolute;left:517.21px;top:406.76px" class="cls_003"><span class="cls_003">sequence generation, allocation of</span></div>
<div style="position:absolute;left:655.09px;top:406.76px" class="cls_003"><span class="cls_003">Sterility: 4.426</span></div>
<div style="position:absolute;left:199.96px;top:416.74px" class="cls_003"><span class="cls_003">Slow freezing: 5% glycerol and 9%</span></div>
<div style="position:absolute;left:357.22px;top:416.74px" class="cls_003"><span class="cls_003">141</span></div>
<div style="position:absolute;left:390.84px;top:416.74px" class="cls_003"><span class="cls_003">freezing</span></div>
<div style="position:absolute;left:432.28px;top:416.74px" class="cls_003"><span class="cls_003">790</span></div>
<div style="position:absolute;left:465.85px;top:416.74px" class="cls_003"><span class="cls_003">rate</span></div>
<div style="position:absolute;left:517.21px;top:416.74px" class="cls_003"><span class="cls_003">concealment acceptable, and blinding</span></div>
<div style="position:absolute;left:199.96px;top:426.72px" class="cls_003"><span class="cls_003">glycerol + 0.2 M sucrose</span></div>
<div style="position:absolute;left:357.22px;top:426.72px" class="cls_003"><span class="cls_003">embryos</span></div>
<div style="position:absolute;left:432.28px;top:426.72px" class="cls_003"><span class="cls_003">embryos</span></div>
<div style="position:absolute;left:63.89px;top:439.76px" class="cls_022"><span class="cls_022">Paffoni</span></div>
<div style="position:absolute;left:106.36px;top:439.76px" class="cls_003"><span class="cls_003">Italy</span></div>
<div style="position:absolute;left:144.57px;top:439.76px" class="cls_003"><span class="cls_003">Randomization</span></div>
<div style="position:absolute;left:199.96px;top:439.76px" class="cls_003"><span class="cls_003">Vitrification 15% DMSO, 15% EG,</span></div>
<div style="position:absolute;left:316.52px;top:439.76px" class="cls_003"><span class="cls_003">Oocyte</span></div>
<div style="position:absolute;left:357.22px;top:439.76px" class="cls_003"><span class="cls_003">90</span></div>
<div style="position:absolute;left:390.84px;top:439.76px" class="cls_003"><span class="cls_003">Oocyte</span></div>
<div style="position:absolute;left:432.28px;top:439.76px" class="cls_003"><span class="cls_003">90</span></div>
<div style="position:absolute;left:465.85px;top:439.76px" class="cls_003"><span class="cls_003">Cryosurvival</span></div>
<div style="position:absolute;left:517.21px;top:439.76px" class="cls_003"><span class="cls_003">Serious risk of bias due to randomization</span></div>
<div style="position:absolute;left:655.09px;top:439.76px" class="cls_003"><span class="cls_003">Reproductive</span></div>
<div style="position:absolute;left:63.89px;top:449.74px" class="cls_022"><span class="cls_022">et al.</span></div>
<div style="position:absolute;left:144.57px;top:449.74px" class="cls_003"><span class="cls_003">of sibling</span></div>
<div style="position:absolute;left:199.96px;top:449.74px" class="cls_003"><span class="cls_003">and 0.5 M sucrose - closed</span></div>
<div style="position:absolute;left:316.52px;top:449.74px" class="cls_003"><span class="cls_003">vitrification</span></div>
<div style="position:absolute;left:357.22px;top:449.74px" class="cls_003"><span class="cls_003">oocytes</span></div>
<div style="position:absolute;left:390.84px;top:449.74px" class="cls_003"><span class="cls_003">slow-</span></div>
<div style="position:absolute;left:432.28px;top:449.74px" class="cls_003"><span class="cls_003">oocytes</span></div>
<div style="position:absolute;left:465.85px;top:449.74px" class="cls_003"><span class="cls_003">rate</span></div>
<div style="position:absolute;left:517.21px;top:449.74px" class="cls_003"><span class="cls_003">method, concealment of allocation,</span></div>
<div style="position:absolute;left:655.09px;top:449.74px" class="cls_003"><span class="cls_003">Sciences: 2.429</span></div>
<div style="position:absolute;left:63.89px;top:459.72px" class="cls_022"><span class="cls_022">(2008)</span></div>
<div style="position:absolute;left:144.57px;top:459.72px" class="cls_003"><span class="cls_003">oocytes</span></div>
<div style="position:absolute;left:199.96px;top:459.72px" class="cls_003"><span class="cls_003">system</span></div>
<div style="position:absolute;left:390.84px;top:459.72px" class="cls_003"><span class="cls_003">freezing</span></div>
<div style="position:absolute;left:517.21px;top:459.72px" class="cls_003"><span class="cls_003">blinding</span></div>
<div style="position:absolute;left:199.96px;top:469.75px" class="cls_003"><span class="cls_003">Slow freezing: 1.5 mol/L PROH</span></div>
<div style="position:absolute;left:199.96px;top:479.73px" class="cls_003"><span class="cls_003">and 0.3 mol/L sucrose</span></div>
<div style="position:absolute;left:63.89px;top:492.71px" class="cls_022"><span class="cls_022">Parmegiani</span></div>
<div style="position:absolute;left:106.36px;top:492.71px" class="cls_003"><span class="cls_003">Italy</span></div>
<div style="position:absolute;left:144.57px;top:492.71px" class="cls_003"><span class="cls_003">Randomization</span></div>
<div style="position:absolute;left:199.96px;top:492.71px" class="cls_003"><span class="cls_003">Vitrification 15% EG + 15%</span></div>
<div style="position:absolute;left:316.52px;top:492.71px" class="cls_003"><span class="cls_003">Oocyte</span></div>
<div style="position:absolute;left:357.22px;top:492.71px" class="cls_003"><span class="cls_003">168</span></div>
<div style="position:absolute;left:390.84px;top:492.71px" class="cls_003"><span class="cls_003">Oocyte</span></div>
<div style="position:absolute;left:432.28px;top:492.71px" class="cls_003"><span class="cls_003">120</span></div>
<div style="position:absolute;left:465.84px;top:492.71px" class="cls_003"><span class="cls_003">Cryosurvival</span></div>
<div style="position:absolute;left:517.21px;top:492.71px" class="cls_003"><span class="cls_003">Serious risk of bias due to randomization</span></div>
<div style="position:absolute;left:655.08px;top:492.71px" class="cls_003"><span class="cls_003">RBM online:2.796</span></div>
<div style="position:absolute;left:63.89px;top:502.75px" class="cls_022"><span class="cls_022">et al.</span></div>
<div style="position:absolute;left:144.57px;top:502.75px" class="cls_003"><span class="cls_003">of sibling</span></div>
<div style="position:absolute;left:199.96px;top:502.75px" class="cls_003"><span class="cls_003">DMSO + 0.5 M sucrose - open</span></div>
<div style="position:absolute;left:316.52px;top:502.74px" class="cls_003"><span class="cls_003">vitrification</span></div>
<div style="position:absolute;left:357.22px;top:502.74px" class="cls_003"><span class="cls_003">oocytes</span></div>
<div style="position:absolute;left:390.84px;top:502.74px" class="cls_003"><span class="cls_003">Fresh</span></div>
<div style="position:absolute;left:432.28px;top:502.74px" class="cls_003"><span class="cls_003">oocytes</span></div>
<div style="position:absolute;left:465.84px;top:502.74px" class="cls_003"><span class="cls_003">rate</span></div>
<div style="position:absolute;left:517.21px;top:502.74px" class="cls_003"><span class="cls_003">method, concealment of allocation, and</span></div>
<div style="position:absolute;left:63.89px;top:512.72px" class="cls_022"><span class="cls_022">(2011)</span></div>
<div style="position:absolute;left:144.57px;top:512.72px" class="cls_003"><span class="cls_003">oocytes</span></div>
<div style="position:absolute;left:199.96px;top:512.72px" class="cls_003"><span class="cls_003">system</span></div>
<div style="position:absolute;left:517.21px;top:512.72px" class="cls_003"><span class="cls_003">blinding</span></div>
<div style="position:absolute;left:63.89px;top:525.71px" class="cls_022"><span class="cls_022">Rama Raju</span></div>
<div style="position:absolute;left:106.36px;top:525.71px" class="cls_003"><span class="cls_003">India</span></div>
<div style="position:absolute;left:144.57px;top:525.71px" class="cls_003"><span class="cls_003">Randomization</span></div>
<div style="position:absolute;left:199.96px;top:525.71px" class="cls_003"><span class="cls_003">Vitrification 40% EG + 0.6 M</span></div>
<div style="position:absolute;left:316.52px;top:525.71px" class="cls_003"><span class="cls_003">Cleavage</span></div>
<div style="position:absolute;left:357.22px;top:525.71px" class="cls_003"><span class="cls_003">84</span></div>
<div style="position:absolute;left:390.84px;top:525.71px" class="cls_003"><span class="cls_003">Cleavage</span></div>
<div style="position:absolute;left:432.28px;top:525.71px" class="cls_003"><span class="cls_003">80</span></div>
<div style="position:absolute;left:465.85px;top:525.71px" class="cls_003"><span class="cls_003">CPR,</span></div>
<div style="position:absolute;left:517.21px;top:525.71px" class="cls_003"><span class="cls_003">Unclear risk of bias related to random</span></div>
<div style="position:absolute;left:655.09px;top:525.71px" class="cls_003"><span class="cls_003">RBM online:2.796</span></div>
<div style="position:absolute;left:63.89px;top:535.69px" class="cls_022"><span class="cls_022">et al.</span></div>
<div style="position:absolute;left:144.57px;top:535.69px" class="cls_003"><span class="cls_003">of embryos</span></div>
<div style="position:absolute;left:199.96px;top:535.69px" class="cls_003"><span class="cls_003">sucrose - open system</span></div>
<div style="position:absolute;left:316.52px;top:535.69px" class="cls_003"><span class="cls_003">stage</span></div>
<div style="position:absolute;left:357.22px;top:535.69px" class="cls_003"><span class="cls_003">cycles</span></div>
<div style="position:absolute;left:390.84px;top:535.69px" class="cls_003"><span class="cls_003">stage slow-</span></div>
<div style="position:absolute;left:432.28px;top:535.69px" class="cls_003"><span class="cls_003">cycles</span></div>
<div style="position:absolute;left:465.85px;top:535.69px" class="cls_003"><span class="cls_003">cryosurvival</span></div>
<div style="position:absolute;left:517.21px;top:535.69px" class="cls_003"><span class="cls_003">sequence generation, allocation of</span></div>
<div style="position:absolute;left:63.89px;top:545.72px" class="cls_022"><span class="cls_022">(2005)</span></div>
<div style="position:absolute;left:199.96px;top:545.72px" class="cls_003"><span class="cls_003">Slow-freezing: 1.5 M PROH- 0.1 M</span></div>
<div style="position:absolute;left:316.52px;top:545.72px" class="cls_003"><span class="cls_003">vitrification</span></div>
<div style="position:absolute;left:357.22px;top:545.72px" class="cls_003"><span class="cls_003">127</span></div>
<div style="position:absolute;left:390.84px;top:545.72px" class="cls_003"><span class="cls_003">freezing</span></div>
<div style="position:absolute;left:432.28px;top:545.72px" class="cls_003"><span class="cls_003">120</span></div>
<div style="position:absolute;left:465.85px;top:545.72px" class="cls_003"><span class="cls_003">rate</span></div>
<div style="position:absolute;left:517.21px;top:545.72px" class="cls_003"><span class="cls_003">concealment acceptable, and blinding</span></div>
<div style="position:absolute;left:199.96px;top:555.70px" class="cls_003"><span class="cls_003">Sucrose</span></div>
<div style="position:absolute;left:357.22px;top:555.70px" class="cls_003"><span class="cls_003">embryos</span></div>
<div style="position:absolute;left:432.28px;top:555.70px" class="cls_003"><span class="cls_003">embryos</span></div>
</div>
<div style="position:absolute;left:50%;margin-left:-306px;top:4622px;width:612px;height:790px;border-style:outset;overflow:hidden">
<div style="position:absolute;left:0px;top:0px">
<img src="fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_id_fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_files/background07.jpg" width=612 height=790></div>
<div style="position:absolute;left:48.19px;top:26.63px" class="cls_014"><span class="cls_014">Slow-freezing versus vitrification in ART</span></div>
<div style="position:absolute;left:550.66px;top:25.13px" class="cls_013"><span class="cls_013">145</span></div>
<div style="position:absolute;left:317.48px;top:56.96px" class="cls_014"><span class="cls_014">additional two studies described by the authors as RCT’s were not truly</span></div>
<div style="position:absolute;left:317.48px;top:67.96px" class="cls_014"><span class="cls_014">randomized studies and were therefore included in the analysis with</span></div>
<div style="position:absolute;left:317.48px;top:78.96px" class="cls_014"><span class="cls_014">observational studies (</span><span class="cls_019">Li et al., 2007</span><span class="cls_014"> and</span><span class="cls_019"> Summers et al., 2016</span><span class="cls_014">).</span></div>
<div style="position:absolute;left:325.98px;top:89.96px" class="cls_014"><span class="cls_014">LBR  per  cycle  and/or  per  transfer  was  reported  in  six  studies</span></div>
<div style="position:absolute;left:317.48px;top:100.96px" class="cls_014"><span class="cls_014">(</span><span class="cls_019">Kuwayama et al., 2005a</span><span class="cls_014">,</span><span class="cls_019">b</span><span class="cls_014">;</span><span class="cls_019"> Wilding et al., 2010</span><span class="cls_014">;</span><span class="cls_019"> Wang et al., 2012</span><span class="cls_014">;</span><span class="cls_019"> Liu</span></div>
<div style="position:absolute;left:317.48px;top:111.96px" class="cls_019"><span class="cls_019">et al., 2013</span><span class="cls_014">;</span><span class="cls_019"> Van Landuyt et al., 2013</span><span class="cls_014">;</span><span class="cls_019"> Kaartinen et al., 2016</span><span class="cls_014">).</span></div>
<div style="position:absolute;left:317.48px;top:138.58px" class="cls_013"><span class="cls_013">Slow-frozen versus vitrified embryos: survival</span></div>
<div style="position:absolute;left:317.48px;top:152.04px" class="cls_014"><span class="cls_014">A secondary analysis was performed focusing on embryo cryosurvival</span></div>
<div style="position:absolute;left:317.48px;top:163.04px" class="cls_014"><span class="cls_014">rate. Seven RCTs (</span><span class="cls_019">Kim et al., 2000</span><span class="cls_014">;</span><span class="cls_019"> Huang et al., 2005</span><span class="cls_014">;</span><span class="cls_019"> Rama Raju et al.,</span></div>
<div style="position:absolute;left:317.48px;top:174.04px" class="cls_019"><span class="cls_019">2005</span><span class="cls_014">;</span><span class="cls_019"> Zheng et al.,</span></div>
<div style="position:absolute;left:392.20px;top:174.04px" class="cls_019"><span class="cls_019">2005</span><span class="cls_014">;</span><span class="cls_019"> Balaban et al.,</span></div>
<div style="position:absolute;left:471.40px;top:174.04px" class="cls_019"><span class="cls_019">2008</span><span class="cls_014">;</span><span class="cls_019"> Fasano et al.,</span></div>
<div style="position:absolute;left:547.88px;top:174.04px" class="cls_019"><span class="cls_019">2014</span><span class="cls_014">;</span></div>
<div style="position:absolute;left:317.48px;top:185.03px" class="cls_019"><span class="cls_019">Debrock et al.,2015</span><span class="cls_014">) were included. Characteristics of these studies are</span></div>
<div style="position:absolute;left:317.48px;top:196.03px" class="cls_014"><span class="cls_014">described in Table</span><span class="cls_019"> I</span><span class="cls_014">. Moreover,</span></div>
<div style="position:absolute;left:437.22px;top:196.03px" class="cls_014"><span class="cls_014">12 observational studies</span></div>
<div style="position:absolute;left:527.64px;top:196.03px" class="cls_014"><span class="cls_014">(</span><span class="cls_019">Kuwayama</span></div>
<div style="position:absolute;left:317.48px;top:207.03px" class="cls_019"><span class="cls_019">et al.,</span></div>
<div style="position:absolute;left:341.46px;top:207.03px" class="cls_019"><span class="cls_019">2005a</span><span class="cls_014">,</span><span class="cls_019">b</span><span class="cls_014">;</span><span class="cls_019"> Stehilk et al.,</span></div>
<div style="position:absolute;left:424.69px;top:207.03px" class="cls_019"><span class="cls_019">2005</span><span class="cls_014">;</span><span class="cls_019"> Liebermann and Tucker, 2006</span><span class="cls_014">;</span><span class="cls_019"> Li</span></div>
<div style="position:absolute;left:317.48px;top:218.03px" class="cls_019"><span class="cls_019">et al., 2007</span><span class="cls_014">;</span><span class="cls_019"> Rezazadeh Valojerdi et al., 2009</span><span class="cls_014">;</span><span class="cls_019"> Wilding et al., 2010</span><span class="cls_014">;</span><span class="cls_019"> Sifer</span></div>
<div style="position:absolute;left:317.48px;top:229.03px" class="cls_019"><span class="cls_019">et al., 2012</span><span class="cls_014">;</span><span class="cls_019"> Wang et al., 2012</span><span class="cls_014">;</span><span class="cls_019"> Van Landuyt et al., 2013</span><span class="cls_014"> and</span><span class="cls_019"> Liu et al.,</span></div>
<div style="position:absolute;left:317.48px;top:240.03px" class="cls_019"><span class="cls_019">2013</span><span class="cls_014">;</span><span class="cls_019"> Zhu et al., 2015</span><span class="cls_014">;</span><span class="cls_019"> Summers et al., 2016</span><span class="cls_014">) and two meta-analyses</span></div>
<div style="position:absolute;left:317.48px;top:251.02px" class="cls_014"><span class="cls_014">comparing results obtained with vitrification/warming and slow-freezing/</span></div>
<div style="position:absolute;left:317.48px;top:262.02px" class="cls_014"><span class="cls_014">thawing (</span><span class="cls_019">Loutradi et al., 2008</span><span class="cls_014">;</span><span class="cls_019"> Kolibianakis et al., 2009</span><span class="cls_014">) were identified.</span></div>
<div style="position:absolute;left:317.48px;top:296.62px" class="cls_002"><span class="cls_002">Assessing the quality of each study</span></div>
<div style="position:absolute;left:317.48px;top:314.12px" class="cls_014"><span class="cls_014">According to the WHO Handbook for Guideline Development (</span><span class="cls_019">WHO,</span></div>
<div style="position:absolute;left:317.48px;top:325.12px" class="cls_019"><span class="cls_019">2012</span><span class="cls_014">) the quality of each study was assessed. In particular, each RCT was</span></div>
<div style="position:absolute;left:317.48px;top:336.12px" class="cls_014"><span class="cls_014">evaluated for the following factors: how randomization was performed,</span></div>
<div style="position:absolute;left:317.48px;top:347.12px" class="cls_014"><span class="cls_014">whether there was concealment of allocation, whether participants and</span></div>
<div style="position:absolute;left:317.48px;top:358.12px" class="cls_014"><span class="cls_014">personnel were blinded to the intervention and outcome, whether there</span></div>
<div style="position:absolute;left:317.48px;top:369.11px" class="cls_014"><span class="cls_014">was complete data reporting, whether an intention to treat analysis was</span></div>
<div style="position:absolute;left:317.48px;top:380.11px" class="cls_014"><span class="cls_014">performed  and  whether  any  other  potential  sources  of  bias  existed</span></div>
<div style="position:absolute;left:317.48px;top:391.11px" class="cls_014"><span class="cls_014">(</span><span class="cls_019">WHO, 2012</span><span class="cls_014">). The overall risk of bias was classified as serious, not ser-</span></div>
<div style="position:absolute;left:317.48px;top:402.11px" class="cls_014"><span class="cls_014">ious, or unclear and is presented in Table</span><span class="cls_019"> I</span><span class="cls_014"> for each randomized trial</span></div>
<div style="position:absolute;left:317.48px;top:413.11px" class="cls_014"><span class="cls_014">included. The risk of bias is considered serious for all observational stud-</span></div>
<div style="position:absolute;left:317.48px;top:424.16px" class="cls_014"><span class="cls_014">ies given the high risk for selection bias and confounding inherent in these</span></div>
<div style="position:absolute;left:317.48px;top:435.16px" class="cls_014"><span class="cls_014">study designs.</span></div>
<div style="position:absolute;left:317.48px;top:469.70px" class="cls_002"><span class="cls_002">Data synthesis and meta-analysis</span></div>
<div style="position:absolute;left:317.48px;top:487.21px" class="cls_014"><span class="cls_014">Meta-analyses of studies were undertaken to estimate the pooled relative</span></div>
<div style="position:absolute;left:317.48px;top:498.21px" class="cls_014"><span class="cls_014">risk ratios (RR) of outcomes including CPR per cycle, CPR per transfer and</span></div>
<div style="position:absolute;left:317.48px;top:509.20px" class="cls_014"><span class="cls_014">cryosurvival of thawed/warmed oocytes or embryos. Statistical analyses</span></div>
<div style="position:absolute;left:317.48px;top:520.20px" class="cls_014"><span class="cls_014">and construction of forest and funnel plots were performed with Stata ver-</span></div>
<div style="position:absolute;left:317.48px;top:531.20px" class="cls_014"><span class="cls_014">sion 12.1 (StataCorp, TX, USA). RR and 95% CIs were calculated for each</span></div>
<div style="position:absolute;left:317.48px;top:542.20px" class="cls_014"><span class="cls_014">outcome.  A  random  effects  model  was  used  for  the  meta-analysis.</span></div>
<div style="position:absolute;left:317.48px;top:551.95px" class="cls_014"><span class="cls_014">Heterogeneity was assessed with the use of the I</span><span class="cls_023"><sup>2</sup></span><span class="cls_014">  test. Publication bias</span></div>
<div style="position:absolute;left:317.48px;top:564.25px" class="cls_014"><span class="cls_014">was assessed by constructing funnel plots.</span></div>
<div style="position:absolute;left:317.48px;top:598.79px" class="cls_002"><span class="cls_002">Assessment of the quality of the literature as</span></div>
<div style="position:absolute;left:317.48px;top:612.80px" class="cls_002"><span class="cls_002">a whole</span></div>
<div style="position:absolute;left:317.48px;top:630.30px" class="cls_014"><span class="cls_014">According to the WHO Handbook for Guideline Development (</span><span class="cls_019">WHO,</span></div>
<div style="position:absolute;left:317.48px;top:641.30px" class="cls_019"><span class="cls_019">2012</span><span class="cls_014">) used to guide methodology in this systematic review, the quality of</span></div>
<div style="position:absolute;left:317.48px;top:652.30px" class="cls_014"><span class="cls_014">the literature for each analysis was classified as high, moderate, low or</span></div>
<div style="position:absolute;left:317.48px;top:663.29px" class="cls_014"><span class="cls_014">very low. A grade of high indicates that further research is very unlikely</span></div>
<div style="position:absolute;left:317.48px;top:674.29px" class="cls_014"><span class="cls_014">to change confidence in the estimate of effect; moderate indicates that</span></div>
<div style="position:absolute;left:317.48px;top:685.29px" class="cls_014"><span class="cls_014">further research is likely to have an important impact on confidence in</span></div>
<div style="position:absolute;left:317.48px;top:696.29px" class="cls_014"><span class="cls_014">the estimate of effect and may change the estimate; low indicates that</span></div>
<div style="position:absolute;left:317.48px;top:707.29px" class="cls_014"><span class="cls_014">further research is very likely to have an important impact on confidence</span></div>
<div style="position:absolute;left:317.48px;top:718.29px" class="cls_014"><span class="cls_014">in the estimate of effect and is likely to change the estimate; very low</span></div>
<div style="position:absolute;left:317.48px;top:729.28px" class="cls_014"><span class="cls_014">indicates that any estimate of effect is very uncertain (</span><span class="cls_019">WHO, 2012</span><span class="cls_014">).</span></div>
</div>
<div style="position:absolute;left:50%;margin-left:-306px;top:5422px;width:612px;height:790px;border-style:outset;overflow:hidden">
<div style="position:absolute;left:0px;top:0px">
<img src="fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_id_fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_files/background08.jpg" width=612 height=790></div>
<div style="position:absolute;left:45.35px;top:25.13px" class="cls_013"><span class="cls_013">146</span></div>
<div style="position:absolute;left:525.71px;top:26.63px" class="cls_014"><span class="cls_014">Rienzi et al.</span></div>
<div style="position:absolute;left:53.86px;top:56.96px" class="cls_014"><span class="cls_014">Factors used to determine the classification for any analysis took into</span></div>
<div style="position:absolute;left:314.65px;top:55.42px" class="cls_011"><span class="cls_011">2046 cycles; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011">  = 0.0%, very low quality evidence), and lower LBRs</span></div>
<div style="position:absolute;left:45.35px;top:67.96px" class="cls_014"><span class="cls_014">account the following factors: study design, consistency of the results</span></div>
<div style="position:absolute;left:314.65px;top:68.82px" class="cls_011"><span class="cls_011">per utilized oocyte (RR = 0.26, 95% CI: 0.21-0.32; P &lt; 0.0001; three</span></div>
<div style="position:absolute;left:45.35px;top:78.96px" class="cls_014"><span class="cls_014">across the available studies, precision of the results (width of the CI), the</span></div>
<div style="position:absolute;left:314.65px;top:79.45px" class="cls_011"><span class="cls_011">studies; 5513 and 6670 cycles; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011"> = 0.0%, very low quality evidence)</span></div>
<div style="position:absolute;left:45.35px;top:89.96px" class="cls_014"><span class="cls_014">directness or generalizability of the results across populations, and the</span></div>
<div style="position:absolute;left:314.65px;top:92.80px" class="cls_011"><span class="cls_011">when slow-freeze was compared to fresh oocytes.</span></div>
<div style="position:absolute;left:45.35px;top:100.96px" class="cls_014"><span class="cls_014">likelihood of publications bias.</span></div>
<div style="position:absolute;left:323.66px;top:104.82px" class="cls_011"><span class="cls_011">The CPR per cycle (RR = 0.42, 95% CI: 0.31-0.58; P &lt; 0.0001;</span></div>
<div style="position:absolute;left:314.65px;top:116.79px" class="cls_011"><span class="cls_011">five  studies,</span></div>
<div style="position:absolute;left:366.07px;top:116.79px" class="cls_011"><span class="cls_011">1809</span></div>
<div style="position:absolute;left:390.28px;top:116.79px" class="cls_011"><span class="cls_011">and</span></div>
<div style="position:absolute;left:409.38px;top:116.79px" class="cls_011"><span class="cls_011">3323</span></div>
<div style="position:absolute;left:433.59px;top:116.79px" class="cls_011"><span class="cls_011">cycles,  slow-freezing  versus  fresh,</span></div>
<div style="position:absolute;left:314.65px;top:127.42px" class="cls_011"><span class="cls_011">respectively; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011">  = 64.5%, very low quality evidence) (<A HREF="http://humupd.oxfordjournals.org/lookup/suppl/doi:10.1093/humupd/dmw038/-/DC1">Supplementary</A> </span></div>
<div style="position:absolute;left:45.35px;top:128.13px" class="cls_017"><span class="cls_017">Results</span></div>
<div style="position:absolute;left:314.65px;top:140.82px" class="cls_011"><span class="cls_011"> </span><A HREF="http://humupd.oxfordjournals.org/lookup/suppl/doi:10.1093/humupd/dmw038/-/DC1">Fig. S1b</A>), the CPR per transfer (RR = 0.45, 95% CI: 0.29-0.65, five</div>
<div style="position:absolute;left:314.65px;top:151.45px" class="cls_011"><span class="cls_011">studies; P &lt; 0.0001; 1534 and 2989 transfers; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011"> = 78.5%, very low</span></div>
<div style="position:absolute;left:45.35px;top:154.15px" class="cls_002"><span class="cls_002">Oocyte slow-freezing versus vitrification:</span></div>
<div style="position:absolute;left:314.65px;top:164.80px" class="cls_011"><span class="cls_011">quality evidence) and the CPR per utilized oocytes (RR = 0.29, 95%</span></div>
<div style="position:absolute;left:45.35px;top:168.15px" class="cls_002"><span class="cls_002">clinical outcomes and oocyte cryosurvival</span></div>
<div style="position:absolute;left:314.65px;top:176.82px" class="cls_011"><span class="cls_011">CI: 0.25-0.35, four studies; 6600 and 9115 oocytes, slow-freezing</span></div>
<div style="position:absolute;left:45.35px;top:186.12px" class="cls_011"><span class="cls_011">A single RCT (</span><span class="cls_018">Smith et al., 2010</span><span class="cls_011">) revealed evidence of a difference in</span></div>
<div style="position:absolute;left:314.65px;top:187.45px" class="cls_011"><span class="cls_011">versus, fresh, respectively; P &lt; 0.0001; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011">  = 4.8%, very low quality</span></div>
<div style="position:absolute;left:45.35px;top:198.14px" class="cls_011"><span class="cls_011">favor  of  vitrification  regarding  ongoing  pregnancy  rate  per  cycle</span></div>
<div style="position:absolute;left:314.65px;top:200.80px" class="cls_011"><span class="cls_011">evidence) were all in favor of fresh oocytes as compared to slow-</span></div>
<div style="position:absolute;left:45.35px;top:210.16px" class="cls_011"><span class="cls_011">(RR = 2.81, 95% CI: 1.05-7.51; P = 0.039; 48 and 30 cycles, vitrifica-</span></div>
<div style="position:absolute;left:314.65px;top:212.82px" class="cls_011"><span class="cls_011">frozen oocytes (</span><span class="cls_018">Chamayou et al., 2006</span><span class="cls_011">;</span><span class="cls_018"> Levi Setti et al., 2006</span><span class="cls_011">;</span><span class="cls_018"> Borini</span></div>
<div style="position:absolute;left:45.35px;top:222.12px" class="cls_011"><span class="cls_011">tion versus slow-freezing, respectively; low quality evidence) (Fig.</span><span class="cls_018"> 2</span><span class="cls_011">a)</span></div>
<div style="position:absolute;left:314.65px;top:224.79px" class="cls_018"><span class="cls_018">et al., 2007</span><span class="cls_011">,</span><span class="cls_018">2010</span><span class="cls_011">;</span><span class="cls_018"> Virant-Klun et al., 2011</span><span class="cls_011">). Each utilized slow-frozen</span></div>
<div style="position:absolute;left:45.35px;top:234.14px" class="cls_011"><span class="cls_011">and per warmed/thawed oocyte (RR = 1.14, 95% CI: 1.02-1.28;</span></div>
<div style="position:absolute;left:314.65px;top:236.80px" class="cls_011"><span class="cls_011">oocyte had a 2.27% (150/6600) likelihood of resulting in a pregnancy</span></div>
<div style="position:absolute;left:45.35px;top:246.16px" class="cls_011"><span class="cls_011">P = 0.018; 260 and 238 oocytes, vitrification versus slow-freezing,</span></div>
<div style="position:absolute;left:314.65px;top:248.82px" class="cls_011"><span class="cls_011">in the population of women studied.</span></div>
<div style="position:absolute;left:45.35px;top:258.12px" class="cls_011"><span class="cls_011">respectively; low quality evidence). Limited evidence demonstrated</span></div>
<div style="position:absolute;left:45.35px;top:270.14px" class="cls_011"><span class="cls_011">that clinical outcomes following vitrification versus slow-freezing were</span></div>
<div style="position:absolute;left:45.35px;top:282.16px" class="cls_011"><span class="cls_011">similar when ongoing pregnancy rate was expressed per embryo trans-</span></div>
<div style="position:absolute;left:314.65px;top:288.80px" class="cls_002"><span class="cls_002">Oocyte vitrification versus fresh oocytes:</span></div>
<div style="position:absolute;left:45.35px;top:294.12px" class="cls_011"><span class="cls_011">fer (RR = 1.81, 95% CI: 0.71-4.67; P = 0.214; 47 and 19 transfers, vit-</span></div>
<div style="position:absolute;left:45.35px;top:306.14px" class="cls_011"><span class="cls_011">rification versus slow-freezing, respectively; low quality evidence).</span></div>
<div style="position:absolute;left:314.65px;top:302.80px" class="cls_002"><span class="cls_002">clinical outcomes</span></div>
<div style="position:absolute;left:54.37px;top:318.16px" class="cls_011"><span class="cls_011">In two cohort studies (</span><span class="cls_018">Fadini et al., 2009</span><span class="cls_011">;</span><span class="cls_018"> Levi Setti et al., 2014</span><span class="cls_011">)</span></div>
<div style="position:absolute;left:314.65px;top:320.82px" class="cls_011"><span class="cls_011">Analysis of a single RCT (</span><span class="cls_018">Cobo et al., 2010</span><span class="cls_011">) revealed no evidence for</span></div>
<div style="position:absolute;left:45.35px;top:330.12px" class="cls_011"><span class="cls_011">the evidence also favored vitrification for CPR per cycle (RR = 1.72,</span></div>
<div style="position:absolute;left:314.65px;top:332.84px" class="cls_011"><span class="cls_011">a difference in ongoing CPR between the two groups when results</span></div>
<div style="position:absolute;left:45.35px;top:342.14px" class="cls_011"><span class="cls_011">95% CI: 0.74-3.95; P = 0.212; 5460 and 9212 cycles, vitrification ver-</span></div>
<div style="position:absolute;left:314.65px;top:344.80px" class="cls_011"><span class="cls_011">were expressed per woman randomized (RR = 1.03, 95% CI: 0.87-</span></div>
<div style="position:absolute;left:45.35px;top:352.77px" class="cls_011"><span class="cls_011">sus slow-freezing, respectively; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011"> = 81.5%, very low quality evidence)</span></div>
<div style="position:absolute;left:314.65px;top:356.82px" class="cls_011"><span class="cls_011">1.21; P = 0.744, 300 women in each group; moderate quality evi-</span></div>
<div style="position:absolute;left:45.35px;top:366.12px" class="cls_011"><span class="cls_011">(Fig.</span><span class="cls_018"> 2</span><span class="cls_011">b), per transfer (RR = 1.55, 95% CI: 0.82-2.92; P = 0.180, two</span></div>
<div style="position:absolute;left:314.65px;top:368.84px" class="cls_011"><span class="cls_011">dence), per cycle (RR = 1.01, 95% CI: 0.86-1.18; P = 0.934; 267 ver-</span></div>
<div style="position:absolute;left:45.35px;top:376.75px" class="cls_011"><span class="cls_011">studies; I</span><span class="cls_016"><sup>2</sup></span></div>
<div style="position:absolute;left:86.00px;top:378.14px" class="cls_011"><span class="cls_011">= 70.0%, very low quality evidence) and per warmed/</span></div>
<div style="position:absolute;left:314.65px;top:380.80px" class="cls_011"><span class="cls_011">sus 259 cycles vitrification versus fresh, respectively; moderate quality</span></div>
<div style="position:absolute;left:45.35px;top:390.16px" class="cls_011"><span class="cls_011">thawed oocyte (RR = 1.72, 95% CI: 0.84-3.52; P = 0.135; 26789</span></div>
<div style="position:absolute;left:314.65px;top:392.82px" class="cls_011"><span class="cls_011">evidence) or per utilized oocyte (RR = 1.02, 95% CI: 0.82-1.26;</span></div>
<div style="position:absolute;left:45.35px;top:402.12px" class="cls_011"><span class="cls_011">and  49264  oocytes,  vitrification  versus  slow-freezing,  respectively;</span></div>
<div style="position:absolute;left:314.65px;top:404.84px" class="cls_011"><span class="cls_011">P</span></div>
<div style="position:absolute;left:324.00px;top:404.84px" class="cls_011"><span class="cls_011">= 0.873;  3286  versus  3185  oocytes,  vitrification  versus  fresh,</span></div>
<div style="position:absolute;left:45.35px;top:414.14px" class="cls_011"><span class="cls_011">very low quality evidence). However, the differences were not statis-</span></div>
<div style="position:absolute;left:314.65px;top:416.80px" class="cls_011"><span class="cls_011">respectively; moderate quality evidence).</span></div>
<div style="position:absolute;left:45.35px;top:426.16px" class="cls_011"><span class="cls_011">tically significant. Of note the CPR per cycle was relatively low in the</span></div>
<div style="position:absolute;left:323.66px;top:428.82px" class="cls_011"><span class="cls_011">The combined analysis of the cohort studies and the RCTs in</span></div>
<div style="position:absolute;left:45.35px;top:438.12px" class="cls_011"><span class="cls_011">unselected  population  of  patients  undergoing  autologous  oocyte</span></div>
<div style="position:absolute;left:314.65px;top:440.84px" class="cls_011"><span class="cls_011">which sibling oocytes were randomized to be vitrified or used fresh</span></div>
<div style="position:absolute;left:45.35px;top:450.14px" class="cls_011"><span class="cls_011">cryopreservation due to law restrictions for both approaches, 11.8%</span></div>
<div style="position:absolute;left:314.64px;top:452.80px" class="cls_011"><span class="cls_011">(</span><span class="cls_018">Sole et al., 2013</span><span class="cls_011">;</span><span class="cls_018"> Parmegiani et al., 2011</span><span class="cls_011">;</span><span class="cls_018"> Trokoudes et al., 2011</span><span class="cls_011">)</span></div>
<div style="position:absolute;left:45.35px;top:462.16px" class="cls_011"><span class="cls_011">and 14.4% for slow freezing and vitrification, respectively.</span></div>
<div style="position:absolute;left:314.65px;top:464.82px" class="cls_011"><span class="cls_011">revealed no evidence of a difference between cycles using exclusively</span></div>
<div style="position:absolute;left:54.37px;top:474.12px" class="cls_011"><span class="cls_011">The superiority of vitrification over slow-freezing was also observed</span></div>
<div style="position:absolute;left:314.65px;top:476.84px" class="cls_011"><span class="cls_011">vitrified versus fresh oocytes for LBR per cycle (RR = 1.04, 95% CI:</span></div>
<div style="position:absolute;left:45.35px;top:486.14px" class="cls_011"><span class="cls_011">when cryosurvival rates of MII oocytes were compared. In three RCTs</span></div>
<div style="position:absolute;left:314.65px;top:488.80px" class="cls_011"><span class="cls_011">0.61-1.76, P = 0.892; three studies; 171 and 171 cycles, vitrification</span></div>
<div style="position:absolute;left:45.35px;top:498.16px" class="cls_011"><span class="cls_011">(</span><span class="cls_018">Paffoni et al., 2008</span><span class="cls_011">;</span><span class="cls_018"> Cao et al., 2009</span><span class="cls_011">;</span><span class="cls_018"> Smith et al., 2010</span><span class="cls_011">) MII cryosurvi-</span></div>
<div style="position:absolute;left:314.65px;top:499.43px" class="cls_011"><span class="cls_011">versus fresh, respectively; I</span><span class="cls_016"><sup>2</sup></span></div>
<div style="position:absolute;left:424.91px;top:500.82px" class="cls_011"><span class="cls_011">= 52.3%; very low quality evidence)</span></div>
<div style="position:absolute;left:45.35px;top:510.12px" class="cls_011"><span class="cls_011">val  rate  was</span></div>
<div style="position:absolute;left:98.48px;top:510.12px" class="cls_011"><span class="cls_011">82.3%  (602/731)  following  vitrification/warming  and</span></div>
<div style="position:absolute;left:314.65px;top:512.84px" class="cls_011"><span class="cls_011">(</span><A HREF="http://humupd.oxfordjournals.org/lookup/suppl/doi:10.1093/humupd/dmw038/-/DC1">Supplementary Fig. S2</A>), LBR per oocyte utilized (RR = 2.35, 95% CI:</div>
<div style="position:absolute;left:45.35px;top:522.14px" class="cls_011"><span class="cls_011">66.1% (298/451) following slow-freezing/thawing (RR = 1.23, 95% CI:</span></div>
<div style="position:absolute;left:314.65px;top:524.80px" class="cls_011"><span class="cls_011">0.29-19.3, P = 0.427; two studies; 378 and 367 oocytes, vitrification</span></div>
<div style="position:absolute;left:45.35px;top:532.77px" class="cls_011"><span class="cls_011">1.02-1.49; P = 0.031; three studies; 1182 oocytes thawed; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011"> = 82.9%,</span></div>
<div style="position:absolute;left:314.65px;top:535.44px" class="cls_011"><span class="cls_011">versus fresh, respectively; I</span><span class="cls_016"><sup>2</sup></span></div>
<div style="position:absolute;left:424.91px;top:536.82px" class="cls_011"><span class="cls_011">= 58.5%; very low quality evidence)</span></div>
<div style="position:absolute;left:45.35px;top:546.12px" class="cls_011"><span class="cls_011">low quality evidence) (Fig.</span><span class="cls_018"> 2</span><span class="cls_011">c). In the three cohort studies, cryosurvival</span></div>
<div style="position:absolute;left:314.65px;top:548.84px" class="cls_011"><span class="cls_011">(</span><span class="cls_018">Parmegiani et al., 2011</span><span class="cls_011">;</span><span class="cls_018"> Trokoudes et al., 2011</span><span class="cls_011">), or LBR per transfer</span></div>
<div style="position:absolute;left:45.35px;top:558.14px" class="cls_011"><span class="cls_011">rate after vitrification was also significantly higher than after slow-</span></div>
<div style="position:absolute;left:314.65px;top:560.80px" class="cls_011"><span class="cls_011">(RR = 1.10, 95% CI: 0.64-1.88, P = 0.730; three studies; 166 and</span></div>
<div style="position:absolute;left:45.35px;top:570.16px" class="cls_011"><span class="cls_011">freezing (RR = 1.23, 95% CI: 1.11-1.36, P &lt; 0.001; three studies;</span></div>
<div style="position:absolute;left:314.65px;top:571.43px" class="cls_011"><span class="cls_011">170 transfers, vitrification versus fresh, respectively, I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011"> = 54.6%; very</span></div>
<div style="position:absolute;left:45.35px;top:580.79px" class="cls_011"><span class="cls_011">99679 oocytes thawed; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011"> = 91.6%, very low quality evidence) (</span><span class="cls_018">Fadini</span></div>
<div style="position:absolute;left:314.65px;top:584.84px" class="cls_011"><span class="cls_011">low quality evidence). The two groups were also similar for CPR per</span></div>
<div style="position:absolute;left:45.35px;top:594.14px" class="cls_018"><span class="cls_018">et al., 2009</span><span class="cls_011">;</span><span class="cls_018"> Levi-Setti et al., 2016</span><span class="cls_011">;</span><span class="cls_018"> Grifo and Noyes, 2010</span><span class="cls_011">).</span></div>
<div style="position:absolute;left:314.65px;top:596.80px" class="cls_011"><span class="cls_011">cycle (RR = 0.94, 95% CI: 0.81-1.10; P = 0.457; eight studies; 526</span></div>
<div style="position:absolute;left:314.65px;top:607.43px" class="cls_011"><span class="cls_011">and 892 cycles, vitrification versus fresh, respectively; I</span><span class="cls_016"><sup>2</sup></span></div>
<div style="position:absolute;left:529.57px;top:608.82px" class="cls_011"><span class="cls_011">= 22.9%,</span></div>
<div style="position:absolute;left:314.64px;top:620.84px" class="cls_011"><span class="cls_011">very low quality evidence) (</span><span class="cls_018">Sole et al., 2013</span><span class="cls_011">;</span><span class="cls_018"> Antinori et al., 2007</span><span class="cls_011">;</span></div>
<div style="position:absolute;left:45.35px;top:624.82px" class="cls_002"><span class="cls_002">Oocyte slow-freezing versus fresh oocytes:</span></div>
<div style="position:absolute;left:314.65px;top:632.80px" class="cls_018"><span class="cls_018">Almodin et al., 2010</span><span class="cls_011">;</span><span class="cls_018"> Rienzi et al., 2010</span><span class="cls_011">;</span><span class="cls_018"> Ubaldi et al., 2010</span><span class="cls_011">;</span><span class="cls_018"> Garcia</span></div>
<div style="position:absolute;left:45.35px;top:638.82px" class="cls_002"><span class="cls_002">clinical outcomes</span></div>
<div style="position:absolute;left:314.65px;top:644.82px" class="cls_018"><span class="cls_018">et al., 2011</span><span class="cls_011">;</span><span class="cls_018"> Parmegiani et al., 2011</span><span class="cls_011">;</span><span class="cls_018"> Trokoudes et al., 2011</span><span class="cls_011">); CPR</span></div>
<div style="position:absolute;left:45.35px;top:656.84px" class="cls_011"><span class="cls_011">Analyses of the cohort studies (</span><span class="cls_018">Chamayou et al., 2006</span><span class="cls_011">;</span><span class="cls_018"> Borini et al.,</span></div>
<div style="position:absolute;left:314.65px;top:656.84px" class="cls_011"><span class="cls_011">per transfer (RR = 0.97, 95% CI: 0.81-1.16; P = 0.714; seven st-</span></div>
<div style="position:absolute;left:45.35px;top:668.80px" class="cls_018"><span class="cls_018">2010</span><span class="cls_011">;</span><span class="cls_018"> Virant-Klun et al., 2011</span><span class="cls_011">) in which sibling oocytes were not ran-</span></div>
<div style="position:absolute;left:314.65px;top:668.80px" class="cls_011"><span class="cls_011">udies,</span></div>
<div style="position:absolute;left:339.44px;top:668.80px" class="cls_011"><span class="cls_011">477  and  754  transfers,  vitrification  versus  fresh,  respectively;</span></div>
<div style="position:absolute;left:45.35px;top:680.82px" class="cls_011"><span class="cls_011">domized to be slow-frozen or used fresh revealed lower LBRs per</span></div>
<div style="position:absolute;left:314.64px;top:680.82px" class="cls_011"><span class="cls_011">I</span><span class="cls_016">2</span><span class="cls_011"> = 38.1%, very low quality evidence) (</span><span class="cls_018">Sole et al., 2013</span><span class="cls_011">; </span><span class="cls_018">Antinori et al.,</span></div>
<div style="position:absolute;left:45.35px;top:692.79px" class="cls_011"><span class="cls_011">cycle with slow-freezing (RR = 0.49, 95% CI: 0.39-0.60; P &lt; 0.0001;</span></div>
<div style="position:absolute;left:314.65px;top:692.84px" class="cls_018"><span class="cls_018">2007</span><span class="cls_011">;</span><span class="cls_018"> Almodin et al., 2010</span><span class="cls_011">;</span><span class="cls_018"> Ubaldi et al., 2010</span><span class="cls_011">;</span><span class="cls_018"> Garcia et al., 2011</span><span class="cls_011">;</span></div>
<div style="position:absolute;left:45.35px;top:703.47px" class="cls_011"><span class="cls_011">three studies; 990 and 2271 cycles; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011">  = 0.0%, very low quality evi-</span></div>
<div style="position:absolute;left:314.65px;top:704.80px" class="cls_018"><span class="cls_018">Parmegiani et al., 2011</span><span class="cls_011">;</span><span class="cls_018"> Trokoudes et al., 2011</span><span class="cls_011">); and CPR per oocyte</span></div>
<div style="position:absolute;left:45.35px;top:716.82px" class="cls_011"><span class="cls_011">dence)</span></div>
<div style="position:absolute;left:78.58px;top:716.82px" class="cls_011"><span class="cls_011">(</span><A HREF="http://humupd.oxfordjournals.org/lookup/suppl/doi:10.1093/humupd/dmw038/-/DC1">Supplementary  Fig.  S1a</A>),  lower  LBRs  per  transfer</div>
<div style="position:absolute;left:314.65px;top:716.82px" class="cls_011"><span class="cls_011">utilized (RR = 1.16, 95% CI: 0.57-2.69; P = 0.654; six studies; 1759</span></div>
<div style="position:absolute;left:45.35px;top:728.79px" class="cls_011"><span class="cls_011">(RR = 0.55, 95% CI: 0.44-0.68; P &lt; 0.0001; three studies; 799 and</span></div>
<div style="position:absolute;left:314.65px;top:727.45px" class="cls_011"><span class="cls_011">and 3832 oocytes, vitrification versus fresh, respectively; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011"> = 89.5%,</span></div>
</div>
<div style="position:absolute;left:50%;margin-left:-306px;top:6222px;width:612px;height:790px;border-style:outset;overflow:hidden">
<div style="position:absolute;left:0px;top:0px">
<img src="fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_id_fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_files/background09.jpg" width=612 height=790></div>
<div style="position:absolute;left:48.19px;top:26.63px" class="cls_014"><span class="cls_014">Slow-freezing versus vitrification in ART</span></div>
<div style="position:absolute;left:550.66px;top:25.13px" class="cls_013"><span class="cls_013">147</span></div>
<div style="position:absolute;left:56.18px;top:627.36px" class="cls_020"><span class="cls_020">Figure 2</span><span class="cls_014"> Comparison of slow-freezing versus vitrification: oocytes. (a) Comparison based on CPR/cycle for oocytes: RCT; (b) Comparison based</span></div>
<div style="position:absolute;left:56.18px;top:638.86px" class="cls_014"><span class="cls_014">on CPR/cycle for oocytes: cohort studies; (c) Comparison based on oocyte cryosurvival rate: RCTs. CPR, clinical pregnancy rate.</span></div>
<div style="position:absolute;left:48.19px;top:680.82px" class="cls_011"><span class="cls_011">very low quality evidence) (</span><span class="cls_018">Antinori et al., 2007</span><span class="cls_011">;</span><span class="cls_018"> Almodin et al., 2010</span><span class="cls_011">;</span></div>
<div style="position:absolute;left:317.48px;top:679.86px" class="cls_002"><span class="cls_002">Embryo slow-freezing versus vitrification</span></div>
<div style="position:absolute;left:48.19px;top:692.79px" class="cls_018"><span class="cls_018">Ubaldi et al.,</span></div>
<div style="position:absolute;left:102.61px;top:692.79px" class="cls_018"><span class="cls_018">2010</span><span class="cls_011">;</span><span class="cls_018"> Garcia et al.,</span></div>
<div style="position:absolute;left:182.32px;top:692.79px" class="cls_018"><span class="cls_018">2011</span><span class="cls_011">;</span><span class="cls_018"> Parmegiani et al.,</span></div>
<div style="position:absolute;left:277.45px;top:692.79px" class="cls_018"><span class="cls_018">2011</span><span class="cls_011">;</span></div>
<div style="position:absolute;left:317.48px;top:698.87px" class="cls_013"><span class="cls_013">Slow-freezing versus vitrification: CPR</span></div>
<div style="position:absolute;left:48.19px;top:704.80px" class="cls_018"><span class="cls_018">Trokoudes et al., 2011</span><span class="cls_011">). Each utilized vitrified oocyte had an 8.36%</span></div>
<div style="position:absolute;left:317.48px;top:712.86px" class="cls_011"><span class="cls_011">Given the limited number of RCTs available, results obtained in three</span></div>
<div style="position:absolute;left:48.19px;top:716.82px" class="cls_011"><span class="cls_011">(147/1759) likelihood of resulting in a pregnancy in the population of</span></div>
<div style="position:absolute;left:317.48px;top:724.87px" class="cls_011"><span class="cls_011">RCTs  with  slow-freezing/thawing  versus  vitrification/warming  for</span></div>
<div style="position:absolute;left:48.19px;top:728.79px" class="cls_011"><span class="cls_011">women studied.</span></div>
</div>
<div style="position:absolute;left:50%;margin-left:-306px;top:7022px;width:612px;height:790px;border-style:outset;overflow:hidden">
<div style="position:absolute;left:0px;top:0px">
<img src="fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_id_fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_files/background10.jpg" width=612 height=790></div>
<div style="position:absolute;left:45.35px;top:25.13px" class="cls_013"><span class="cls_013">148</span></div>
<div style="position:absolute;left:525.71px;top:26.63px" class="cls_014"><span class="cls_014">Rienzi et al.</span></div>
<div style="position:absolute;left:45.35px;top:56.80px" class="cls_011"><span class="cls_011">cleavage-stage embryos and blastocysts (</span><span class="cls_018">Kim et al., 2000</span><span class="cls_011">;</span><span class="cls_018"> Rama Raju</span></div>
<div style="position:absolute;left:314.65px;top:56.80px" class="cls_018"><span class="cls_018">Li et al.,</span></div>
<div style="position:absolute;left:351.55px;top:56.80px" class="cls_018"><span class="cls_018">2007</span><span class="cls_011">;</span><span class="cls_018"> Rezazadeh Valojerdi et al., 2009</span><span class="cls_011">;</span><span class="cls_018"> Wilding et al.,</span></div>
<div style="position:absolute;left:45.35px;top:68.82px" class="cls_018"><span class="cls_018">et al., 2005</span><span class="cls_011">;</span><span class="cls_018"> Debrock et al., 2015</span><span class="cls_011">) were pooled. Overall, 638 warming/</span></div>
<div style="position:absolute;left:314.64px;top:68.82px" class="cls_018"><span class="cls_018">2010</span><span class="cls_011">;</span><span class="cls_018"> Sifer et al., 2012</span><span class="cls_011">;</span><span class="cls_018"> Wang et al., 2012</span><span class="cls_011">;</span><span class="cls_018"> Liu et al., 2013</span><span class="cls_011">;</span><span class="cls_018"> Van</span></div>
<div style="position:absolute;left:45.35px;top:80.79px" class="cls_011"><span class="cls_011">thawing cycles (vitrification: n</span></div>
<div style="position:absolute;left:156.02px;top:80.79px" class="cls_011"><span class="cls_011">= 247; slow-freezing: n = 391) were</span></div>
<div style="position:absolute;left:314.65px;top:80.79px" class="cls_018"><span class="cls_018">Landuyt et al., 2013</span><span class="cls_011">;</span><span class="cls_018"> Zhu et al., 2015</span><span class="cls_011">;</span><span class="cls_018"> Kaartinen et al., 2016</span><span class="cls_011">), there</span></div>
<div style="position:absolute;left:45.35px;top:92.80px" class="cls_011"><span class="cls_011">included. Data from pronuclear-stage warming cycles were not available.</span></div>
<div style="position:absolute;left:314.65px;top:92.80px" class="cls_011"><span class="cls_011">was no statistically significant difference in CPR per cycle or CPR</span></div>
<div style="position:absolute;left:45.35px;top:104.82px" class="cls_011"><span class="cls_011">A higher CPR per cycle was obtained with embryo vitrification com-</span></div>
<div style="position:absolute;left:314.65px;top:104.82px" class="cls_011"><span class="cls_011">per  transfer  with  vitrification  compared  with  slow-freezing</span></div>
<div style="position:absolute;left:45.35px;top:116.78px" class="cls_011"><span class="cls_011">pared with slow-freezing though this was of borderline statistical signifi-</span></div>
<div style="position:absolute;left:314.65px;top:116.79px" class="cls_011"><span class="cls_011">(RR = 1.27, 95% CI: 1.00-1.55; P = 0.62; six observational stud-</span></div>
<div style="position:absolute;left:45.35px;top:128.80px" class="cls_011"><span class="cls_011">cance (RR = 1.89, 95% CI: 1.00-3.58; P = 0.051, 638 cycles, three</span></div>
<div style="position:absolute;left:314.65px;top:128.80px" class="cls_011"><span class="cls_011">ies;</span></div>
<div style="position:absolute;left:332.66px;top:128.80px" class="cls_011"><span class="cls_011">7789</span></div>
<div style="position:absolute;left:357.05px;top:127.42px" class="cls_011"><span class="cls_011">cycles;  I</span><span class="cls_016"><sup>2</sup></span></div>
<div style="position:absolute;left:398.55px;top:128.80px" class="cls_011"><span class="cls_011">= 78.8%,  very  low  quality  evidence  and</span></div>
<div style="position:absolute;left:45.35px;top:139.44px" class="cls_011"><span class="cls_011">RCTs; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011"> = 71.9%, low quality evidence, Fig.</span><span class="cls_018"> 3</span><span class="cls_011">a). However, a significant</span></div>
<div style="position:absolute;left:314.64px;top:140.82px" class="cls_011"><span class="cls_011">RR = 1.05, 95% CI: 0.95-1.16; P = 0.33; 10 observational studies;</span></div>
<div style="position:absolute;left:45.35px;top:152.79px" class="cls_011"><span class="cls_011">difference in favor of vitrification was observed when CPR per embryo</span></div>
<div style="position:absolute;left:314.64px;top:151.45px" class="cls_011"><span class="cls_011">17448 embryo transfers; I</span><span class="cls_016"><sup>2</sup></span></div>
<div style="position:absolute;left:427.58px;top:152.79px" class="cls_011"><span class="cls_011">= 67%; very low quality evidence,</span></div>
<div style="position:absolute;left:45.35px;top:164.80px" class="cls_011"><span class="cls_011">transfer was calculated (RR = 1.51, 95% CI: 1.03-2.23; P =</span></div>
<div style="position:absolute;left:257.67px;top:164.80px" class="cls_011"><span class="cls_011">0.036; 488</span></div>
<div style="position:absolute;left:314.64px;top:164.80px" class="cls_011"><span class="cls_011">respectively).</span></div>
<div style="position:absolute;left:45.35px;top:175.44px" class="cls_011"><span class="cls_011">embryo transfers; three RCTs; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011"> = 35%, low quality evidence, Fig.</span><span class="cls_018"> 3</span><span class="cls_011">b).</span></div>
<div style="position:absolute;left:323.66px;top:176.82px" class="cls_011"><span class="cls_011">When restricting the analysis of observational studies to those</span></div>
<div style="position:absolute;left:54.37px;top:188.79px" class="cls_011"><span class="cls_011">When pooling data from cohort studies (</span><span class="cls_018">Kuwayama et al., 2005a</span><span class="cls_011">,</span><span class="cls_018">b</span><span class="cls_011">;</span></div>
<div style="position:absolute;left:314.64px;top:188.79px" class="cls_011"><span class="cls_011">including only blastocyst stage embryos (</span><span class="cls_018">Kuwayama et al., 2005a</span><span class="cls_011">,</span><span class="cls_018">b</span><span class="cls_011">;</span></div>
<div style="position:absolute;left:45.35px;top:200.80px" class="cls_018"><span class="cls_018">Stehlik et al.,</span></div>
<div style="position:absolute;left:97.45px;top:200.80px" class="cls_018"><span class="cls_018">2005</span><span class="cls_011">;</span><span class="cls_018"> Liebermann and Tucker, 2006</span><span class="cls_011">;</span><span class="cls_018"> Li et al., 2007</span><span class="cls_011">;</span></div>
<div style="position:absolute;left:314.65px;top:200.80px" class="cls_018"><span class="cls_018">Stehlik et al.,</span></div>
<div style="position:absolute;left:367.14px;top:200.80px" class="cls_018"><span class="cls_018">2005</span><span class="cls_011">;</span><span class="cls_018"> Liebermann and Tucker, 2006</span><span class="cls_011">), there was no</span></div>
<div style="position:absolute;left:45.35px;top:212.82px" class="cls_018"><span class="cls_018">Rezazadeh Valojerdi et al., 2009</span><span class="cls_011">;</span><span class="cls_018"> Wilding et al., 2010</span><span class="cls_011">;</span><span class="cls_018"> Sifer et al., 2012</span><span class="cls_011">;</span></div>
<div style="position:absolute;left:314.65px;top:212.82px" class="cls_011"><span class="cls_011">statistically significant difference in CPR per cycle or CPR per transfer</span></div>
<div style="position:absolute;left:45.35px;top:224.79px" class="cls_018"><span class="cls_018">Wang et al., 2012</span><span class="cls_011">;</span><span class="cls_018"> Liu et al., 2013</span><span class="cls_011">;</span><span class="cls_018"> Van Landuyt et al., 2013</span><span class="cls_011">;</span><span class="cls_018"> Zhu et al.,</span></div>
<div style="position:absolute;left:314.64px;top:224.79px" class="cls_011"><span class="cls_011">with vitrification compared with slow-freezing (RR = 1.51, 95% CI:</span></div>
<div style="position:absolute;left:45.35px;top:236.80px" class="cls_018"><span class="cls_018">2015</span><span class="cls_011">;</span><span class="cls_018"> Kaartinen et al., 2016</span><span class="cls_011">), there was a significantly higher CPR per</span></div>
<div style="position:absolute;left:314.65px;top:236.80px" class="cls_011"><span class="cls_011">0.69-3.29; P = 0.31; two observational studies;</span></div>
<div style="position:absolute;left:501.96px;top:235.42px" class="cls_011"><span class="cls_011">602 cycles; I</span><span class="cls_016"><sup>2</sup></span></div>
<div style="position:absolute;left:557.97px;top:236.80px" class="cls_011"><span class="cls_011">=</span></div>
<div style="position:absolute;left:45.35px;top:248.82px" class="cls_011"><span class="cls_011">cycle (</span><A HREF="http://humupd.oxfordjournals.org/lookup/suppl/doi:10.1093/humupd/dmw038/-/DC1">Supplementary Fig. S3a</A>), but not per transfer, with vitrification</div>
<div style="position:absolute;left:314.65px;top:248.82px" class="cls_011"><span class="cls_011">78.8%, very low quality evidence and RR = 1.16, 95% CI: 0.89-1.50;</span></div>
<div style="position:absolute;left:45.35px;top:260.79px" class="cls_011"><span class="cls_011">compared  with  slow-freezing</span></div>
<div style="position:absolute;left:161.86px;top:260.79px" class="cls_011"><span class="cls_011">(RR</span></div>
<div style="position:absolute;left:181.81px;top:260.79px" class="cls_011"><span class="cls_011">= 1.27,</span></div>
<div style="position:absolute;left:218.85px;top:260.79px" class="cls_011"><span class="cls_011">95%  CI:</span></div>
<div style="position:absolute;left:257.79px;top:260.79px" class="cls_011"><span class="cls_011">1.05-1.55;</span></div>
<div style="position:absolute;left:314.65px;top:259.45px" class="cls_011"><span class="cls_011">P = 0.27; three observational studies; 5437 embryo transfers; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011"> =</span></div>
<div style="position:absolute;left:45.35px;top:271.42px" class="cls_011"><span class="cls_011">P = 0.015; eight observational studies; 8391 cycles; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011"> = 76.5%, very</span></div>
<div style="position:absolute;left:314.65px;top:272.80px" class="cls_011"><span class="cls_011">61.8%; very low quality evidence, respectively).</span></div>
<div style="position:absolute;left:45.35px;top:284.82px" class="cls_011"><span class="cls_011">low quality evidence and RR = 1.07, 95% CI: 0.98-1.16; P = 0.16; 12</span></div>
<div style="position:absolute;left:45.36px;top:295.45px" class="cls_011"><span class="cls_011">observational studies; 22 885 embryo transfers; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011">  = 64.7%; very low</span></div>
<div style="position:absolute;left:314.65px;top:296.64px" class="cls_013"><span class="cls_013">Slow-freezing versus vitrification LBR</span></div>
<div style="position:absolute;left:45.35px;top:308.80px" class="cls_011"><span class="cls_011">quality evidence, respectively).</span></div>
<div style="position:absolute;left:314.65px;top:310.68px" class="cls_011"><span class="cls_011">The LBR per cycle and per transfer was reported in only one RCT</span></div>
<div style="position:absolute;left:54.37px;top:320.82px" class="cls_011"><span class="cls_011">When restricting the analysis of observational studies to those</span></div>
<div style="position:absolute;left:314.65px;top:322.64px" class="cls_011"><span class="cls_011">performed  with  embryos  at  the  cleavage-stage</span></div>
<div style="position:absolute;left:501.79px;top:322.64px" class="cls_011"><span class="cls_011">(</span><span class="cls_018">Debrock  et  al.,</span></div>
<div style="position:absolute;left:45.35px;top:332.79px" class="cls_011"><span class="cls_011">including only cleavage-stage embryos (</span><span class="cls_018">Kuwayama et al., 2005a</span><span class="cls_011">,</span><span class="cls_018">b</span><span class="cls_011">;</span></div>
<div style="position:absolute;left:314.65px;top:334.66px" class="cls_018"><span class="cls_018">2015</span><span class="cls_011">), with higher rates observed for vitrification (RR = 2.28; 95%</span></div>
<div style="position:absolute;left:53.35px;top:697.72px" class="cls_020"><span class="cls_020">Figure 3</span><span class="cls_014"> Comparison of slow-freezing versus vitrification: embryos. (a) Comparison of slow-freezing versus vitrification on CPR/cycle for</span></div>
<div style="position:absolute;left:53.35px;top:709.22px" class="cls_014"><span class="cls_014">cleavage-stage embryos and blastocysts: RCTs; (b) Comparison of slow-freezing versus vitrification on CPR/embryo transfer for cleavage-stage</span></div>
<div style="position:absolute;left:53.35px;top:720.21px" class="cls_014"><span class="cls_014">embryos and blastocysts: RCTs.</span></div>
</div>
<div style="position:absolute;left:50%;margin-left:-306px;top:7822px;width:612px;height:790px;border-style:outset;overflow:hidden">
<div style="position:absolute;left:0px;top:0px">
<img src="fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_id_fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_files/background11.jpg" width=612 height=790></div>
<div style="position:absolute;left:48.19px;top:26.63px" class="cls_014"><span class="cls_014">Slow-freezing versus vitrification in ART</span></div>
<div style="position:absolute;left:550.66px;top:25.13px" class="cls_013"><span class="cls_013">149</span></div>
<div style="position:absolute;left:48.19px;top:56.80px" class="cls_011"><span class="cls_011">CI:</span></div>
<div style="position:absolute;left:63.38px;top:56.80px" class="cls_011"><span class="cls_011">1.17-4.44; P =</span></div>
<div style="position:absolute;left:130.22px;top:56.80px" class="cls_011"><span class="cls_011">0.016; 216 cycles; low quality evidence and</span></div>
<div style="position:absolute;left:326.49px;top:56.80px" class="cls_011"><span class="cls_011">When restricted to cryosurvival of only cleavage-stage embryos,</span></div>
<div style="position:absolute;left:48.19px;top:68.82px" class="cls_011"><span class="cls_011">RR = 1.862 95% CI: 0.97-3.58; P =</span></div>
<div style="position:absolute;left:190.66px;top:68.82px" class="cls_011"><span class="cls_011">0.062; 179 embryo transfers;</span></div>
<div style="position:absolute;left:317.48px;top:68.82px" class="cls_011"><span class="cls_011">vitrification was superior to slow-freezing (RR = 1.74, 95% CI: 1.39-</span></div>
<div style="position:absolute;left:48.19px;top:80.79px" class="cls_011"><span class="cls_011">low quality evidence, respectively).</span></div>
<div style="position:absolute;left:317.48px;top:79.45px" class="cls_011"><span class="cls_011">2.18; 2531 embryos; P &lt; 0.001; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011">  = 92.2%; moderate quality evi-</span></div>
<div style="position:absolute;left:57.20px;top:92.80px" class="cls_011"><span class="cls_011">Only three observational trials reported LBR per cycle</span></div>
<div style="position:absolute;left:268.10px;top:92.80px" class="cls_011"><span class="cls_011">(</span><span class="cls_018">Wilding</span></div>
<div style="position:absolute;left:317.48px;top:92.80px" class="cls_011"><span class="cls_011">dence) (</span><span class="cls_018">Rama Raju et al., 2005</span><span class="cls_011">;</span><span class="cls_018"> Zheng et al., 2005</span><span class="cls_011">;</span><span class="cls_018"> Balaban et al.,</span></div>
<div style="position:absolute;left:48.19px;top:104.82px" class="cls_018"><span class="cls_018">et  al.,</span></div>
<div style="position:absolute;left:78.75px;top:104.82px" class="cls_018"><span class="cls_018">2010</span><span class="cls_011">;</span><span class="cls_018">  Wang  et  al.,</span></div>
<div style="position:absolute;left:164.41px;top:104.82px" class="cls_018"><span class="cls_018">2012</span><span class="cls_011">;</span><span class="cls_018">  Van  Landuyt  et  al.,</span></div>
<div style="position:absolute;left:277.23px;top:104.82px" class="cls_018"><span class="cls_018">2013</span><span class="cls_011">)</span></div>
<div style="position:absolute;left:317.48px;top:104.82px" class="cls_018"><span class="cls_018">2008</span><span class="cls_011">;</span><span class="cls_018"> Fasano et al., 2014</span><span class="cls_011">;</span><span class="cls_018"> Debrock et al., 2015</span><span class="cls_011">). Post-warming cryo-</span></div>
<div style="position:absolute;left:48.19px;top:116.79px" class="cls_011"><span class="cls_011">(</span><A HREF="http://humupd.oxfordjournals.org/lookup/suppl/doi:10.1093/humupd/dmw038/-/DC1">Supplementary Fig. S3b</A>) and six reported LBR per transfer (<span class="cls_018">Kuwayama</span></div>
<div style="position:absolute;left:317.48px;top:116.79px" class="cls_011"><span class="cls_011">survival rates of vitrified blastocysts were also higher than those</span></div>
<div style="position:absolute;left:48.19px;top:128.80px" class="cls_018"><span class="cls_018">et al., 2005a</span><span class="cls_011">,</span><span class="cls_018">b</span><span class="cls_011">;</span><span class="cls_018"> Wilding et al., 2010</span><span class="cls_011">;</span><span class="cls_018"> Wang et al., 2012</span><span class="cls_011">;</span><span class="cls_018"> Liu et al., 2013</span><span class="cls_011">;</span></div>
<div style="position:absolute;left:317.48px;top:128.80px" class="cls_011"><span class="cls_011">observed with slow-freezing, but did not reach statistical significance</span></div>
<div style="position:absolute;left:48.19px;top:140.82px" class="cls_018"><span class="cls_018">Van Landuyt et al., 2013</span><span class="cls_011">;</span><span class="cls_018"> Kaartinen et al., 2016</span><span class="cls_011">). No differences were</span></div>
<div style="position:absolute;left:317.48px;top:140.82px" class="cls_011"><span class="cls_011">(RR = 1.25: 95% CI: 0.93-1.67; P = 0.13; two RCTs; 1084 blasto-</span></div>
<div style="position:absolute;left:48.19px;top:152.79px" class="cls_011"><span class="cls_011">observed between vitrification and slow-freezing (RR = 1.05, 95% CI:</span></div>
<div style="position:absolute;left:317.48px;top:151.45px" class="cls_011"><span class="cls_011">cysts; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011"> = 82.2%, moderate quality evidence).</span></div>
<div style="position:absolute;left:48.19px;top:163.42px" class="cls_011"><span class="cls_011">0.67-1.65; P = 0.831; 1621 cycles; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011">  = 74.8%; very low quality evi-</span></div>
<div style="position:absolute;left:326.49px;top:164.80px" class="cls_011"><span class="cls_011">Twelve cohort studies (</span><span class="cls_018">Kuwayama et al., 2005a</span><span class="cls_011">,</span><span class="cls_018">b</span><span class="cls_011">;</span><span class="cls_018"> Stehlik et al., 2005</span><span class="cls_011">;</span></div>
<div style="position:absolute;left:48.19px;top:176.82px" class="cls_011"><span class="cls_011">dence and RR = 1.03, 95% CI: 0.91-1.18; P = 0.62; 14 996 embryo</span></div>
<div style="position:absolute;left:317.48px;top:176.82px" class="cls_018"><span class="cls_018">Liebermann and Tucker, 2006</span><span class="cls_011">;</span><span class="cls_018"> Li et al., 2007</span><span class="cls_011">;</span><span class="cls_018"> Rezazadeh Valojerdi</span></div>
<div style="position:absolute;left:48.19px;top:187.45px" class="cls_011"><span class="cls_011">transfers; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011"> = 45.8%; very low quality evidence, respectively).</span></div>
<div style="position:absolute;left:317.48px;top:188.79px" class="cls_018"><span class="cls_018">et al., 2009</span><span class="cls_011">;</span><span class="cls_018"> Wilding et al., 2010</span><span class="cls_011">;</span><span class="cls_018"> Sifer et al., 2012</span><span class="cls_011">;</span><span class="cls_018"> Wang et al., 2012</span><span class="cls_011">;</span></div>
<div style="position:absolute;left:57.20px;top:200.80px" class="cls_011"><span class="cls_011">When restricting the analysis of observational studies to those</span></div>
<div style="position:absolute;left:317.48px;top:200.80px" class="cls_018"><span class="cls_018">Liu et al., 2013</span><span class="cls_011">;</span><span class="cls_018"> Van Landuyt et al., 2013</span><span class="cls_011">;</span><span class="cls_018"> Zhu et al., 2015</span><span class="cls_011">;</span><span class="cls_018"> Summers</span></div>
<div style="position:absolute;left:48.19px;top:212.82px" class="cls_011"><span class="cls_011">including only cleavage-stage embryos (</span><span class="cls_018">Kuwayama et al., 2005a</span><span class="cls_011">,</span><span class="cls_018">b</span><span class="cls_011">;</span><span class="cls_018"> Li</span></div>
<div style="position:absolute;left:317.48px;top:212.82px" class="cls_018"><span class="cls_018">et al., 2016</span><span class="cls_011">) with 64 982 cryopreserved pronuclear stage, cleavage-stage</span></div>
<div style="position:absolute;left:48.19px;top:224.79px" class="cls_018"><span class="cls_018">et al.,</span></div>
<div style="position:absolute;left:72.57px;top:224.79px" class="cls_018"><span class="cls_018">2007</span><span class="cls_011">;</span><span class="cls_018"> Rezazadeh Valojerdi et al., 2009</span><span class="cls_011">;</span><span class="cls_018"> Wilding et al., 2010</span><span class="cls_011">;</span></div>
<div style="position:absolute;left:317.48px;top:224.79px" class="cls_011"><span class="cls_011">embryos or blastocysts were identified. The pooled data showed that</span></div>
<div style="position:absolute;left:48.19px;top:236.80px" class="cls_018"><span class="cls_018">Sifer et al.,</span></div>
<div style="position:absolute;left:91.79px;top:236.80px" class="cls_018"><span class="cls_018">2012</span><span class="cls_011">;</span><span class="cls_018"> Wang et al., 2012</span><span class="cls_011">;</span><span class="cls_018"> Liu et al., 2013</span><span class="cls_011">;</span><span class="cls_018"> Van Landuyt</span></div>
<div style="position:absolute;left:317.48px;top:236.80px" class="cls_011"><span class="cls_011">vitrification was associated with a significant improvement in embryo</span></div>
<div style="position:absolute;left:48.19px;top:248.82px" class="cls_018"><span class="cls_018">et al., 2013</span><span class="cls_011">;</span><span class="cls_018"> Zhu et al., 2015</span><span class="cls_011">;</span><span class="cls_018"> Kaartinen et al., 2016</span><span class="cls_011">), there was no</span></div>
<div style="position:absolute;left:317.48px;top:247.44px" class="cls_011"><span class="cls_011">cryosurvival (RR = 1.12, 95% CI: 1.07-1.18; P &lt; 0.001; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011"> = 98.6% very</span></div>
<div style="position:absolute;left:48.19px;top:260.79px" class="cls_011"><span class="cls_011">significant difference in LBR per cycle or LBR per transfer with vitrifi-</span></div>
<div style="position:absolute;left:317.48px;top:260.79px" class="cls_011"><span class="cls_011">low  quality  evidence)</span></div>
<div style="position:absolute;left:401.55px;top:260.79px" class="cls_011"><span class="cls_011">(</span><A HREF="http://humupd.oxfordjournals.org/lookup/suppl/doi:10.1093/humupd/dmw038/-/DC1">Supplementary  Fig.  S4</A>).  When  stratified  by</div>
<div style="position:absolute;left:48.19px;top:272.80px" class="cls_011"><span class="cls_011">cation compared with slow-freezing (RR = 1.05, 95% CI: 0.67-1.65;</span></div>
<div style="position:absolute;left:317.48px;top:272.80px" class="cls_011"><span class="cls_011">embryo  stage,  the  cryosurvival  rates  favored  vitrification  for  both</span></div>
<div style="position:absolute;left:48.19px;top:283.44px" class="cls_011"><span class="cls_011">P = 0.83; three observational studies; 1621 cycles; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011"> = 74.8%, very</span></div>
<div style="position:absolute;left:317.48px;top:284.82px" class="cls_011"><span class="cls_011">cleavage-stage embryos (RR = 1.14, 95% CI: 1.07-1.22; P &lt; 0.001; 10</span></div>
<div style="position:absolute;left:48.19px;top:296.79px" class="cls_011"><span class="cls_011">low quality evidence and RR = 1.02, 95% CI: 0.87-1.20; P = 0.77;</span></div>
<div style="position:absolute;left:317.48px;top:295.45px" class="cls_011"><span class="cls_011">cohort studies; 49 200 embryos; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011"> = 99%; very low quality evidence)</span></div>
<div style="position:absolute;left:48.19px;top:307.42px" class="cls_011"><span class="cls_011">five observational studies; 10 153 embryo transfers; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011"> = 52.7%; very</span></div>
<div style="position:absolute;left:317.48px;top:308.80px" class="cls_011"><span class="cls_011">and blastocysts (RR = 1.08, 95% CI: 1.02-1.15; P = 0.005; three cohort</span></div>
<div style="position:absolute;left:48.19px;top:320.82px" class="cls_011"><span class="cls_011">low quality evidence, respectively).</span></div>
<div style="position:absolute;left:317.48px;top:319.43px" class="cls_011"><span class="cls_011">studies; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011"> = 70.0%, very low quality evidence).</span></div>
<div style="position:absolute;left:57.20px;top:332.79px" class="cls_011"><span class="cls_011">When restricting the analysis of observational studies to those</span></div>
<div style="position:absolute;left:48.19px;top:344.80px" class="cls_011"><span class="cls_011">including only blastocyst stage embryos (</span><span class="cls_018">Kuwayama et al., 2005a</span><span class="cls_011">,</span><span class="cls_018">b</span><span class="cls_011">;</span></div>
<div style="position:absolute;left:48.19px;top:356.82px" class="cls_018"><span class="cls_018">Stehlik et al., 2005</span><span class="cls_011">;</span><span class="cls_018"> Liebermann and Tucker, 2006</span><span class="cls_011">), there was no sig-</span></div>
<div style="position:absolute;left:317.48px;top:356.10px" class="cls_017"><span class="cls_017">Discussion</span></div>
<div style="position:absolute;left:48.19px;top:368.79px" class="cls_011"><span class="cls_011">nificant difference in LBR per cycle with vitrification compared with</span></div>
<div style="position:absolute;left:48.19px;top:380.80px" class="cls_011"><span class="cls_011">slow-freezing (RR = 1.10, 95% CI: 0.87-1.40; P = 0.42; 1 observa-</span></div>
<div style="position:absolute;left:317.48px;top:380.07px" class="cls_011"><span class="cls_011">The principal findings of this systematic review and meta-analysis</span></div>
<div style="position:absolute;left:48.19px;top:392.82px" class="cls_011"><span class="cls_011">tional study; 4843 cycles; very low quality evidence).</span></div>
<div style="position:absolute;left:317.48px;top:392.09px" class="cls_011"><span class="cls_011">support vitrification as being superior to slow-freezing for cryopreser-</span></div>
<div style="position:absolute;left:317.48px;top:404.11px" class="cls_011"><span class="cls_011">vation of both human oocytes and embryos in clinical ART. While</span></div>
<div style="position:absolute;left:317.48px;top:416.07px" class="cls_011"><span class="cls_011">the quality of the evidence for clinical outcomes comparing the two</span></div>
<div style="position:absolute;left:48.19px;top:426.07px" class="cls_013"><span class="cls_013">Slow-freezing versus vitrification: embryo cryosurvival</span></div>
<div style="position:absolute;left:317.48px;top:428.09px" class="cls_011"><span class="cls_011">cryopreservation methods was mostly low and based on clinical preg-</span></div>
<div style="position:absolute;left:48.19px;top:440.11px" class="cls_011"><span class="cls_011">Data were pooled from the seven RCTs (</span><span class="cls_018">Kim et al., 2000</span><span class="cls_011">;</span><span class="cls_018"> Huang et al.,</span></div>
<div style="position:absolute;left:317.48px;top:440.10px" class="cls_011"><span class="cls_011">nancy,  rather  than  live-birth,  that  for  post-thaw  cryosurvival  of</span></div>
<div style="position:absolute;left:48.19px;top:452.07px" class="cls_018"><span class="cls_018">2005</span><span class="cls_011">;</span><span class="cls_018"> Rama Raju et al., 2005</span><span class="cls_011">;</span><span class="cls_018"> Zheng et al., 2005</span><span class="cls_011">;</span><span class="cls_018"> Balaban et al., 2008</span><span class="cls_011">;</span></div>
<div style="position:absolute;left:317.48px;top:452.07px" class="cls_011"><span class="cls_011">oocytes and embryos was moderate.</span></div>
<div style="position:absolute;left:48.19px;top:464.09px" class="cls_018"><span class="cls_018">Fasano et al., 2014</span><span class="cls_011">;</span><span class="cls_018"> Debrock et al., 2015</span><span class="cls_011">) involving 3615 cleavage-stage</span></div>
<div style="position:absolute;left:326.49px;top:464.08px" class="cls_011"><span class="cls_011">The introduction of vitrification over the last decade and its exten-</span></div>
<div style="position:absolute;left:48.19px;top:476.11px" class="cls_011"><span class="cls_011">embryos and blastocysts (slow-freezing: n = 2061; vitrification: n</span></div>
<div style="position:absolute;left:291.57px;top:476.11px" class="cls_011"><span class="cls_011">=</span></div>
<div style="position:absolute;left:317.48px;top:476.10px" class="cls_011"><span class="cls_011">sive application has improved human oocyte and embryo cryosurvival</span></div>
<div style="position:absolute;left:48.19px;top:488.07px" class="cls_011"><span class="cls_011">1554). The analysis revealed that vitrification was associated with a sig-</span></div>
<div style="position:absolute;left:317.48px;top:488.07px" class="cls_011"><span class="cls_011">rates and clinical outcomes after replacement of embryos cryopre-</span></div>
<div style="position:absolute;left:48.19px;top:500.09px" class="cls_011"><span class="cls_011">nificant improvement in embryo cryosurvival (RR = 1.59, 95% CI: 1.30-</span></div>
<div style="position:absolute;left:317.48px;top:500.08px" class="cls_011"><span class="cls_011">served at different stages of development. As shown in this study,</span></div>
<div style="position:absolute;left:48.19px;top:510.72px" class="cls_011"><span class="cls_011">1.93; P &lt; 0.001; I</span><span class="cls_016"><sup>2</sup></span><span class="cls_011"> = 93%; moderate quality evidence) (Fig.</span><span class="cls_018"> 4</span><span class="cls_011">).</span></div>
<div style="position:absolute;left:317.48px;top:512.10px" class="cls_011"><span class="cls_011">recent evidence has revealed that this technique has closed the gap</span></div>
<div style="position:absolute;left:56.18px;top:719.15px" class="cls_020"><span class="cls_020">Figure 4</span><span class="cls_014"> Comparison of slow-freezing versus vitrification on cryosurvival rate for cleavage-stage embryos and blastocysts: RCTs.</span></div>
</div>
<div style="position:absolute;left:50%;margin-left:-306px;top:8622px;width:612px;height:790px;border-style:outset;overflow:hidden">
<div style="position:absolute;left:0px;top:0px">
<img src="fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_id_fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_files/background12.jpg" width=612 height=790></div>
<div style="position:absolute;left:45.35px;top:25.13px" class="cls_013"><span class="cls_013">150</span></div>
<div style="position:absolute;left:525.71px;top:26.63px" class="cls_014"><span class="cls_014">Rienzi et al.</span></div>
<div style="position:absolute;left:45.35px;top:56.80px" class="cls_011"><span class="cls_011">between fresh and cryopreserved oocytes in good-prognosis patients.</span></div>
<div style="position:absolute;left:314.65px;top:56.80px" class="cls_011"><span class="cls_011">2001). It has been estimated that in Europe in 2011 cryopreservation</span></div>
<div style="position:absolute;left:45.35px;top:68.82px" class="cls_011"><span class="cls_011">However, although vitrification has allowed a substantial improve-</span></div>
<div style="position:absolute;left:314.65px;top:68.82px" class="cls_011"><span class="cls_011">contributed to the overall LBR by 4% (LBR increasing from 19.7%</span></div>
<div style="position:absolute;left:45.35px;top:80.79px" class="cls_011"><span class="cls_011">ment in oocyte cryosurvival, when applied in an unselected popula-</span></div>
<div style="position:absolute;left:314.65px;top:80.78px" class="cls_011"><span class="cls_011">with only fresh cycles to 24.0% including cryo-cycles) (</span><span class="cls_018">Kupka et al.,</span></div>
<div style="position:absolute;left:45.35px;top:92.80px" class="cls_011"><span class="cls_011">tion  of  patients</span></div>
<div style="position:absolute;left:111.18px;top:92.80px" class="cls_011"><span class="cls_011">(e.g.  as  a  result  of  law)  the  clinical  outcomes</span></div>
<div style="position:absolute;left:314.64px;top:92.80px" class="cls_018"><span class="cls_018">2016</span><span class="cls_011">). In countries where cryopreservation is systematically applied,</span></div>
<div style="position:absolute;left:45.35px;top:104.82px" class="cls_011"><span class="cls_011">remained generally low (Fig.</span><span class="cls_018"> 2</span><span class="cls_011">b). For embryo and blastocyst cryosur-</span></div>
<div style="position:absolute;left:314.65px;top:104.82px" class="cls_011"><span class="cls_011">the contribution is even more apparent: Finland +13.4%, Switzerland</span></div>
<div style="position:absolute;left:45.35px;top:116.79px" class="cls_011"><span class="cls_011">vival, available data suggest an improvement with the use of vitrifica-</span></div>
<div style="position:absolute;left:314.65px;top:116.79px" class="cls_011"><span class="cls_011">+10.2% and Australia and New Zealand +13.5% (</span><span class="cls_018">Macaldowie et al.,</span></div>
<div style="position:absolute;left:45.35px;top:128.80px" class="cls_011"><span class="cls_011">tion compared to slow-freezing, albeit over a wide range (30-93%).</span></div>
<div style="position:absolute;left:314.65px;top:128.80px" class="cls_018"><span class="cls_018">2012</span><span class="cls_011">;</span><span class="cls_018"> Kupka et al., 2016</span><span class="cls_011">). These data reflect improvements obtained</span></div>
<div style="position:absolute;left:45.35px;top:140.82px" class="cls_011"><span class="cls_011">Accordingly, a typical laboratory could improve from ~60% embryo</span></div>
<div style="position:absolute;left:314.65px;top:140.82px" class="cls_011"><span class="cls_011">in embryo culture, cryopreservation technologies and/or the adop-</span></div>
<div style="position:absolute;left:45.35px;top:152.78px" class="cls_011"><span class="cls_011">cryosurvival rate using slow-freezing to 78-100% embryo cryosurvival</span></div>
<div style="position:absolute;left:314.65px;top:152.79px" class="cls_011"><span class="cls_011">tion of a more conservative embryo transfer policy (i.e. when fewer</span></div>
<div style="position:absolute;left:45.35px;top:164.80px" class="cls_011"><span class="cls_011">rate using vitrification. A beneficial treatment effect was also identi-</span></div>
<div style="position:absolute;left:314.65px;top:164.80px" class="cls_011"><span class="cls_011">embryos  are  transferred  in  fresh  cycles,  more  are  available  for</span></div>
<div style="position:absolute;left:45.35px;top:176.82px" class="cls_011"><span class="cls_011">fied in RCTs for CPRs and LBRs per embryo and/or blastocyst</span></div>
<div style="position:absolute;left:314.65px;top:176.82px" class="cls_011"><span class="cls_011">cryopreservation).</span></div>
<div style="position:absolute;left:45.35px;top:188.78px" class="cls_011"><span class="cls_011">warming cycle and per transfer.</span></div>
<div style="position:absolute;left:54.37px;top:200.80px" class="cls_011"><span class="cls_011">Due  to  the  improved  cryosurvival  outcomes  with  vitrification</span></div>
<div style="position:absolute;left:45.35px;top:212.82px" class="cls_011"><span class="cls_011">(</span><span class="cls_018">Evans et al., 2014</span><span class="cls_011">;</span><span class="cls_018"> Argyle et al., 2016</span><span class="cls_011">) many laboratories worldwide</span></div>
<div style="position:absolute;left:314.65px;top:212.83px" class="cls_002"><span class="cls_002">Embryo transfer policy and cryopreservation</span></div>
<div style="position:absolute;left:45.35px;top:224.79px" class="cls_011"><span class="cls_011">have completely replaced slow-freezing with vitrification. It is there-</span></div>
<div style="position:absolute;left:314.65px;top:230.80px" class="cls_011"><span class="cls_011">Considerable differences exist in embryo transfer policies across the</span></div>
<div style="position:absolute;left:45.35px;top:236.80px" class="cls_011"><span class="cls_011">fore unlikely that additional prospective comparisons with current</span></div>
<div style="position:absolute;left:314.65px;top:242.81px" class="cls_011"><span class="cls_011">world. Where not legally restricted, the number of embryos transferred</span></div>
<div style="position:absolute;left:45.35px;top:248.82px" class="cls_011"><span class="cls_011">protocols will be performed.</span></div>
<div style="position:absolute;left:314.65px;top:254.83px" class="cls_011"><span class="cls_011">simultaneously depends upon clinical decision-making, reimbursement</span></div>
<div style="position:absolute;left:54.37px;top:260.78px" class="cls_011"><span class="cls_011">The optimized oocyte/embryo/blastocyst cryosurvival rates and</span></div>
<div style="position:absolute;left:314.65px;top:266.79px" class="cls_011"><span class="cls_011">strategies and other financial considerations and competency in cryo-</span></div>
<div style="position:absolute;left:45.35px;top:272.80px" class="cls_011"><span class="cls_011">clinical outcomes achieved with the use of vitrification have important</span></div>
<div style="position:absolute;left:314.65px;top:278.81px" class="cls_011"><span class="cls_011">preservation technologies. Despite a general trend towards transferring</span></div>
<div style="position:absolute;left:45.35px;top:284.82px" class="cls_011"><span class="cls_011">clinical implications, which together allow a personalized approach in</span></div>
<div style="position:absolute;left:314.65px;top:290.83px" class="cls_011"><span class="cls_011">fewer embryos (</span><span class="cls_018">Clua et al.,</span></div>
<div style="position:absolute;left:423.55px;top:290.83px" class="cls_018"><span class="cls_018">2012</span><span class="cls_011">), the mean percentage of single</span></div>
<div style="position:absolute;left:45.35px;top:296.78px" class="cls_011"><span class="cls_011">the care of different patient populations (Fig.</span><span class="cls_018"> 5</span><span class="cls_011">).</span></div>
<div style="position:absolute;left:314.65px;top:302.80px" class="cls_011"><span class="cls_011">embryo transfers was only 27% in Europe in 2011 (</span><span class="cls_018">Kupka et al., 2016</span><span class="cls_011">)</span></div>
<div style="position:absolute;left:314.65px;top:314.81px" class="cls_011"><span class="cls_011">and 17% in the USA (</span><span class="cls_018">CDC, 2011</span><span class="cls_011">). On the other hand, in Australia and</span></div>
<div style="position:absolute;left:314.65px;top:326.83px" class="cls_011"><span class="cls_011">New Zealand, single embryo transfer is performed in more than 75% of</span></div>
<div style="position:absolute;left:45.35px;top:326.89px" class="cls_002"><span class="cls_002">Contribution of cryopreservation to the</span></div>
<div style="position:absolute;left:314.65px;top:338.79px" class="cls_011"><span class="cls_011">cycles (</span><span class="cls_018">Macaldowie et al., 2012</span><span class="cls_011">). The incidence of multiple pregnancies,</span></div>
<div style="position:absolute;left:45.35px;top:340.90px" class="cls_002"><span class="cls_002">cumulative LBR</span></div>
<div style="position:absolute;left:314.65px;top:350.81px" class="cls_011"><span class="cls_011">an unavoidable outcome of IVF when more than one embryo is</span></div>
<div style="position:absolute;left:45.35px;top:358.92px" class="cls_011"><span class="cls_011">Cryopreserved embryo transfers contribute substantially to the total</span></div>
<div style="position:absolute;left:314.65px;top:362.83px" class="cls_011"><span class="cls_011">transferred, is strongly correlated to the embryo transfer policy and</span></div>
<div style="position:absolute;left:45.35px;top:370.88px" class="cls_011"><span class="cls_011">success  rate  of  an  IVF  cycle.  Cumulative  live  birthrate</span></div>
<div style="position:absolute;left:263.23px;top:370.88px" class="cls_011"><span class="cls_011">(CLB)  is</span></div>
<div style="position:absolute;left:314.65px;top:374.79px" class="cls_011"><span class="cls_011">varies from 19.8% in USA (</span><span class="cls_018">CDC, 2011</span><span class="cls_011">) and 19.2% in Europe (</span><span class="cls_018">Kupka</span></div>
<div style="position:absolute;left:45.35px;top:382.90px" class="cls_011"><span class="cls_011">defined as the likelihood of having an offspring after the utilization of</span></div>
<div style="position:absolute;left:314.65px;top:386.81px" class="cls_018"><span class="cls_018">et al.,</span></div>
<div style="position:absolute;left:340.27px;top:386.81px" class="cls_018"><span class="cls_018">2016</span><span class="cls_011">) to 6.5% in Australia and New Zealand (</span><span class="cls_018">Macaldowie</span></div>
<div style="position:absolute;left:45.35px;top:394.92px" class="cls_011"><span class="cls_011">all retrieved oocytes and associated embryos, thereby involving the</span></div>
<div style="position:absolute;left:314.65px;top:398.83px" class="cls_018"><span class="cls_018">et al., 2012</span><span class="cls_011">).</span></div>
<div style="position:absolute;left:45.35px;top:406.88px" class="cls_011"><span class="cls_011">transfer  of  fresh  as  well  as  all  cryopreserved  embryos.  CLB  is</span></div>
<div style="position:absolute;left:323.66px;top:410.80px" class="cls_011"><span class="cls_011">The main reasons for transferring more than one embryo are asso-</span></div>
<div style="position:absolute;left:45.35px;top:418.90px" class="cls_011"><span class="cls_011">acknowledged as the most appropriate outcome measure in IVF to</span></div>
<div style="position:absolute;left:314.65px;top:422.81px" class="cls_011"><span class="cls_011">ciated with the relative low efficiency of IVF, the poor prediction for</span></div>
<div style="position:absolute;left:45.35px;top:430.92px" class="cls_011"><span class="cls_011">be used by practitioners and health administrators (Tiitinen et al.,</span></div>
<div style="position:absolute;left:314.65px;top:434.83px" class="cls_011"><span class="cls_011">embryo implantation potential and concerns regarding the quality of</span></div>
<div style="position:absolute;left:314.65px;top:446.79px" class="cls_011"><span class="cls_011">cryopreservation programmes. Other motivations are also related to</span></div>
<div style="position:absolute;left:314.65px;top:458.81px" class="cls_011"><span class="cls_011">the emotional and financial burden of ART treatment and lack of</span></div>
<div style="position:absolute;left:314.65px;top:470.83px" class="cls_011"><span class="cls_011">strong guidelines or regulatory bodies concerning embryo transfer</span></div>
<div style="position:absolute;left:155.55px;top:483.00px" class="cls_024"><span class="cls_024">Enhances</span></div>
<div style="position:absolute;left:314.65px;top:482.79px" class="cls_011"><span class="cls_011">policy (</span><span class="cls_018">ESHRE Campus report 2001</span><span class="cls_011">). In this context, it is clear that</span></div>
<div style="position:absolute;left:148.29px;top:491.41px" class="cls_024"><span class="cls_024">cumulative live</span></div>
<div style="position:absolute;left:314.65px;top:494.81px" class="cls_011"><span class="cls_011">improvements in embryology technologies, including embryo assess-</span></div>
<div style="position:absolute;left:151.44px;top:499.80px" class="cls_024"><span class="cls_024">birth rate per</span></div>
<div style="position:absolute;left:147.54px;top:508.21px" class="cls_024"><span class="cls_024">oocyte retrieval</span></div>
<div style="position:absolute;left:314.65px;top:506.83px" class="cls_011"><span class="cls_011">ment and cryopreservation protocols, are essential for promoting sin-</span></div>
<div style="position:absolute;left:163.18px;top:516.60px" class="cls_024"><span class="cls_024">cycle</span></div>
<div style="position:absolute;left:230.25px;top:518.78px" class="cls_024"><span class="cls_024">Allows</span></div>
<div style="position:absolute;left:82.35px;top:522.98px" class="cls_024"><span class="cls_024">Enables egg</span></div>
<div style="position:absolute;left:314.65px;top:518.79px" class="cls_011"><span class="cls_011">gle embryo transfer policies with an aim to reduce the maternal and</span></div>
<div style="position:absolute;left:224.02px;top:527.18px" class="cls_024"><span class="cls_024">systematic</span></div>
<div style="position:absolute;left:84.60px;top:531.38px" class="cls_024"><span class="cls_024">banking for</span></div>
<div style="position:absolute;left:314.65px;top:530.81px" class="cls_011"><span class="cls_011">neonatal risks associated with multiple gestations. Of note, elective</span></div>
<div style="position:absolute;left:219.78px;top:535.58px" class="cls_024"><span class="cls_024">application of</span></div>
<div style="position:absolute;left:77.58px;top:539.78px" class="cls_024"><span class="cls_024">donation and/or</span></div>
<div style="position:absolute;left:218.39px;top:543.98px" class="cls_024"><span class="cls_024">elective single</span></div>
<div style="position:absolute;left:314.65px;top:542.83px" class="cls_011"><span class="cls_011">single embryo transfer policy combined with enhanced embryo selec-</span></div>
<div style="position:absolute;left:86.55px;top:548.18px" class="cls_024"><span class="cls_024">for oocyte</span></div>
<div style="position:absolute;left:216.06px;top:552.38px" class="cls_024"><span class="cls_024">embryo transfer</span></div>
<div style="position:absolute;left:81.23px;top:556.58px" class="cls_024"><span class="cls_024">accumulation</span></div>
<div style="position:absolute;left:314.65px;top:554.79px" class="cls_011"><span class="cls_011">tion  and  vitrification  is  also  a  realistic  option  in  poor-prognosis</span></div>
<div style="position:absolute;left:157.44px;top:562.96px" class="cls_025"><span class="cls_025">Efficient</span></div>
<div style="position:absolute;left:231.37px;top:560.78px" class="cls_024"><span class="cls_024">policy</span></div>
<div style="position:absolute;left:314.65px;top:566.81px" class="cls_011"><span class="cls_011">patients of advanced maternal age (</span><span class="cls_018">Ubaldi et al., 2015</span><span class="cls_011">).</span></div>
<div style="position:absolute;left:142.84px;top:571.36px" class="cls_025"><span class="cls_025">cryopreservation</span></div>
<div style="position:absolute;left:146.42px;top:579.76px" class="cls_025"><span class="cls_025">programme for</span></div>
<div style="position:absolute;left:150.74px;top:588.16px" class="cls_025"><span class="cls_025">oocytes and</span></div>
<div style="position:absolute;left:156.57px;top:596.56px" class="cls_025"><span class="cls_025">embryos</span></div>
<div style="position:absolute;left:79.08px;top:602.93px" class="cls_024"><span class="cls_024">Permits fertility</span></div>
<div style="position:absolute;left:220.99px;top:607.14px" class="cls_024"><span class="cls_024">Provides the</span></div>
<div style="position:absolute;left:314.65px;top:602.82px" class="cls_002"><span class="cls_002">IVF cycle segmentation</span></div>
<div style="position:absolute;left:77.71px;top:611.34px" class="cls_024"><span class="cls_024">preservation for</span></div>
<div style="position:absolute;left:219.22px;top:615.54px" class="cls_024"><span class="cls_024">opportunity to</span></div>
<div style="position:absolute;left:82.99px;top:619.73px" class="cls_024"><span class="cls_024">medical and</span></div>
<div style="position:absolute;left:219.47px;top:623.94px" class="cls_024"><span class="cls_024">perform cycle</span></div>
<div style="position:absolute;left:314.65px;top:620.84px" class="cls_011"><span class="cls_011">A new strategy, called ‘cycle segmentation’, has recently been pro-</span></div>
<div style="position:absolute;left:82.07px;top:628.14px" class="cls_024"><span class="cls_024">non - medical</span></div>
<div style="position:absolute;left:219.48px;top:632.34px" class="cls_024"><span class="cls_024">segmentation</span></div>
<div style="position:absolute;left:314.65px;top:632.80px" class="cls_011"><span class="cls_011">posed that comprises a planned ‘freeze all’ of all oocytes and/or</span></div>
<div style="position:absolute;left:85.37px;top:636.53px" class="cls_024"><span class="cls_024">indications</span></div>
<div style="position:absolute;left:314.65px;top:644.82px" class="cls_011"><span class="cls_011">embryos. In this setting ovarian stimulation is optimized, including</span></div>
<div style="position:absolute;left:150.95px;top:651.31px" class="cls_024"><span class="cls_024">Extends time</span></div>
<div style="position:absolute;left:154.50px;top:659.71px" class="cls_024"><span class="cls_024">for embryo</span></div>
<div style="position:absolute;left:314.65px;top:656.84px" class="cls_011"><span class="cls_011">final oocyte maturation triggering with GnRH agonist in an antagonist</span></div>
<div style="position:absolute;left:155.27px;top:668.11px" class="cls_024"><span class="cls_024">evaluation</span></div>
<div style="position:absolute;left:314.65px;top:668.80px" class="cls_011"><span class="cls_011">cycle, all oocytes and/or embryos are cryopreserved (segment A)</span></div>
<div style="position:absolute;left:314.65px;top:680.82px" class="cls_011"><span class="cls_011">and later transferred to a receptive endometrium in a subsequent</span></div>
<div style="position:absolute;left:314.65px;top:692.78px" class="cls_011"><span class="cls_011">cycle (segment B) (</span><span class="cls_018">Devroey et al., 2011</span><span class="cls_011">). This approach has been</span></div>
<div style="position:absolute;left:314.65px;top:704.80px" class="cls_011"><span class="cls_011">tested with cryopreserved oocytes, pronuclear-stage and/or cleaved</span></div>
<div style="position:absolute;left:53.35px;top:708.72px" class="cls_020"><span class="cls_020">Figure 5</span><span class="cls_014"> Clinical  implications  related  to  optimization  of  cryo-</span></div>
<div style="position:absolute;left:314.65px;top:716.82px" class="cls_011"><span class="cls_011">embryos in patients at risk of ovarian hyperstimulation syndrome</span></div>
<div style="position:absolute;left:53.35px;top:720.21px" class="cls_014"><span class="cls_014">preservation in IVF.</span></div>
<div style="position:absolute;left:314.65px;top:728.78px" class="cls_011"><span class="cls_011">(OHSS) (</span><span class="cls_018">Griesinger et al., 2007</span><span class="cls_011">,</span><span class="cls_018">2011</span><span class="cls_011">;</span><span class="cls_018"> Herrero et al., 2011</span><span class="cls_011">). With this</span></div>
</div>
<div style="position:absolute;left:50%;margin-left:-306px;top:9422px;width:612px;height:790px;border-style:outset;overflow:hidden">
<div style="position:absolute;left:0px;top:0px">
<img src="fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_id_fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_files/background13.jpg" width=612 height=790></div>
<div style="position:absolute;left:48.19px;top:26.63px" class="cls_014"><span class="cls_014">Slow-freezing versus vitrification in ART</span></div>
<div style="position:absolute;left:550.66px;top:25.13px" class="cls_013"><span class="cls_013">151</span></div>
<div style="position:absolute;left:48.19px;top:56.80px" class="cls_011"><span class="cls_011">strategy, the risk of OHSS can be almost eliminated (</span><span class="cls_018">Fatemi et al.,</span></div>
<div style="position:absolute;left:317.48px;top:56.80px" class="cls_011"><span class="cls_011">implementation of new forms of collaboration between centres (even</span></div>
<div style="position:absolute;left:48.19px;top:68.82px" class="cls_018"><span class="cls_018">2010</span><span class="cls_011">;</span><span class="cls_018"> Youssef et al., 2014</span><span class="cls_011">).</span></div>
<div style="position:absolute;left:317.48px;top:68.82px" class="cls_011"><span class="cls_011">when located in different countries). For example, an egg bank may</span></div>
<div style="position:absolute;left:57.20px;top:80.79px" class="cls_011"><span class="cls_011">Furthermore, transfer of exclusively cryopreserved single blasto-</span></div>
<div style="position:absolute;left:317.48px;top:80.78px" class="cls_011"><span class="cls_011">provide donor evaluation and screening, ovarian stimulation, oocyte</span></div>
<div style="position:absolute;left:48.19px;top:92.80px" class="cls_011"><span class="cls_011">cysts in a population-based cohort study was found to decrease the</span></div>
<div style="position:absolute;left:317.48px;top:92.80px" class="cls_011"><span class="cls_011">retrieval and cryopreservation, and then release these cryopreserved</span></div>
<div style="position:absolute;left:48.19px;top:104.82px" class="cls_011"><span class="cls_011">risk of ectopic pregnancy (</span><span class="cls_018">Li et al., 2015</span><span class="cls_011">) and increase IVF success</span></div>
<div style="position:absolute;left:317.48px;top:104.82px" class="cls_011"><span class="cls_011">donor oocytes for recipient use at associated IVF clinics (</span><span class="cls_018">Nagy et al.,</span></div>
<div style="position:absolute;left:48.19px;top:116.79px" class="cls_011"><span class="cls_011">rates with no increase in adverse perinatal outcomes (</span><span class="cls_018">Li et al., 2014</span><span class="cls_011">).</span></div>
<div style="position:absolute;left:317.48px;top:116.79px" class="cls_018"><span class="cls_018">2015</span><span class="cls_011">).  Consequently,  oocyte  vitrification  has  provided  important</span></div>
<div style="position:absolute;left:48.19px;top:128.80px" class="cls_011"><span class="cls_011">Improvements of clinical and ongoing pregnancy rates with the use of</span></div>
<div style="position:absolute;left:317.48px;top:128.80px" class="cls_011"><span class="cls_011">benefits for patients requiring donation, especially in those countries</span></div>
<div style="position:absolute;left:48.19px;top:140.82px" class="cls_011"><span class="cls_011">cryopreserved compared to fresh embryos have been reported in a</span></div>
<div style="position:absolute;left:317.48px;top:140.82px" class="cls_011"><span class="cls_011">where there is a lack of donors.</span></div>
<div style="position:absolute;left:48.19px;top:152.79px" class="cls_011"><span class="cls_011">recent meta-analysis (</span><span class="cls_018">Roque et al., 2013</span><span class="cls_011">). Additionally, similar efficacy</span></div>
<div style="position:absolute;left:326.49px;top:152.79px" class="cls_011"><span class="cls_011">Oocyte cryopreservation can be used as a new strategy to accu-</span></div>
<div style="position:absolute;left:48.19px;top:164.80px" class="cls_011"><span class="cls_011">was found in an RCT comparing outcomes following fresh transfer to</span></div>
<div style="position:absolute;left:317.48px;top:164.80px" class="cls_011"><span class="cls_011">mulate oocytes in poor-responder patients (</span><span class="cls_018">Cobo et al., 2012</span><span class="cls_011">). It is</span></div>
<div style="position:absolute;left:48.19px;top:176.82px" class="cls_011"><span class="cls_011">that following freeze-all at either the blastocyst or the pronuclear-</span></div>
<div style="position:absolute;left:317.48px;top:176.82px" class="cls_011"><span class="cls_011">also a back-up procedure, which can be performed in case of failure</span></div>
<div style="position:absolute;left:48.19px;top:188.79px" class="cls_011"><span class="cls_011">stage (</span><span class="cls_018">Shapiro et al., 2015</span><span class="cls_011">). Although cryopreservation cannot guar-</span></div>
<div style="position:absolute;left:317.48px;top:188.79px" class="cls_011"><span class="cls_011">to obtain a semen sample on the day of oocyte retrieval.</span></div>
<div style="position:absolute;left:48.19px;top:200.80px" class="cls_011"><span class="cls_011">antee the survival of all embryos, these results clearly underscore the</span></div>
<div style="position:absolute;left:326.49px;top:200.80px" class="cls_011"><span class="cls_011">The developments in oocyte cryopreservation after the introduc-</span></div>
<div style="position:absolute;left:48.19px;top:212.82px" class="cls_011"><span class="cls_011">utility of cryopreservation in increasing the safety of IVF treatments,</span></div>
<div style="position:absolute;left:317.48px;top:212.82px" class="cls_011"><span class="cls_011">tion of vitrification have also increased incentives to offer fertility</span></div>
<div style="position:absolute;left:48.19px;top:224.79px" class="cls_011"><span class="cls_011">especially among high-responder patients, without affecting the cumu-</span></div>
<div style="position:absolute;left:317.48px;top:224.78px" class="cls_011"><span class="cls_011">preservation for patients receiving gonadotoxic therapies for cancer</span></div>
<div style="position:absolute;left:48.19px;top:236.80px" class="cls_011"><span class="cls_011">lative pregnancy rate.</span></div>
<div style="position:absolute;left:317.48px;top:236.80px" class="cls_011"><span class="cls_011">or other medical diseases (</span><span class="cls_018">ASRM 2013</span><span class="cls_011">;</span><span class="cls_018"> De Vos et al., 2014</span><span class="cls_011">). The</span></div>
<div style="position:absolute;left:317.48px;top:248.82px" class="cls_011"><span class="cls_011">possibility of preserving oocytes is of considerable importance in this</span></div>
<div style="position:absolute;left:317.48px;top:260.79px" class="cls_011"><span class="cls_011">context. Oocyte cryopreservation, instead of the use of male-partner/</span></div>
<div style="position:absolute;left:48.19px;top:270.83px" class="cls_002"><span class="cls_002">Cryopreservation and enhanced embryo</span></div>
<div style="position:absolute;left:317.48px;top:272.80px" class="cls_011"><span class="cls_011">donor sperm to create embryos, allows the possibility of reproductive</span></div>
<div style="position:absolute;left:317.48px;top:284.82px" class="cls_011"><span class="cls_011">autonomy in women without partners at the time when their fertility</span></div>
<div style="position:absolute;left:48.19px;top:284.83px" class="cls_002"><span class="cls_002">evaluation</span></div>
<div style="position:absolute;left:317.48px;top:296.78px" class="cls_011"><span class="cls_011">preservation is desired (</span><span class="cls_018">Rienzi and Ubaldi, 2015</span><span class="cls_011">). Finally, oocyte vitri-</span></div>
<div style="position:absolute;left:48.19px;top:302.80px" class="cls_011"><span class="cls_011">Embryo evaluation continues to be performed primarily by morpho-</span></div>
<div style="position:absolute;left:317.48px;top:308.80px" class="cls_011"><span class="cls_011">fication can also be used for elective fertility preservation for women</span></div>
<div style="position:absolute;left:48.19px;top:314.81px" class="cls_011"><span class="cls_011">logical assessment and/or morphokinetic analysis at different stages</span></div>
<div style="position:absolute;left:317.48px;top:320.82px" class="cls_011"><span class="cls_011">who are conscious of the decline in oocyte quality and quantity with</span></div>
<div style="position:absolute;left:48.19px;top:326.83px" class="cls_011"><span class="cls_011">of development. However, static and dynamic morphological evalua-</span></div>
<div style="position:absolute;left:317.48px;top:332.79px" class="cls_011"><span class="cls_011">advancing maternal age but who are not ready to become pregnant</span></div>
<div style="position:absolute;left:48.19px;top:338.79px" class="cls_011"><span class="cls_011">tions have limited clinical value (</span><span class="cls_018">Guerif et al., 2007</span><span class="cls_011">;</span><span class="cls_018"> Racowsky et al.,</span></div>
<div style="position:absolute;left:317.48px;top:344.80px" class="cls_011"><span class="cls_011">(</span><span class="cls_018">Stoop 2011</span><span class="cls_011">).</span></div>
<div style="position:absolute;left:48.19px;top:350.81px" class="cls_018"><span class="cls_018">2009</span><span class="cls_011">;</span><span class="cls_018">  Kaser  and  Racowsky</span></div>
<div style="position:absolute;left:162.82px;top:350.81px" class="cls_018"><span class="cls_018">2014</span><span class="cls_011">).  Significant  improvements  in</span></div>
<div style="position:absolute;left:326.49px;top:356.82px" class="cls_011"><span class="cls_011">Of note, when oocyte cryopreservation is imposed by law restric-</span></div>
<div style="position:absolute;left:48.19px;top:362.83px" class="cls_011"><span class="cls_011">implantation rates in different patient populations have been obtained</span></div>
<div style="position:absolute;left:317.48px;top:368.79px" class="cls_011"><span class="cls_011">tions and applied to an unselected population of infertile patients the</span></div>
<div style="position:absolute;left:48.19px;top:374.79px" class="cls_011"><span class="cls_011">by the introduction of chromosomal aneuploidy testing at the blasto-</span></div>
<div style="position:absolute;left:317.48px;top:380.80px" class="cls_011"><span class="cls_011">clinical outcomes are compromised.</span></div>
<div style="position:absolute;left:48.19px;top:386.81px" class="cls_011"><span class="cls_011">cyst stage (</span><span class="cls_018">Dahdouh et al., 2015</span><span class="cls_011">;</span><span class="cls_018"> Lee et al., 2015</span><span class="cls_011">). This strategy com-</span></div>
<div style="position:absolute;left:48.19px;top:398.83px" class="cls_011"><span class="cls_011">bines different procedures including blastocyst culture, biopsy and</span></div>
<div style="position:absolute;left:48.19px;top:410.79px" class="cls_011"><span class="cls_011">cryopreservation. The improvements in cryosurvival rates achieved</span></div>
<div style="position:absolute;left:317.48px;top:410.80px" class="cls_002"><span class="cls_002">Standardization of protocols and automation</span></div>
<div style="position:absolute;left:48.19px;top:422.81px" class="cls_011"><span class="cls_011">with vitrification of biopsied blastocysts (</span><span class="cls_018">Escriba et al., 2008</span><span class="cls_011">;</span><span class="cls_018"> Zhang</span></div>
<div style="position:absolute;left:317.48px;top:428.82px" class="cls_011"><span class="cls_011">Unlike slow-freezing, vitrification does not require a programmable</span></div>
<div style="position:absolute;left:48.19px;top:434.83px" class="cls_018"><span class="cls_018">et al.,</span></div>
<div style="position:absolute;left:72.28px;top:434.83px" class="cls_018"><span class="cls_018">2009</span><span class="cls_011">) have provided an important contribution to the wide-</span></div>
<div style="position:absolute;left:317.48px;top:440.79px" class="cls_011"><span class="cls_011">freezing machine to provide specific cooling parameters. The technique</span></div>
<div style="position:absolute;left:48.19px;top:446.80px" class="cls_011"><span class="cls_011">spread  implementation  of  this  technology.  Future  challenges  in</span></div>
<div style="position:absolute;left:317.48px;top:452.80px" class="cls_011"><span class="cls_011">is exclusively manual and is thus operator dependent. Furthermore, dif-</span></div>
<div style="position:absolute;left:48.19px;top:458.81px" class="cls_011"><span class="cls_011">embryology will deal with further enhancement of embryo evaluation</span></div>
<div style="position:absolute;left:317.48px;top:464.82px" class="cls_011"><span class="cls_011">ferent commercial kits for vitrification are available and differ with</span></div>
<div style="position:absolute;left:48.19px;top:470.83px" class="cls_011"><span class="cls_011">beyond aneuploidy testing and to identify the patient populations</span></div>
<div style="position:absolute;left:317.48px;top:476.78px" class="cls_011"><span class="cls_011">respect to the solutions and devices utilized. Vitrification effectiveness</span></div>
<div style="position:absolute;left:48.19px;top:482.79px" class="cls_011"><span class="cls_011">best served by such testing. Several studies are currently ongoing that</span></div>
<div style="position:absolute;left:317.48px;top:488.80px" class="cls_011"><span class="cls_011">may thus be highly variable and dependent on the protocols and</span></div>
<div style="position:absolute;left:48.19px;top:494.81px" class="cls_011"><span class="cls_011">investigate correlations among</span></div>
<div style="position:absolute;left:165.49px;top:494.81px" class="cls_011"><span class="cls_011">‘-omic’ profiling, metabolism, spent</span></div>
<div style="position:absolute;left:317.48px;top:500.82px" class="cls_011"><span class="cls_011">experience of a laboratory. The heterogeneity of methods applied can</span></div>
<div style="position:absolute;left:48.19px;top:506.83px" class="cls_011"><span class="cls_011">culture  media  analysis  and  embryo  quality</span></div>
<div style="position:absolute;left:215.49px;top:506.83px" class="cls_011"><span class="cls_011">(reviewed  in</span><span class="cls_018">  Gardner</span></div>
<div style="position:absolute;left:317.48px;top:512.78px" class="cls_011"><span class="cls_011">create  challenges  with  transportation  of  vitrified  samples  between</span></div>
<div style="position:absolute;left:48.19px;top:518.80px" class="cls_018"><span class="cls_018">et al.,</span></div>
<div style="position:absolute;left:73.59px;top:518.80px" class="cls_018"><span class="cls_018">2015</span><span class="cls_011">). These studies offer promise in the coming years to</span></div>
<div style="position:absolute;left:317.48px;top:524.80px" class="cls_011"><span class="cls_011">laboratories using different cryoprotectant mixtures and/or vitrification</span></div>
<div style="position:absolute;left:48.19px;top:530.81px" class="cls_011"><span class="cls_011">increase the predictive power for implantation. The availability of reli-</span></div>
<div style="position:absolute;left:317.48px;top:536.82px" class="cls_011"><span class="cls_011">devices. A rigorous process of standardization is therefore advocated.</span></div>
<div style="position:absolute;left:48.19px;top:542.83px" class="cls_011"><span class="cls_011">able vitrification protocols for cryopreservation allows an extension</span></div>
<div style="position:absolute;left:317.48px;top:548.78px" class="cls_011"><span class="cls_011">Comparative studies should be undertaken to establish best practices</span></div>
<div style="position:absolute;left:48.19px;top:554.79px" class="cls_011"><span class="cls_011">of time available for embryo evaluation by such indirect measures,</span></div>
<div style="position:absolute;left:317.48px;top:560.80px" class="cls_011"><span class="cls_011">that would then be adopted universally (as occurred for slow-freezing</span></div>
<div style="position:absolute;left:48.19px;top:566.81px" class="cls_011"><span class="cls_011">thereby affording a potential for implementation of new validated</span></div>
<div style="position:absolute;left:317.48px;top:572.82px" class="cls_011"><span class="cls_011">30 years ago). Indeed, attempts to promote standardization, consi-</span></div>
<div style="position:absolute;left:48.19px;top:578.83px" class="cls_011"><span class="cls_011">approaches for embryo selection.</span></div>
<div style="position:absolute;left:317.48px;top:584.78px" class="cls_011"><span class="cls_011">stency and efficiency are already underway with the introduction</span></div>
<div style="position:absolute;left:317.48px;top:596.80px" class="cls_011"><span class="cls_011">of automation (</span><span class="cls_018">Roy et al., 2014</span><span class="cls_011">). However, this approach requires</span></div>
<div style="position:absolute;left:317.48px;top:608.82px" class="cls_011"><span class="cls_011">considerable financial investment and its implementation is thus still</span></div>
<div style="position:absolute;left:48.19px;top:612.80px" class="cls_002"><span class="cls_002">New possibilities related to oocyte</span></div>
<div style="position:absolute;left:317.48px;top:620.79px" class="cls_011"><span class="cls_011">limited.</span></div>
<div style="position:absolute;left:48.19px;top:626.80px" class="cls_002"><span class="cls_002">cryopreservation</span></div>
<div style="position:absolute;left:48.19px;top:644.82px" class="cls_011"><span class="cls_011">Oocyte cryopreservation is a relatively new technology in ART but</span></div>
<div style="position:absolute;left:317.48px;top:650.84px" class="cls_002"><span class="cls_002">Obstetric and perinatal outcomes</span></div>
<div style="position:absolute;left:48.19px;top:656.84px" class="cls_011"><span class="cls_011">has already important indications. One of the most common applica-</span></div>
<div style="position:absolute;left:48.19px;top:668.80px" class="cls_011"><span class="cls_011">tions of oocyte cryopreservation is for oocyte donation programmes.</span></div>
<div style="position:absolute;left:317.48px;top:668.80px" class="cls_011"><span class="cls_011">Although cryopreservation of oocytes and embryos is now a well-</span></div>
<div style="position:absolute;left:48.19px;top:680.82px" class="cls_011"><span class="cls_011">The introduction of oocyte banks offers different advantages including</span></div>
<div style="position:absolute;left:317.48px;top:680.82px" class="cls_011"><span class="cls_011">established procedure, long-term follow-up studies of children are</span></div>
<div style="position:absolute;left:48.19px;top:692.78px" class="cls_011"><span class="cls_011">reduced waiting time, no need for patient synchronization, improved</span></div>
<div style="position:absolute;left:317.48px;top:692.84px" class="cls_011"><span class="cls_011">still sparse. Data from systematic reviews and individual cohort stud-</span></div>
<div style="position:absolute;left:48.19px;top:704.80px" class="cls_011"><span class="cls_011">safety to prevent disease transmission and the possibility to increase</span></div>
<div style="position:absolute;left:317.48px;top:704.80px" class="cls_011"><span class="cls_011">ies are mostly reassuring, suggesting that pregnancies obtained from a</span></div>
<div style="position:absolute;left:48.19px;top:716.82px" class="cls_011"><span class="cls_011">donor pools. The increased availability of vitrified donor eggs has, in</span></div>
<div style="position:absolute;left:317.48px;top:716.82px" class="cls_011"><span class="cls_011">cryopreserved oocyte and/or embryo transfer are not associated</span></div>
<div style="position:absolute;left:48.19px;top:728.78px" class="cls_011"><span class="cls_011">turn, allowed the widespread application of oocyte donation and the</span></div>
<div style="position:absolute;left:317.48px;top:728.78px" class="cls_011"><span class="cls_011">with increased perinatal risks compared with those resulting from</span></div>
</div>
<div style="position:absolute;left:50%;margin-left:-306px;top:10222px;width:612px;height:790px;border-style:outset;overflow:hidden">
<div style="position:absolute;left:0px;top:0px">
<img src="fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_id_fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_files/background14.jpg" width=612 height=790></div>
<div style="position:absolute;left:45.35px;top:25.13px" class="cls_013"><span class="cls_013">152</span></div>
<div style="position:absolute;left:525.71px;top:26.63px" class="cls_014"><span class="cls_014">Rienzi et al.</span></div>
<div style="position:absolute;left:45.35px;top:56.80px" class="cls_011"><span class="cls_011">fresh embryo transfer (</span><span class="cls_018">Wang et al., 2005</span><span class="cls_011">;</span><span class="cls_018"> Chian et al., 2009</span><span class="cls_011">;</span><span class="cls_018"> Noyes</span></div>
<div style="position:absolute;left:314.65px;top:54.89px" class="cls_017"><span class="cls_017">Funding</span></div>
<div style="position:absolute;left:45.35px;top:68.82px" class="cls_018"><span class="cls_018">et al., 2009</span><span class="cls_011">;</span><span class="cls_018"> Wennerholm et al., 2009</span><span class="cls_011">;</span><span class="cls_018"> Cobo et al., 2010</span><span class="cls_011">;</span><span class="cls_018"> Pelkonen</span></div>
<div style="position:absolute;left:45.35px;top:80.79px" class="cls_018"><span class="cls_018">et al., 2010</span><span class="cls_011">;</span><span class="cls_018"> Pinborg et al., 2010</span><span class="cls_011">;</span><span class="cls_018"> Maheshwari et al., 2012</span><span class="cls_011">;</span><span class="cls_018"> Levi-Setti</span></div>
<div style="position:absolute;left:314.65px;top:78.92px" class="cls_011"><span class="cls_011">This study was funded by the World Health Organization (WHO) to</span></div>
<div style="position:absolute;left:45.35px;top:92.80px" class="cls_018"><span class="cls_018">et al., 2013</span><span class="cls_011">;</span><span class="cls_018"> Liu et al., 2013</span><span class="cls_011">;</span><span class="cls_018"> Cobo et al., 2014</span><span class="cls_011">;</span><span class="cls_018"> Belva et al., 2016</span><span class="cls_011">;</span><span class="cls_018"> De</span></div>
<div style="position:absolute;left:314.65px;top:90.88px" class="cls_011"><span class="cls_011">support the gathering of evidence in the context of the WHO Global</span></div>
<div style="position:absolute;left:45.35px;top:104.82px" class="cls_018"><span class="cls_018">Munch et al., 2016</span><span class="cls_011">;</span><span class="cls_018"> Levi-Setti et al., 2016</span><span class="cls_011">). Obstetric and perinatal</span></div>
<div style="position:absolute;left:314.65px;top:102.90px" class="cls_011"><span class="cls_011">Consultation for the development of global guidance: Addressing</span></div>
<div style="position:absolute;left:45.35px;top:116.79px" class="cls_011"><span class="cls_011">complications (e.g. antepartum haemorrhage, preterm birth, small for</span></div>
<div style="position:absolute;left:314.65px;top:114.91px" class="cls_011"><span class="cls_011">evidence-based  guidance  on  infertility  diagnosis,  management  and</span></div>
<div style="position:absolute;left:45.35px;top:128.80px" class="cls_011"><span class="cls_011">gestational age, low birthweight and perinatal mortality) are even</span></div>
<div style="position:absolute;left:314.65px;top:126.88px" class="cls_011"><span class="cls_011">treatment.</span></div>
<div style="position:absolute;left:45.35px;top:140.82px" class="cls_011"><span class="cls_011">lower when frozen or vitrified embryos are replaced, likely as a con-</span></div>
<div style="position:absolute;left:45.35px;top:152.78px" class="cls_011"><span class="cls_011">sequence of the natural uterine environment that may better support</span></div>
<div style="position:absolute;left:314.65px;top:154.84px" class="cls_017"><span class="cls_017">Conflict of interest</span></div>
<div style="position:absolute;left:45.35px;top:164.80px" class="cls_011"><span class="cls_011">early placentation and embryogenesis</span></div>
<div style="position:absolute;left:192.02px;top:164.80px" class="cls_011"><span class="cls_011">(</span><span class="cls_018">Wennerholm et al.,</span></div>
<div style="position:absolute;left:274.68px;top:164.80px" class="cls_018"><span class="cls_018">2009</span><span class="cls_011">;</span></div>
<div style="position:absolute;left:45.35px;top:176.82px" class="cls_018"><span class="cls_018">Maheshwari  et  al.,</span></div>
<div style="position:absolute;left:121.15px;top:176.82px" class="cls_018"><span class="cls_018">2012</span><span class="cls_011">;</span><span class="cls_018">  Belva  et  al.,</span></div>
<div style="position:absolute;left:198.60px;top:176.82px" class="cls_018"><span class="cls_018">2016</span><span class="cls_011">).  Moreover,  further</span></div>
<div style="position:absolute;left:314.65px;top:178.86px" class="cls_011"><span class="cls_011">None declared.</span></div>
<div style="position:absolute;left:45.35px;top:188.79px" class="cls_011"><span class="cls_011">reassuring  evidence  comes  from  studies  evaluating  the  safety  of</span></div>
<div style="position:absolute;left:45.35px;top:200.80px" class="cls_011"><span class="cls_011">oocyte vitrification in oocyte donation programmes</span></div>
<div style="position:absolute;left:245.03px;top:200.80px" class="cls_011"><span class="cls_011">(</span><span class="cls_018">Chian et al.,</span></div>
<div style="position:absolute;left:45.35px;top:212.82px" class="cls_018"><span class="cls_018">2009</span><span class="cls_011">;</span><span class="cls_018"> Noyes et al., 2009</span><span class="cls_011">;</span><span class="cls_018"> Cobo et al., 2010</span><span class="cls_011">;</span><span class="cls_018"> Cobo et al., 2014</span><span class="cls_011">;</span><span class="cls_018"> De</span></div>
<div style="position:absolute;left:314.65px;top:206.82px" class="cls_017"><span class="cls_017">References</span></div>
<div style="position:absolute;left:45.35px;top:224.79px" class="cls_018"><span class="cls_018">Munch et al., 2016</span><span class="cls_011">) and in fertility preservation patients (</span><span class="cls_018">Martinez</span></div>
<div style="position:absolute;left:314.65px;top:230.31px" class="cls_008"><span class="cls_008">AbdelHafez FF, Desai N, Abou-Setta AM, Falcone T, Goldfarb J. et al. Slow-freezing,</span></div>
<div style="position:absolute;left:45.35px;top:236.80px" class="cls_018"><span class="cls_018">et al., 2014</span><span class="cls_011">).</span></div>
<div style="position:absolute;left:322.64px;top:240.29px" class="cls_008"><span class="cls_008">vitrification and ultra-rapid freezing of human embryos: a systematic review and</span></div>
<div style="position:absolute;left:322.64px;top:250.32px" class="cls_008"><span class="cls_008">meta-analysis. Reprod Biomed Online 2010;20:209-222.</span></div>
<div style="position:absolute;left:314.64px;top:260.30px" class="cls_008"><span class="cls_008">Abdelhafez F, Xu J, Goldberg J, Desai N. Vitrification in open and closed carriers at dif-</span></div>
<div style="position:absolute;left:322.64px;top:270.34px" class="cls_008"><span class="cls_008">ferent cell stages: assessment of embryo survival, development, dna integrity and</span></div>
<div style="position:absolute;left:45.35px;top:269.81px" class="cls_017"><span class="cls_017">Conclusions</span></div>
<div style="position:absolute;left:322.64px;top:280.31px" class="cls_008"><span class="cls_008">stability during vapor phase storage for transport. BMC Biotechnol 2011;11:29.</span></div>
<div style="position:absolute;left:314.65px;top:290.29px" class="cls_008"><span class="cls_008">Almodin CG, Minguetti-Camara VC, Paixao CL, Pereira PC. Embryo development</span></div>
<div style="position:absolute;left:45.35px;top:293.78px" class="cls_011"><span class="cls_011">Cryopreservation  is  an  essential  component  in  the  treatment  of</span></div>
<div style="position:absolute;left:322.64px;top:300.33px" class="cls_008"><span class="cls_008">and gestation using fresh and vitrified oocytes. Hum Reprod 2010;25:1192-1198.</span></div>
<div style="position:absolute;left:45.35px;top:305.80px" class="cls_011"><span class="cls_011">patients  undergoing  ART  and  should  be  optimized  in  every  IVF</span></div>
<div style="position:absolute;left:314.64px;top:310.31px" class="cls_008"><span class="cls_008">Antinori M, Licata E, Dani G, Cerusico F, Versaci C, Antinori S. Cryotop vitrifica-</span></div>
<div style="position:absolute;left:45.35px;top:317.82px" class="cls_011"><span class="cls_011">laboratory, as it allows for increased cumulative LBRs and offers the</span></div>
<div style="position:absolute;left:322.64px;top:320.34px" class="cls_008"><span class="cls_008">tion of human oocytes results in high survival rate and healthy deliveries. Reprod</span></div>
<div style="position:absolute;left:45.35px;top:329.78px" class="cls_011"><span class="cls_011">possibility to reduce multiple gestations and OHSS risk. According to</span></div>
<div style="position:absolute;left:322.64px;top:330.32px" class="cls_008"><span class="cls_008">Biomed Online 2007;14:72-79.</span></div>
<div style="position:absolute;left:314.65px;top:340.30px" class="cls_008"><span class="cls_008">Argyle CE, Harper JC, Davies MC. Oocyte cryopreservation: where are we now?</span></div>
<div style="position:absolute;left:45.35px;top:341.80px" class="cls_011"><span class="cls_011">the available evidence appraised in this systematic review and meta-</span></div>
<div style="position:absolute;left:322.64px;top:350.33px" class="cls_008"><span class="cls_008">Hum Reprod Update 2016;22:440-449.</span></div>
<div style="position:absolute;left:45.35px;top:353.82px" class="cls_011"><span class="cls_011">analysis, vitrification is the best strategy for cryopreservation of all</span></div>
<div style="position:absolute;left:314.65px;top:360.31px" class="cls_008"><span class="cls_008">Balaban B, Urman B, Ata B, Isiklar A, Larman MG, Hamilton R, Gardner DK. A ran-</span></div>
<div style="position:absolute;left:45.35px;top:365.78px" class="cls_011"><span class="cls_011">developmental stages from mature oocyte to embryos at the blasto-</span></div>
<div style="position:absolute;left:322.64px;top:370.29px" class="cls_008"><span class="cls_008">domized controlled study of human Day 3 embryo cryopreservation by slow-</span></div>
<div style="position:absolute;left:45.35px;top:377.80px" class="cls_011"><span class="cls_011">cyst  stage.  As  this  technique  significantly  increases  oocyte  and</span></div>
<div style="position:absolute;left:322.64px;top:380.32px" class="cls_008"><span class="cls_008">freezing or vitrification: vitrification is associated with higher survival, metabolism</span></div>
<div style="position:absolute;left:45.35px;top:389.82px" class="cls_011"><span class="cls_011">embryo cryosurvival rates when compared to slow-freezing, it has led</span></div>
<div style="position:absolute;left:322.64px;top:390.30px" class="cls_008"><span class="cls_008">and blastocyst formation. Hum Reprod 2008;23:1976-1982.</span></div>
<div style="position:absolute;left:314.65px;top:400.33px" class="cls_008"><span class="cls_008">Belva F, Bonduelle M, Roelants M, Verheyen G, Van Landuyt L. Neonatal health</span></div>
<div style="position:absolute;left:45.35px;top:401.78px" class="cls_011"><span class="cls_011">to an improvement in clinical outcomes in cryopreserved cycles and</span></div>
<div style="position:absolute;left:322.64px;top:410.31px" class="cls_008"><span class="cls_008">including  congenital  malformation  risk  of</span></div>
<div style="position:absolute;left:457.17px;top:410.31px" class="cls_008"><span class="cls_008">1072  children  born  after  vitrified</span></div>
<div style="position:absolute;left:45.35px;top:413.80px" class="cls_011"><span class="cls_011">also has made fertility preservation and donor oocyte banks a viable</span></div>
<div style="position:absolute;left:322.64px;top:420.29px" class="cls_008"><span class="cls_008">embryo transfer. Hum Reprod 2016;31:1610-1620.</span></div>
<div style="position:absolute;left:45.35px;top:425.82px" class="cls_011"><span class="cls_011">option for patients. Furthermore, it allows for reliable segmentation</span></div>
<div style="position:absolute;left:314.65px;top:430.32px" class="cls_008"><span class="cls_008">Bernal D, Colturato LF, Leef DM, Kort HI, Nagy ZP. Evaluation of blastocyst recu-</span></div>
<div style="position:absolute;left:45.35px;top:437.78px" class="cls_011"><span class="cls_011">of the IVF cycle by temporally disconnecting the stimulation process</span></div>
<div style="position:absolute;left:322.64px;top:440.30px" class="cls_008"><span class="cls_008">peration, implantation and pregnancy rates after vitrification/warming or slow</span></div>
<div style="position:absolute;left:45.35px;top:449.80px" class="cls_011"><span class="cls_011">from embryo transfer; consequently, this affords additional time for</span></div>
<div style="position:absolute;left:322.64px;top:450.34px" class="cls_008"><span class="cls_008">freezing/ thawing cycles. Fertil Steril 2008;90:277-278.</span></div>
<div style="position:absolute;left:314.65px;top:460.32px" class="cls_008"><span class="cls_008">Borini A, Lagalla C, Bonu MA, Bianchi V, Flamigni C, Coticchio G. Cumulative preg-</span></div>
<div style="position:absolute;left:45.35px;top:461.81px" class="cls_011"><span class="cls_011">new invasive and non-invasive methods of embryo selection. Finally, if</span></div>
<div style="position:absolute;left:322.64px;top:470.29px" class="cls_008"><span class="cls_008">nancy rates resulting from the use of fresh and frozen oocytes: 7 years’ experi-</span></div>
<div style="position:absolute;left:45.35px;top:473.78px" class="cls_011"><span class="cls_011">standardized and/or automated, the consistency and efficiency of the</span></div>
<div style="position:absolute;left:322.64px;top:480.33px" class="cls_008"><span class="cls_008">ence. Reprod Biomed Online 2006a;12:481-486.</span></div>
<div style="position:absolute;left:45.35px;top:485.80px" class="cls_011"><span class="cls_011">technique would likely be assured across all laboratories.</span></div>
<div style="position:absolute;left:314.65px;top:490.31px" class="cls_008"><span class="cls_008">Borini A, Sciajno R, Bianchi V, Sereni E, Flamigni C, Coticchio G. Cinical outcome</span></div>
<div style="position:absolute;left:322.64px;top:500.34px" class="cls_008"><span class="cls_008">of oocyte cryopreservation after slow-cooling with a protocol utilizing a high</span></div>
<div style="position:absolute;left:322.64px;top:510.32px" class="cls_008"><span class="cls_008">sucrose concentration. Hum Reprod 2006b;21:512-517.</span></div>
<div style="position:absolute;left:314.65px;top:520.30px" class="cls_008"><span class="cls_008">Borini A, Bianchi V, Bonu MA, Sciajno R, Sereni E, Cattoli M, Mazzone S, Trevisi</span></div>
<div style="position:absolute;left:45.35px;top:518.80px" class="cls_017"><span class="cls_017">Supplementary data</span></div>
<div style="position:absolute;left:322.64px;top:530.33px" class="cls_008"><span class="cls_008">MR, Iadarola I, Distratis V et al. Evidence-based clinical outcome of oocyte slow-</span></div>
<div style="position:absolute;left:322.64px;top:540.31px" class="cls_008"><span class="cls_008">cooling. Reprod Biomed Online 2007;15:175-181.</span></div>
<div style="position:absolute;left:45.35px;top:542.83px" class="cls_011"><span class="cls_011"> </span><A HREF="http://humupd.oxfordjournals.org/lookup/suppl/doi:10.1093/humupd/dmw038/-/DC1">Supplementary data are available at Human Reproduction Update</A> </div>
<div style="position:absolute;left:314.64px;top:550.29px" class="cls_008"><span class="cls_008">Borini A, Levi Setti PE, Anserini P, De Luca R, De Santis L, Porcu E, La Sala GB,</span></div>
<div style="position:absolute;left:45.35px;top:554.79px" class="cls_011"><span class="cls_011"> </span><A HREF="http://humupd.oxfordjournals.org/lookup/suppl/doi:10.1093/humupd/dmw038/-/DC1">online.</A> </div>
<div style="position:absolute;left:322.64px;top:560.32px" class="cls_008"><span class="cls_008">Ferraretti A, Bartolotti T, Coticchio G et al. Multicenter observational study on</span></div>
<div style="position:absolute;left:322.64px;top:570.30px" class="cls_008"><span class="cls_008">slow-cooling  oocyte  cryopreservation:  clinical  outcome.  Fertil  Steril</span></div>
<div style="position:absolute;left:537.33px;top:570.30px" class="cls_008"><span class="cls_008">2010;94:</span></div>
<div style="position:absolute;left:322.64px;top:580.33px" class="cls_008"><span class="cls_008">1662-1668.</span></div>
<div style="position:absolute;left:314.65px;top:590.31px" class="cls_008"><span class="cls_008">Cao YX, Xing Q, Li L, Cong L, Zhang ZG, Wei ZL, Zhou P. Comparison of sur-</span></div>
<div style="position:absolute;left:45.35px;top:587.80px" class="cls_017"><span class="cls_017">Acknowledgements</span></div>
<div style="position:absolute;left:322.64px;top:600.29px" class="cls_008"><span class="cls_008">vival and embryonic development in human oocytes cryopreserved by slow-</span></div>
<div style="position:absolute;left:322.64px;top:610.32px" class="cls_008"><span class="cls_008">freezing and vitrification. Fertil Steril 2009;92:1306-1311.</span></div>
<div style="position:absolute;left:45.35px;top:611.83px" class="cls_011"><span class="cls_011">The authors acknowledge the assistance of Ms Jessica Goldstein, RN,</span></div>
<div style="position:absolute;left:314.65px;top:620.30px" class="cls_008"><span class="cls_008">CDC, Centres for Disease Control and Prevention. Reproductive Health. Assisted</span></div>
<div style="position:absolute;left:45.35px;top:623.79px" class="cls_011"><span class="cls_011">with the systematic search of the literature pertaining to oocyte cryo-</span></div>
<div style="position:absolute;left:322.64px;top:630.34px" class="cls_008"><span class="cls_008">Reproductive Technology. National Summary and Fertility Clinic Reports 2011.</span></div>
<div style="position:absolute;left:45.35px;top:635.81px" class="cls_011"><span class="cls_011">preservation and Mary D. Sammel, ScD, with data analysis.</span></div>
<div style="position:absolute;left:322.64px;top:640.31px" class="cls_026"><span class="cls_026"> </span><A HREF="http://www.cdc.gov/ART/ART2011">http://www.cdc.gov/ART/ART2011</A> <span class="cls_008">.</span></div>
<div style="position:absolute;left:314.65px;top:650.29px" class="cls_008"><span class="cls_008">Chamayou S, Alecci C, Ragolia C, Storaci G, Maglia E, Russo E, Guglielmino A.</span></div>
<div style="position:absolute;left:322.64px;top:660.33px" class="cls_008"><span class="cls_008">Comparison of in-vitro outcomes from cryopreserved oocytes and sibling fresh</span></div>
<div style="position:absolute;left:322.64px;top:670.30px" class="cls_008"><span class="cls_008">oocytes. Reprod Biomed Online 2006;12:730-736.</span></div>
<div style="position:absolute;left:45.35px;top:668.81px" class="cls_017"><span class="cls_017">Authors’ roles</span></div>
<div style="position:absolute;left:314.65px;top:680.34px" class="cls_008"><span class="cls_008">Chian RC, Huang JY, Gilber L, Son WY, Holzer H, Cui SJ, Buckett WM, Tulandi T,</span></div>
<div style="position:absolute;left:322.64px;top:690.32px" class="cls_008"><span class="cls_008">Tan SL. Obstetric outcomes following vitrification of in vitro and in vivo matured</span></div>
<div style="position:absolute;left:45.35px;top:692.79px" class="cls_011"><span class="cls_011">Conception and design (LR, CR, SV, CG); search strategy (RM, AL,</span></div>
<div style="position:absolute;left:322.64px;top:700.30px" class="cls_008"><span class="cls_008">oocytes. Fertil Steril 2009;91:2391-2398.</span></div>
<div style="position:absolute;left:45.35px;top:704.80px" class="cls_011"><span class="cls_011">DJK); data extraction, analysis (CG) and interpretation (all authors);</span></div>
<div style="position:absolute;left:314.65px;top:710.33px" class="cls_008"><span class="cls_008">Cil AP, Bang H, Oktay K. Age-specific probability of live birth with oocyte cryo-</span></div>
<div style="position:absolute;left:45.35px;top:716.82px" class="cls_011"><span class="cls_011">drafting the manuscript (LR); critical revision of the manuscript (all</span></div>
<div style="position:absolute;left:322.64px;top:720.31px" class="cls_008"><span class="cls_008">preservation: an individual patient data meta-analysis. Fertil Steril 2013;100:492-</span></div>
<div style="position:absolute;left:45.35px;top:728.78px" class="cls_011"><span class="cls_011">authors).</span></div>
<div style="position:absolute;left:322.64px;top:730.29px" class="cls_008"><span class="cls_008">499.</span></div>
</div>
<div style="position:absolute;left:50%;margin-left:-306px;top:11022px;width:612px;height:790px;border-style:outset;overflow:hidden">
<div style="position:absolute;left:0px;top:0px">
<img src="fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_id_fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_files/background15.jpg" width=612 height=790></div>
<div style="position:absolute;left:48.19px;top:26.63px" class="cls_014"><span class="cls_014">Slow-freezing versus vitrification in ART</span></div>
<div style="position:absolute;left:550.66px;top:25.13px" class="cls_013"><span class="cls_013">153</span></div>
<div style="position:absolute;left:48.19px;top:57.28px" class="cls_008"><span class="cls_008">Clua E, Tur R, Coroleu B, Boada M, Rodríguez I, Barri PN, Veiga A. Elective single-</span></div>
<div style="position:absolute;left:325.47px;top:57.29px" class="cls_008"><span class="cls_008">screening: a systematic review of randomized controlled trials. Reprod Biomed</span></div>
<div style="position:absolute;left:56.18px;top:67.26px" class="cls_008"><span class="cls_008">embryo transfer in oocyte donation programmes: should it be the rule? Reprod</span></div>
<div style="position:absolute;left:325.47px;top:67.26px" class="cls_008"><span class="cls_008">Online 2015;30:281-289.</span></div>
<div style="position:absolute;left:56.18px;top:77.30px" class="cls_008"><span class="cls_008">Biomed Online 2012;25:642-648.</span></div>
<div style="position:absolute;left:317.48px;top:77.30px" class="cls_008"><span class="cls_008">ESHRE Campus Course Report. Prevention of twin pregnancies after IVF/ICSI by</span></div>
<div style="position:absolute;left:48.19px;top:87.28px" class="cls_008"><span class="cls_008">Cobo A, Kuwayama M, Pérez S, Ruiz A, Pellicer A, Remohí J. Comparison of con-</span></div>
<div style="position:absolute;left:325.47px;top:87.28px" class="cls_008"><span class="cls_008">single embryo transfer. Hum Reprod 2001;4:790-800.</span></div>
<div style="position:absolute;left:56.18px;top:97.25px" class="cls_008"><span class="cls_008">comitant outcome achieved with fresh and cryopreserved donor oocytes vitri-</span></div>
<div style="position:absolute;left:317.48px;top:97.25px" class="cls_008"><span class="cls_008">Fatemi HM, Kyrou D, Bourgain C, Van den Abbeel E, Griesinger G, Devroey P.</span></div>
<div style="position:absolute;left:56.18px;top:107.29px" class="cls_008"><span class="cls_008">fied by the Cryotop method. Fertil Steril 2008;89:1657-1664.</span></div>
<div style="position:absolute;left:325.47px;top:107.29px" class="cls_008"><span class="cls_008">Cryopreserved-thawed human embryo transfer: spontaneous natural cycle is</span></div>
<div style="position:absolute;left:48.19px;top:117.27px" class="cls_008"><span class="cls_008">Cobo A, Meseguer M, Remohi J, Pellicer A. Use of cryo-banked oocytes in an</span></div>
<div style="position:absolute;left:325.47px;top:117.27px" class="cls_008"><span class="cls_008">superior to human chorionic gonadotropin-induced natural cycle. Fertil Steril</span></div>
<div style="position:absolute;left:56.18px;top:127.30px" class="cls_008"><span class="cls_008">ovum donation programme: a prospective, randomized, controlled, clinical trial.</span></div>
<div style="position:absolute;left:325.47px;top:127.30px" class="cls_008"><span class="cls_008">2010;94:2054-2058.</span></div>
<div style="position:absolute;left:56.18px;top:137.28px" class="cls_008"><span class="cls_008">Hum Reprod 2010;25:2239-2246.</span></div>
<div style="position:absolute;left:317.48px;top:137.28px" class="cls_008"><span class="cls_008">Forman EJ, Li X, Ferry KM, Scott K, Treff NR, Scott RT Jr. Oocyte vitrification does</span></div>
<div style="position:absolute;left:48.19px;top:147.26px" class="cls_008"><span class="cls_008">Cobo A, Remohí J, Chang CC, Nagy ZP. Oocyte cryopreservation for donor egg</span></div>
<div style="position:absolute;left:325.47px;top:147.26px" class="cls_008"><span class="cls_008">not increase the risk of embryonic aneuploidy or diminish the implantation</span></div>
<div style="position:absolute;left:56.18px;top:157.29px" class="cls_008"><span class="cls_008">banking. Reprod Biomed Online 2011a;23:341-346.</span></div>
<div style="position:absolute;left:325.47px;top:157.29px" class="cls_008"><span class="cls_008">potential of blastocysts created after intracytoplasmic sperm injection: a novel,</span></div>
<div style="position:absolute;left:48.19px;top:167.27px" class="cls_008"><span class="cls_008">Cobo A, Diaz C. Clinical application of oocyte vitrification: a systematic review and</span></div>
<div style="position:absolute;left:325.47px;top:167.27px" class="cls_008"><span class="cls_008">paired randomized controlled trial using DNA fingerprinting. Fertil Steril 2012;3:</span></div>
<div style="position:absolute;left:56.19px;top:177.30px" class="cls_008"><span class="cls_008">meta-analysis of randomized controlled trials. Fertil Steril 2011b;96:277-285.</span></div>
<div style="position:absolute;left:325.47px;top:177.30px" class="cls_008"><span class="cls_008">644-649.</span></div>
<div style="position:absolute;left:48.19px;top:187.28px" class="cls_008"><span class="cls_008">Cobo A, Garrido N, Crespo J, José R, Pellicer A. Accumulation of oocytes: a new</span></div>
<div style="position:absolute;left:317.48px;top:187.28px" class="cls_008"><span class="cls_008">Gardner DK, Meseguer M, Rubio C, Treff NR. Diagnosis of human preimplantation</span></div>
<div style="position:absolute;left:56.19px;top:197.26px" class="cls_008"><span class="cls_008">strategy for managing low-responder patients. Reprod Biomed Online 2012;24:</span></div>
<div style="position:absolute;left:325.47px;top:197.26px" class="cls_008"><span class="cls_008">embryo viability. Hum Reprod Update 2015;21:727-747.</span></div>
<div style="position:absolute;left:56.19px;top:207.29px" class="cls_008"><span class="cls_008">424-432.</span></div>
<div style="position:absolute;left:317.48px;top:207.30px" class="cls_008"><span class="cls_008">García JI, Noriega-Portella L, Noriega-Hoces L. Efficacy of oocyte vitrification com-</span></div>
<div style="position:absolute;left:48.19px;top:217.27px" class="cls_008"><span class="cls_008">Cobo A, Serra V, Garrido N, Olmo L, Pellicer A, Remohí J. Obstetric and peri-</span></div>
<div style="position:absolute;left:325.48px;top:217.27px" class="cls_008"><span class="cls_008">bined with blastocyst stage transfer in an egg donation program. Hum Reprod</span></div>
<div style="position:absolute;left:56.19px;top:227.31px" class="cls_008"><span class="cls_008">natal outcome of babies born from vitrified oocytes. Fertil Steril</span></div>
<div style="position:absolute;left:266.23px;top:227.31px" class="cls_008"><span class="cls_008">2014;102:</span></div>
<div style="position:absolute;left:325.48px;top:227.31px" class="cls_008"><span class="cls_008">2011;26:782-790.</span></div>
<div style="position:absolute;left:56.19px;top:237.29px" class="cls_008"><span class="cls_008">1006-1015.</span></div>
<div style="position:absolute;left:317.48px;top:237.29px" class="cls_008"><span class="cls_008">Glujovsky D, Riestra B, Sueldo C, Fiszbajn G, Repping S, Nodar F, Papier S,</span></div>
<div style="position:absolute;left:48.19px;top:247.26px" class="cls_008"><span class="cls_008">Cohen J, Simons RF, Edwards RG, Fehilly CB, Fishel SB. Pregnancies following the</span></div>
<div style="position:absolute;left:325.48px;top:247.26px" class="cls_008"><span class="cls_008">Ciapponi A. Vitrification versus slow-freezing for women undergoing oocyte</span></div>
<div style="position:absolute;left:56.19px;top:257.30px" class="cls_008"><span class="cls_008">frozen storage of expanding human blastocysts. J In Vitro Fert Embryo Transf 1985;</span></div>
<div style="position:absolute;left:325.48px;top:257.30px" class="cls_008"><span class="cls_008">cryopreservation. Cochrane Database Syst Rev 2014;5:CD010047.</span></div>
<div style="position:absolute;left:56.19px;top:267.28px" class="cls_008"><span class="cls_008">2:59-64.</span></div>
<div style="position:absolute;left:317.48px;top:267.28px" class="cls_008"><span class="cls_008">Griesinger  G,  von  Otte  S,  Schroer  A,  Ludwig  AK,  Diedrich  K,  Al-Hasani  S,</span></div>
<div style="position:absolute;left:48.19px;top:277.25px" class="cls_008"><span class="cls_008">Coetsier T, Dhont M. Avoiding multiple pregnancies in in-vitro fertilization: who’s</span></div>
<div style="position:absolute;left:325.48px;top:277.25px" class="cls_008"><span class="cls_008">Schultze-Mosgau A. Elective cryopreservation of all pronuclear oocytes after</span></div>
<div style="position:absolute;left:56.19px;top:287.29px" class="cls_008"><span class="cls_008">afraid of single embryo transfer? Hum Reprod 1998;13:2663-2664.</span></div>
<div style="position:absolute;left:325.48px;top:287.29px" class="cls_008"><span class="cls_008">GnRH agonist triggering of final oocyte maturation in patients at risk of develop-</span></div>
<div style="position:absolute;left:48.19px;top:297.27px" class="cls_008"><span class="cls_008">Debrock S, Peeraer K, Fernandez Gallardo E, De Neubourg D, Spiessens C, D’Hooghe</span></div>
<div style="position:absolute;left:325.48px;top:297.27px" class="cls_008"><span class="cls_008">ing OHSS: a prospective, observational proof-of-concept study. Hum Reprod</span></div>
<div style="position:absolute;left:56.19px;top:307.30px" class="cls_008"><span class="cls_008">TM. Vitrification of cleavage stage day 3 embryos results in higher live birth rates</span></div>
<div style="position:absolute;left:325.48px;top:307.30px" class="cls_008"><span class="cls_008">2007;22:1348-1352.</span></div>
<div style="position:absolute;left:56.19px;top:317.28px" class="cls_008"><span class="cls_008">than conventional slow-freezing: a RCT. Hum Reprod 2015;30:1820-1830.</span></div>
<div style="position:absolute;left:317.48px;top:317.28px" class="cls_008"><span class="cls_008">Griesinger G, Schultz L, Bauer T et al. Ovarian hyperstimulation syndrome preven-</span></div>
<div style="position:absolute;left:48.19px;top:327.26px" class="cls_008"><span class="cls_008">De Munck N, Santos-Ribeiro S, Stoop D, Van de Velde H, Verheyen G. Open ver-</span></div>
<div style="position:absolute;left:325.48px;top:327.26px" class="cls_008"><span class="cls_008">tion by gonadotropin-releasing hormone agonist triggering of final oocyte matur-</span></div>
<div style="position:absolute;left:56.19px;top:337.29px" class="cls_008"><span class="cls_008">sus closed oocyte vitrification in an oocyte donation program: a prospective ran-</span></div>
<div style="position:absolute;left:325.48px;top:337.29px" class="cls_008"><span class="cls_008">ation in a gonadotropin-releasing hormone antagonist protocol in combination</span></div>
<div style="position:absolute;left:56.19px;top:347.27px" class="cls_008"><span class="cls_008">domized sibling oocyte study. Hum Reprod 2016;31:337-384.</span></div>
<div style="position:absolute;left:325.47px;top:347.27px" class="cls_008"><span class="cls_008">with a ‘freeze-all’ strategy: a prospective multicentric study. Fertil Steril 2011;95:</span></div>
<div style="position:absolute;left:48.19px;top:357.30px" class="cls_008"><span class="cls_008">De Santis L, Cino I, Rabellotti E, Papaleo E, Calzi F, Fusi FM, Brigante C, Ferrari A.</span></div>
<div style="position:absolute;left:325.47px;top:357.30px" class="cls_008"><span class="cls_008">2029-2033.</span></div>
<div style="position:absolute;left:56.18px;top:367.28px" class="cls_008"><span class="cls_008">Oocyte cryopreservation: clinical outcome of slow-cooling protocols differing in</span></div>
<div style="position:absolute;left:317.48px;top:367.28px" class="cls_008"><span class="cls_008">Grifo JA, Noyes N. Delivery rate using cryopreserved oocytes is comparable to</span></div>
<div style="position:absolute;left:56.18px;top:377.26px" class="cls_008"><span class="cls_008">sucrose concentration. Reprod Biomed Online 2007;14:57-63.</span></div>
<div style="position:absolute;left:325.47px;top:377.26px" class="cls_008"><span class="cls_008">conventional in vitro fertilization using fresh oocytes: potential fertility preserva-</span></div>
<div style="position:absolute;left:48.19px;top:387.29px" class="cls_008"><span class="cls_008">De Vos M, Smitz J, Woodruff TK. Fertility preservation in women with cancer.</span></div>
<div style="position:absolute;left:325.47px;top:387.29px" class="cls_008"><span class="cls_008">tion for female cancer patients. Fertil Steril 2010;93:391-396.</span></div>
<div style="position:absolute;left:56.18px;top:397.27px" class="cls_008"><span class="cls_008">Lancet 2014;384:1302-1310.</span></div>
<div style="position:absolute;left:317.48px;top:397.27px" class="cls_008"><span class="cls_008">Guerif F, Le Gouge A, Giraudeau B, Poindron J, Bidault R, Gasnier O, Royere D.</span></div>
<div style="position:absolute;left:48.19px;top:407.31px" class="cls_008"><span class="cls_008">Devroey P, Polyzos NP, Blockeel C. An OHSS-Free Clinic by segmentation of IVF</span></div>
<div style="position:absolute;left:325.47px;top:407.31px" class="cls_008"><span class="cls_008">Limited value of morphological assessment at days 1 and 2 to predict blastocyst</span></div>
<div style="position:absolute;left:56.19px;top:417.28px" class="cls_008"><span class="cls_008">treatment. Hum Reprod 2011;26:2593-2597.</span></div>
<div style="position:absolute;left:325.47px;top:417.28px" class="cls_008"><span class="cls_008">development  potential:  a  prospective  study  based  on</span></div>
<div style="position:absolute;left:501.39px;top:417.28px" class="cls_008"><span class="cls_008">4042  embryos.  Hum</span></div>
<div style="position:absolute;left:48.19px;top:427.26px" class="cls_008"><span class="cls_008">Doyle JO, Richter KS, Lim J, Stillman RJ, Graham JR, Tucker MJ. Successful elective</span></div>
<div style="position:absolute;left:325.47px;top:427.26px" class="cls_008"><span class="cls_008">Reprod 2007;2:1973-1981.</span></div>
<div style="position:absolute;left:56.19px;top:437.30px" class="cls_008"><span class="cls_008">and medically indicated oocyte vitrification and warming for autologous in vitro</span></div>
<div style="position:absolute;left:317.48px;top:437.30px" class="cls_008"><span class="cls_008">Heng BC. Oocyte cryopreservation as alternative to embryo cryopreservation -</span></div>
<div style="position:absolute;left:56.19px;top:447.28px" class="cls_008"><span class="cls_008">fertilization, with predicted birth probabilities for fertility preservation according</span></div>
<div style="position:absolute;left:325.48px;top:447.28px" class="cls_008"><span class="cls_008">some pertinent ethical concerns. Reprod Biomed Online 2007;14:402-403.</span></div>
<div style="position:absolute;left:56.19px;top:457.31px" class="cls_008"><span class="cls_008">to number of cryopreserved oocytes and age at retrieval. Fertil Steril 2016;105:</span></div>
<div style="position:absolute;left:317.48px;top:457.31px" class="cls_008"><span class="cls_008">Herrero L, Pareja S, Losada C, Cobo AC, Pellicer A, Garcia-Velasco JA. Avoiding</span></div>
<div style="position:absolute;left:56.19px;top:467.29px" class="cls_008"><span class="cls_008">459-466.</span></div>
<div style="position:absolute;left:325.48px;top:467.29px" class="cls_008"><span class="cls_008">the use of human chorionic gonadotropin combined with oocyte vitrification and</span></div>
<div style="position:absolute;left:48.19px;top:477.27px" class="cls_008"><span class="cls_008">Edgar DH, Gook DA. A critical appraisal of cryopreservation (slow cooling versus</span></div>
<div style="position:absolute;left:325.48px;top:477.27px" class="cls_008"><span class="cls_008">GnRH agonist triggering versus coasting: a new strategy to avoid ovarian hyper-</span></div>
<div style="position:absolute;left:56.19px;top:487.30px" class="cls_008"><span class="cls_008">vitrification) of human oocytes and embryos. Hum Reprod Update 2012;18:536-</span></div>
<div style="position:absolute;left:325.48px;top:487.30px" class="cls_008"><span class="cls_008">stimulation syndrome. Fertil Steril 2011;95:1137-1140.</span></div>
<div style="position:absolute;left:56.19px;top:497.28px" class="cls_008"><span class="cls_008">554.</span></div>
<div style="position:absolute;left:317.48px;top:497.28px" class="cls_008"><span class="cls_008">Huang CC, Lee TH, Chen SU et al. Successful pregnancy following blastocyst cryo-</span></div>
<div style="position:absolute;left:48.19px;top:507.26px" class="cls_008"><span class="cls_008">Escribá MJ, Zulategui  JF, Galán  A, Mercader A, Remohí J. de los Santos MJ.</span></div>
<div style="position:absolute;left:325.48px;top:507.26px" class="cls_008"><span class="cls_008">preservation using super-cooling ultra-rapid vitrification. Hum Reprod 2005;20:</span></div>
<div style="position:absolute;left:56.19px;top:517.29px" class="cls_008"><span class="cls_008">Vitrification of preimplantation genetically diagnosed human blastocysts and its</span></div>
<div style="position:absolute;left:325.48px;top:517.29px" class="cls_008"><span class="cls_008">122-128.</span></div>
<div style="position:absolute;left:56.19px;top:527.27px" class="cls_008"><span class="cls_008">contribution to the cumulative ongoing pregnancy rate per cycle by using a</span></div>
<div style="position:absolute;left:317.48px;top:527.27px" class="cls_008"><span class="cls_008">Isachenko V, Montag M, Isachenko E, Dessole S, Nawroth F, van der Ven H.</span></div>
<div style="position:absolute;left:56.19px;top:537.30px" class="cls_008"><span class="cls_008">closed device. Fertil Steril 2008;89:840-846.</span></div>
<div style="position:absolute;left:325.48px;top:537.30px" class="cls_008"><span class="cls_008">Aseptic vitrification of human germinal vesicle oocytes using dimethyl sulfoxide</span></div>
<div style="position:absolute;left:48.19px;top:547.28px" class="cls_008"><span class="cls_008">Ethics Committee of American Society for Reproductive Medicine. Fertility preser-</span></div>
<div style="position:absolute;left:325.48px;top:547.28px" class="cls_008"><span class="cls_008">as a cryoprotectant. Fertil Steril 2006;85:741-747.</span></div>
<div style="position:absolute;left:56.19px;top:557.26px" class="cls_008"><span class="cls_008">vation and reproduction in patients facing gonadotoxic therapies: a committee</span></div>
<div style="position:absolute;left:317.48px;top:557.26px" class="cls_008"><span class="cls_008">Jelinkova L, Selman HA, Arav A, Strehler E, Reeka N, Sterzik K. Twin pregnancy</span></div>
<div style="position:absolute;left:56.19px;top:567.29px" class="cls_008"><span class="cls_008">opinion. Fertil Steril 2013;100:1224-1231.</span></div>
<div style="position:absolute;left:325.48px;top:567.29px" class="cls_008"><span class="cls_008">after vitrification of 2-pronuclei human embryos. Fertil Steril 2002;77:412-414.</span></div>
<div style="position:absolute;left:48.19px;top:577.27px" class="cls_008"><span class="cls_008">Evans J, Hannan NJ, Edgell TA, Vollenhoven BJ, Lutjen PJ, Osianlis T, Salamonsen</span></div>
<div style="position:absolute;left:317.48px;top:577.27px" class="cls_008"><span class="cls_008">Jericho H, Wilton L, Gook DA, Edgar DH. A modified cryopreservation method</span></div>
<div style="position:absolute;left:56.19px;top:587.31px" class="cls_008"><span class="cls_008">LA, Rombauts L. Fresh versus frozen embryo transfer: backing clinical decisions</span></div>
<div style="position:absolute;left:325.48px;top:587.31px" class="cls_008"><span class="cls_008">increases the survival of human biopsied cleavage stage embryos. Hum Reprod</span></div>
<div style="position:absolute;left:56.19px;top:597.29px" class="cls_008"><span class="cls_008">with scientific and clinical evidence. Hum Reprod Update 2014;20:808-821.</span></div>
<div style="position:absolute;left:325.48px;top:597.29px" class="cls_008"><span class="cls_008">2003;18:568-571.</span></div>
<div style="position:absolute;left:48.19px;top:607.26px" class="cls_008"><span class="cls_008">Fabbri R, Porcu E, Marsella T, Rocchetta G, Venturoli S, Flamigni C. Human oocyte</span></div>
<div style="position:absolute;left:317.48px;top:607.26px" class="cls_008"><span class="cls_008">Jin B, Mazur P. High survival of mouse oocytes/embryos after vitrification without</span></div>
<div style="position:absolute;left:56.19px;top:617.30px" class="cls_008"><span class="cls_008">cryopreservation: new perspectives regarding oocyte survival. Hum Reprod 2001;</span></div>
<div style="position:absolute;left:325.48px;top:617.30px" class="cls_008"><span class="cls_008">permeating cryoprotectants followed by ultra-rapid warming with an IR laser</span></div>
<div style="position:absolute;left:56.19px;top:627.28px" class="cls_008"><span class="cls_008">16:411-416.</span></div>
<div style="position:absolute;left:325.48px;top:627.27px" class="cls_008"><span class="cls_008">pulse. Sci Rep 2015;5:927.</span></div>
<div style="position:absolute;left:48.19px;top:637.31px" class="cls_008"><span class="cls_008">Fadini R, Brambillasca F, Renzini MM, Merola M, Comi R, De Ponti E, Dal Canto</span></div>
<div style="position:absolute;left:317.48px;top:637.31px" class="cls_008"><span class="cls_008">Kaser DJ, Racowsky C. Clinical outcomes following selection of human preimplan-</span></div>
<div style="position:absolute;left:56.19px;top:647.29px" class="cls_008"><span class="cls_008">MB. Human oocyte cryopreservation: comparison between slow and ultrarapid</span></div>
<div style="position:absolute;left:325.47px;top:647.29px" class="cls_008"><span class="cls_008">tation embryos with time-lapse monitoring: a systematic review. Hum Reprod</span></div>
<div style="position:absolute;left:56.19px;top:657.27px" class="cls_008"><span class="cls_008">methods. Reprod Biomed Online 2009;19:171-180.</span></div>
<div style="position:absolute;left:325.47px;top:657.27px" class="cls_008"><span class="cls_008">Update 2014;20:617-631.</span></div>
<div style="position:absolute;left:48.19px;top:667.30px" class="cls_008"><span class="cls_008">Fasano G, Fontenelle N, Vannin AS, Biramane J, Devreker F, Englert Y, Delbaere</span></div>
<div style="position:absolute;left:317.48px;top:667.30px" class="cls_008"><span class="cls_008">Kaartinen N, Kananen K, Huhtala H, Keränen S, Tinkanen H. The freezing method</span></div>
<div style="position:absolute;left:56.18px;top:677.28px" class="cls_008"><span class="cls_008">A. A randomized controlled trial comparing two vitrification methods versus</span></div>
<div style="position:absolute;left:325.47px;top:677.28px" class="cls_008"><span class="cls_008">of cleavage stage embryos has no impact on the weight of the newborns. J Assist</span></div>
<div style="position:absolute;left:56.18px;top:687.26px" class="cls_008"><span class="cls_008">slow-freezing for cryopreservation of human cleavage stage embryos. J Assist</span></div>
<div style="position:absolute;left:325.47px;top:687.26px" class="cls_008"><span class="cls_008">Reprod Genet 2016;33:393-399.</span></div>
<div style="position:absolute;left:56.18px;top:697.29px" class="cls_008"><span class="cls_008">Reprod Genet 2014;31:241-247.</span></div>
<div style="position:absolute;left:317.48px;top:697.29px" class="cls_008"><span class="cls_008">Kim S, Lee S, Lee J et al. Study on the vitrification of human blastocysts. II: Effect of</span></div>
<div style="position:absolute;left:48.19px;top:707.27px" class="cls_008"><span class="cls_008">Dahdouh EM, Balayla J, García-Velasco JA. Impact of blastocyst biopsy and compre-</span></div>
<div style="position:absolute;left:325.47px;top:707.27px" class="cls_008"><span class="cls_008">vitrification on the implantation and the pregnancy of human blastocysts. Korean</span></div>
<div style="position:absolute;left:56.18px;top:717.30px" class="cls_008"><span class="cls_008">hensive  chromosome  screening  technology  on  preimplantation  genetic</span></div>
<div style="position:absolute;left:325.48px;top:717.30px" class="cls_008"><span class="cls_008">J Fertil Steril 2000;27:67-74.</span></div>
</div>
<div style="position:absolute;left:50%;margin-left:-306px;top:11822px;width:612px;height:790px;border-style:outset;overflow:hidden">
<div style="position:absolute;left:0px;top:0px">
<img src="fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_id_fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_files/background16.jpg" width=612 height=790></div>
<div style="position:absolute;left:45.35px;top:25.13px" class="cls_013"><span class="cls_013">154</span></div>
<div style="position:absolute;left:525.71px;top:26.63px" class="cls_014"><span class="cls_014">Rienzi et al.</span></div>
<div style="position:absolute;left:45.35px;top:57.28px" class="cls_008"><span class="cls_008">Kolibianakis EM, Venetis CA, Tarlatzis BC. Cryopreservation of human embryos by</span></div>
<div style="position:absolute;left:314.65px;top:57.29px" class="cls_008"><span class="cls_008">Martinez  M,  Rabadan  S,  Domingo  J,  Cobo  A,  Pellicer  A,  Garcia-Velasco  JA.</span></div>
<div style="position:absolute;left:53.35px;top:67.26px" class="cls_008"><span class="cls_008">vitrification or slow-freezing: which one is better? Curr Opin Obstet Gynecol 2009;</span></div>
<div style="position:absolute;left:322.64px;top:67.26px" class="cls_008"><span class="cls_008">Obstetric outcome after oocyte vitrification and warming for fertility preserva-</span></div>
<div style="position:absolute;left:53.35px;top:77.30px" class="cls_008"><span class="cls_008">21:270-274.</span></div>
<div style="position:absolute;left:322.64px;top:77.30px" class="cls_008"><span class="cls_008">tion in women with cancer. Reprod Biomed Online 2014;29:722-728.</span></div>
<div style="position:absolute;left:45.35px;top:87.28px" class="cls_008"><span class="cls_008">Kuleshova L, Gianaroli L, Magli C, Ferraretti A, Trounson A. Birth following vitrifica-</span></div>
<div style="position:absolute;left:314.65px;top:87.28px" class="cls_008"><span class="cls_008">Mazur P. Equilibrium, quasi-equilibrium, and nonequilibrium freezing of mammalian</span></div>
<div style="position:absolute;left:53.35px;top:97.25px" class="cls_008"><span class="cls_008">tion of a small number of human oocytes: case report. Hum Reprod 1999;14:</span></div>
<div style="position:absolute;left:322.64px;top:97.25px" class="cls_008"><span class="cls_008">embryos. Cell Biophys 1990;17:53-92.</span></div>
<div style="position:absolute;left:53.35px;top:107.29px" class="cls_008"><span class="cls_008">3077-3079.</span></div>
<div style="position:absolute;left:314.65px;top:107.29px" class="cls_008"><span class="cls_008">Mukaida T, Wada S, Takahashi K, Pedro PB, An TZ, Kasai M. Vitrification of human</span></div>
<div style="position:absolute;left:45.36px;top:117.27px" class="cls_008"><span class="cls_008">Kuleshova LL, Shaw JM. A strategy for rapid cooling of mouse embryos within a</span></div>
<div style="position:absolute;left:322.64px;top:117.27px" class="cls_008"><span class="cls_008">embryos  based  on  the  assessment  of  suitable  conditions  for</span></div>
<div style="position:absolute;left:523.84px;top:117.27px" class="cls_008"><span class="cls_008">8-cell  mouse</span></div>
<div style="position:absolute;left:53.35px;top:127.30px" class="cls_008"><span class="cls_008">double straw to eliminate the risk of contamination during storage in liquid nitro-</span></div>
<div style="position:absolute;left:322.64px;top:127.30px" class="cls_008"><span class="cls_008">embryos. Hum Reprod 1998;13:2874-2879.</span></div>
<div style="position:absolute;left:53.35px;top:137.28px" class="cls_008"><span class="cls_008">gen. Hum Reprod 2000;15:2604-2609.</span></div>
<div style="position:absolute;left:314.65px;top:137.28px" class="cls_008"><span class="cls_008">Nachtigall RD, Mac Dougall K, Lee M, Harrington J, Becker G. What do patients</span></div>
<div style="position:absolute;left:45.36px;top:147.26px" class="cls_008"><span class="cls_008">Kupka MS, D’Hooghe T, Ferraretti AP, de Mouzon J, Erb K, Castilla JA, Calhaz-</span></div>
<div style="position:absolute;left:322.64px;top:147.26px" class="cls_008"><span class="cls_008">want? Expectations and perceptions of IVF clinic information and support regard-</span></div>
<div style="position:absolute;left:53.35px;top:157.29px" class="cls_008"><span class="cls_008">Jorge C, De Geyter CH, Goossens V. Assisted reproductive technology in</span></div>
<div style="position:absolute;left:322.64px;top:157.29px" class="cls_008"><span class="cls_008">ing frozen embryo disposition. Fertil Steril 2010;94:2069-2072.</span></div>
<div style="position:absolute;left:53.35px;top:167.27px" class="cls_008"><span class="cls_008">Europe, 2011: results generated from European registers by ESHRE. Hum Reprod</span></div>
<div style="position:absolute;left:314.65px;top:167.27px" class="cls_008"><span class="cls_008">Nagy ZP, Chang CC, Shapiro DB, Bernal DP, Elsner CW, Mitchell-Leef D, Toledo</span></div>
<div style="position:absolute;left:53.35px;top:177.30px" class="cls_008"><span class="cls_008">2016;31:233-248.</span></div>
<div style="position:absolute;left:322.64px;top:177.30px" class="cls_008"><span class="cls_008">AA, Kort HI. Clinical evaluation of the efficiency of an oocyte donation program</span></div>
<div style="position:absolute;left:45.36px;top:187.28px" class="cls_008"><span class="cls_008">Kuwayama M, Vajta G, Kato O, Leibo SP. Highly efficient vitrification method</span></div>
<div style="position:absolute;left:322.64px;top:187.28px" class="cls_008"><span class="cls_008">using egg cryo-banking. Fertil Steril 2009;92:520-526.</span></div>
<div style="position:absolute;left:53.35px;top:197.26px" class="cls_008"><span class="cls_008">for cryopreservation of human oocytes. Reprod Biomed Online 2005a;11:</span></div>
<div style="position:absolute;left:314.65px;top:197.26px" class="cls_008"><span class="cls_008">Nagy ZP, Cobo A, Chang C. Oocyte Vitrification: ‘donor egg banking’ in Vitrification in</span></div>
<div style="position:absolute;left:53.35px;top:207.29px" class="cls_008"><span class="cls_008">300-308.</span></div>
<div style="position:absolute;left:322.64px;top:207.30px" class="cls_008"><span class="cls_008">Assisted Reproduction, 2nd edn. CRC Press, 2015;129-136.</span></div>
<div style="position:absolute;left:45.36px;top:217.27px" class="cls_008"><span class="cls_008">Kuwayama M, Vajta G, Ieda S et al. Comparison of open and closed methods for</span></div>
<div style="position:absolute;left:314.65px;top:217.27px" class="cls_008"><span class="cls_008">Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with</span></div>
<div style="position:absolute;left:53.35px;top:227.31px" class="cls_008"><span class="cls_008">vitrification of human embryos and the elimination of potential contamination.</span></div>
<div style="position:absolute;left:322.64px;top:227.31px" class="cls_008"><span class="cls_008">no apparent increase in congenital anomalies. Reprod Biomed Online 2009;18:</span></div>
<div style="position:absolute;left:53.35px;top:237.29px" class="cls_008"><span class="cls_008">Reprod Biomed Online 2005b;11:608-614.</span></div>
<div style="position:absolute;left:322.64px;top:237.29px" class="cls_008"><span class="cls_008">769-776.</span></div>
<div style="position:absolute;left:45.36px;top:247.26px" class="cls_008"><span class="cls_008">La Sala GB, Nicoli A, Villani MT, Pescarini M, Gallinelli A, Blickstein I. Outcome of</span></div>
<div style="position:absolute;left:314.65px;top:247.26px" class="cls_008"><span class="cls_008">Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: a meta-analysis.</span></div>
<div style="position:absolute;left:53.35px;top:257.30px" class="cls_008"><span class="cls_008">518 salvage oocyte-cryopreservation cycles performed as a routine procedure in</span></div>
<div style="position:absolute;left:322.64px;top:257.30px" class="cls_008"><span class="cls_008">Fertil Steril 2006;86:70-80.</span></div>
<div style="position:absolute;left:53.35px;top:267.28px" class="cls_008"><span class="cls_008">an in vitro fertilization program. Fertil Steril 2006;86:1423-1427.</span></div>
<div style="position:absolute;left:314.65px;top:267.27px" class="cls_008"><span class="cls_008">Paffoni A, Alagna F, Somigliana E, Restelli L, Brevini TA, Gandolfi F, Ragni G.</span></div>
<div style="position:absolute;left:45.36px;top:277.25px" class="cls_008"><span class="cls_008">Lassalle B, Testart J, Renard JP. Human embryo features that influence the suc-</span></div>
<div style="position:absolute;left:322.64px;top:277.25px" class="cls_008"><span class="cls_008">Developmental potential of human oocytes after slow freezing or vitrification: a</span></div>
<div style="position:absolute;left:53.35px;top:287.29px" class="cls_008"><span class="cls_008">cess of cryopreservation with the use of 1,2 propanediol. Fertil Steril 1985;44:</span></div>
<div style="position:absolute;left:322.64px;top:287.29px" class="cls_008"><span class="cls_008">randomized in vitro study based on parthenogenesis. Reprod Sci 2008;15:1027-</span></div>
<div style="position:absolute;left:53.35px;top:297.27px" class="cls_008"><span class="cls_008">645-651.</span></div>
<div style="position:absolute;left:322.64px;top:297.27px" class="cls_008"><span class="cls_008">1033.</span></div>
<div style="position:absolute;left:45.36px;top:307.30px" class="cls_008"><span class="cls_008">Lee E, Illingworth P, Wilton L, Chambers GM. The clinical effectiveness of preim-</span></div>
<div style="position:absolute;left:314.65px;top:307.30px" class="cls_008"><span class="cls_008">Parmegiani L, Cognigni GE, Filicori M. Ultra-violet sterilization of liquid nitrogen</span></div>
<div style="position:absolute;left:53.35px;top:317.28px" class="cls_008"><span class="cls_008">plantation genetic diagnosis for aneuploidy in all 24 chromosomes (PGD-A): sys-</span></div>
<div style="position:absolute;left:322.64px;top:317.28px" class="cls_008"><span class="cls_008">prior to vitrification. Hum Reprod 2009;24:2969.</span></div>
<div style="position:absolute;left:53.35px;top:327.26px" class="cls_008"><span class="cls_008">tematic review. Hum Reprod 2015;30:473-483.</span></div>
<div style="position:absolute;left:314.65px;top:327.26px" class="cls_008"><span class="cls_008">Parmegiani  L, Cognigni  GE, Bernardi S, Cuomo S, Ciampaglia W, Infante  FE,</span></div>
<div style="position:absolute;left:45.36px;top:337.29px" class="cls_008"><span class="cls_008">Leibo  SP,  Songsasen  N.  Cryopreservation  of  gametes  and  embryos  of  non-</span></div>
<div style="position:absolute;left:322.64px;top:337.29px" class="cls_008"><span class="cls_008">Tabarelli de Fatis C, Arnone A, Maccarini AM, Filicori M. Efficiency of aseptic</span></div>
<div style="position:absolute;left:53.35px;top:347.27px" class="cls_008"><span class="cls_008">domestic species. Theriogenology 2002;57:303-326.</span></div>
<div style="position:absolute;left:322.64px;top:347.27px" class="cls_008"><span class="cls_008">open vitrification and hermetical cryostorage of human oocytes. Reprod Biomed</span></div>
<div style="position:absolute;left:45.35px;top:357.30px" class="cls_008"><span class="cls_008">Levi Setti PE, Albani E, Novara PV, Cesana A, Morreale G. Cryopreservation of</span></div>
<div style="position:absolute;left:322.64px;top:357.30px" class="cls_008"><span class="cls_008">Online 2011;23:505-512.</span></div>
<div style="position:absolute;left:53.35px;top:367.28px" class="cls_008"><span class="cls_008">supernumerary oocytes in IVF/ICSI cycles. Hum Reprod 2006;21:370-375.</span></div>
<div style="position:absolute;left:314.64px;top:367.28px" class="cls_008"><span class="cls_008">Pelkonen S, Koivunen R, Gissler M, Nuojua-Huttunen S, Suikkari AM, Hyde´n-</span></div>
<div style="position:absolute;left:45.36px;top:377.26px" class="cls_008"><span class="cls_008">Levi Setti PE, Albani E, Morenghi E, Morreale G, Delle Piane L, Scaravelli G, Patrizio</span></div>
<div style="position:absolute;left:322.64px;top:377.26px" class="cls_008"><span class="cls_008">Granskog C, Martikainen H, Tiitinen A, Hartikainen AL. Perinatal outcome of</span></div>
<div style="position:absolute;left:53.35px;top:387.29px" class="cls_008"><span class="cls_008">P. Comparative analysis of fetal and neonatal outcomes of pregnancies from</span></div>
<div style="position:absolute;left:322.64px;top:387.29px" class="cls_008"><span class="cls_008">children born after frozen and fresh embryo transfer: the Finnish cohort study</span></div>
<div style="position:absolute;left:53.35px;top:397.27px" class="cls_008"><span class="cls_008">fresh and cryopreserved/thawed oocytes in the same group of patients. Fertil</span></div>
<div style="position:absolute;left:322.64px;top:397.27px" class="cls_008"><span class="cls_008">1995-2006. Hum Reprod 2010;25:914-923.</span></div>
<div style="position:absolute;left:53.35px;top:407.31px" class="cls_008"><span class="cls_008">Steril 2013;100:396-401.</span></div>
<div style="position:absolute;left:314.64px;top:407.31px" class="cls_008"><span class="cls_008">Pinborg A, Loft A, Aaris Henningsen AK, Rasmussen S, Andersen AN. Infant out-</span></div>
<div style="position:absolute;left:45.36px;top:417.28px" class="cls_008"><span class="cls_008">Levi Setti PE, Porcu E, Patrizio P, Vigiliano V, de Luca R, d’Aloja P, Spoletini R,</span></div>
<div style="position:absolute;left:322.64px;top:417.29px" class="cls_008"><span class="cls_008">come of 957 singletons born after frozen embryo replacement: the Danish</span></div>
<div style="position:absolute;left:53.35px;top:427.26px" class="cls_008"><span class="cls_008">Scaravelli G. Human oocyte cryopreservation with slow-freezing versus vitrifica-</span></div>
<div style="position:absolute;left:322.64px;top:427.26px" class="cls_008"><span class="cls_008">National Cohort Study 1995-2006. Fertil Steril 2010;94:1320-1327.</span></div>
<div style="position:absolute;left:53.35px;top:437.30px" class="cls_008"><span class="cls_008">tion. Results from the National Italian Registry Data,</span></div>
<div style="position:absolute;left:225.69px;top:437.30px" class="cls_008"><span class="cls_008">2007-2011. Fertil Steril</span></div>
<div style="position:absolute;left:314.65px;top:437.30px" class="cls_008"><span class="cls_008">Potdar N, Gelbaya TA, Nardo LG. Oocyte vitrification in the 21st century and</span></div>
<div style="position:absolute;left:53.35px;top:447.28px" class="cls_008"><span class="cls_008">2014;102:90-95.</span></div>
<div style="position:absolute;left:322.64px;top:447.28px" class="cls_008"><span class="cls_008">post-warming fertility outcomes: a systematic review and meta-analysis. Reprod</span></div>
<div style="position:absolute;left:45.36px;top:457.31px" class="cls_008"><span class="cls_008">Levi-Setti PE, Borini A, Patrizio P, Bolli S, Vigiliano V, De Luca R, Scaravelli G. ART</span></div>
<div style="position:absolute;left:322.64px;top:457.31px" class="cls_008"><span class="cls_008">Biomed Online 2014;29:159-176.</span></div>
<div style="position:absolute;left:53.35px;top:467.29px" class="cls_008"><span class="cls_008">results with frozen oocytes: data from the Italian ART registry (2005-2013).</span></div>
<div style="position:absolute;left:314.65px;top:467.29px" class="cls_008"><span class="cls_008">Racowsky C, Ohno-Machado L, Kim J, Biggers JD. Is there an advantage in scoring</span></div>
<div style="position:absolute;left:53.35px;top:477.27px" class="cls_008"><span class="cls_008">J Assist Reprod Genet 2016;33:123-128.</span></div>
<div style="position:absolute;left:322.64px;top:477.27px" class="cls_008"><span class="cls_008">early embryos on more than one day? Hum Reprod 2009;24:2104-2113.</span></div>
<div style="position:absolute;left:45.35px;top:487.30px" class="cls_008"><span class="cls_008">Li Y, Chen ZJ, Yang HJ et al. Comparison of vitrification and slow-freezing of human</span></div>
<div style="position:absolute;left:314.65px;top:487.30px" class="cls_008"><span class="cls_008">Rama Raju GA, Haranath GB, Krishna KM et al. Vitrification of human 8-cell</span></div>
<div style="position:absolute;left:53.35px;top:497.28px" class="cls_008"><span class="cls_008">day 3 cleavage stage embryos: post vitrification development and pregnancy out-</span></div>
<div style="position:absolute;left:322.64px;top:497.28px" class="cls_008"><span class="cls_008">embryos, a modified protocol for better pregnancy rates. Reprod Biomed Online</span></div>
<div style="position:absolute;left:53.35px;top:507.26px" class="cls_008"><span class="cls_008">comes. Zhonghua Fu Chan Ke Za Zhi 2007;42:753-755.</span></div>
<div style="position:absolute;left:322.64px;top:507.26px" class="cls_008"><span class="cls_008">2005;11:434-437.</span></div>
<div style="position:absolute;left:45.35px;top:517.29px" class="cls_008"><span class="cls_008">Li Z, Wang YA, Ledger W, Edgar DH, Sullivan EA. Clinical outcomes following</span></div>
<div style="position:absolute;left:314.65px;top:517.29px" class="cls_008"><span class="cls_008">Rezazadeh Valojerdi M, Eftekhari-Yazdi P, Karimian L et al. Vitrification versus slow-</span></div>
<div style="position:absolute;left:53.35px;top:527.27px" class="cls_008"><span class="cls_008">cryopreservation of blastocysts by vitrification or slow-freezing: a population-</span></div>
<div style="position:absolute;left:322.64px;top:527.27px" class="cls_008"><span class="cls_008">freezing gives excellent survival post warming embryo morphology and pregnancy</span></div>
<div style="position:absolute;left:53.35px;top:537.30px" class="cls_008"><span class="cls_008">based cohort study. Hum Reprod 2014;29:2794-2801.</span></div>
<div style="position:absolute;left:322.64px;top:537.30px" class="cls_008"><span class="cls_008">outcomes for human cleavedembryos. J Assist Reprod Genet 2009;26:347-354.</span></div>
<div style="position:absolute;left:45.35px;top:547.28px" class="cls_008"><span class="cls_008">Li Z, Sullivan EA, Chapman M, Farquhar C, Wang YA. Risk of ectopic pregnancy</span></div>
<div style="position:absolute;left:314.65px;top:547.28px" class="cls_008"><span class="cls_008">Rienzi L, Romano S, Albricci L, Maggiulli R, Capalbo A, Baroni E, Colamaria S,</span></div>
<div style="position:absolute;left:53.35px;top:557.26px" class="cls_008"><span class="cls_008">lowest  with  transfer  of  single  frozen  blastocyst.  Hum  Reprod</span></div>
<div style="position:absolute;left:268.04px;top:557.26px" class="cls_008"><span class="cls_008">2015;30:</span></div>
<div style="position:absolute;left:322.64px;top:557.26px" class="cls_008"><span class="cls_008">Sapienza F, Ubaldi F. Embryo development of fresh ‘versus’ vitrified metaphase II</span></div>
<div style="position:absolute;left:53.35px;top:567.29px" class="cls_008"><span class="cls_008">2048-2054.</span></div>
<div style="position:absolute;left:322.64px;top:567.29px" class="cls_008"><span class="cls_008">oocytes after ICSI: a prospective randomized sibling-oocyte study. Hum Reprod</span></div>
<div style="position:absolute;left:45.35px;top:577.27px" class="cls_008"><span class="cls_008">Liebermann J, Tucker MJ. Comparison of vitrification and conventional cryopreser-</span></div>
<div style="position:absolute;left:322.64px;top:577.27px" class="cls_008"><span class="cls_008">2010;25:66-73.</span></div>
<div style="position:absolute;left:53.35px;top:587.31px" class="cls_008"><span class="cls_008">vation of day 5 and day 6 blastocysts during clinical application. Fertil Steril 2006;</span></div>
<div style="position:absolute;left:314.65px;top:587.31px" class="cls_008"><span class="cls_008">Rienzi L, Ubaldi FM. Oocyte versus embryo cryopreservation for fertility preserva-</span></div>
<div style="position:absolute;left:53.35px;top:597.29px" class="cls_008"><span class="cls_008">86:20-26.</span></div>
<div style="position:absolute;left:322.64px;top:597.28px" class="cls_008"><span class="cls_008">tion in cancer patients: guaranteeing a women’s autonomy. J Assist Reprod Genet</span></div>
<div style="position:absolute;left:45.35px;top:607.26px" class="cls_008"><span class="cls_008">Liu SY, Teng B, Fu J, Li X, Zheng Y, Sun XX. Obstetric and neonatal outcomes</span></div>
<div style="position:absolute;left:322.64px;top:607.26px" class="cls_008"><span class="cls_008">2015;32:1195-1196.</span></div>
<div style="position:absolute;left:53.35px;top:617.30px" class="cls_008"><span class="cls_008">after transfer of vitrifiedearlycleavageembryos. Hum Reprod 2013;28:2093-2100.</span></div>
<div style="position:absolute;left:314.65px;top:617.30px" class="cls_008"><span class="cls_008">Roy TK, Brandi S, Tappe NM, Bradley CK, Vom E, Henderson C, Lewis C, Battista</span></div>
<div style="position:absolute;left:45.35px;top:627.28px" class="cls_008"><span class="cls_008">Loutradi KE, Kolibianakis EM, Venetis CA, Papanikolaou EG, Pados G, Bontis I,</span></div>
<div style="position:absolute;left:322.64px;top:627.28px" class="cls_008"><span class="cls_008">K, Hobbs B, Hobbs S et al. Embryo vitrification using a novel semi-automated</span></div>
<div style="position:absolute;left:53.35px;top:637.31px" class="cls_008"><span class="cls_008">Tarlatzis BC. Cryopreservation of human embryos by vitrification or slow-freez-</span></div>
<div style="position:absolute;left:322.64px;top:637.31px" class="cls_008"><span class="cls_008">closed system yields in vitro outcomes equivalent to the manual Cryotop meth-</span></div>
<div style="position:absolute;left:53.35px;top:647.29px" class="cls_008"><span class="cls_008">ing: a systematic review and meta-analysis. Fertil Steril 2008;90:186-193.</span></div>
<div style="position:absolute;left:322.64px;top:647.29px" class="cls_008"><span class="cls_008">od. Hum Reprod 2014;29:2431-2438.</span></div>
<div style="position:absolute;left:45.36px;top:657.27px" class="cls_008"><span class="cls_008">Maheshwari A, Pandey S, Shetty A, Hamilton M, Bhattacharya S. Obstetric and</span></div>
<div style="position:absolute;left:314.65px;top:657.27px" class="cls_008"><span class="cls_008">Roque M, Lattes K, Serra S, Sola I, Geber S, Carreras R, Checa MA. Fresh embryo</span></div>
<div style="position:absolute;left:53.35px;top:667.30px" class="cls_008"><span class="cls_008">perinatal outcomes in singleton pregnancies resulting from the transfer of frozen</span></div>
<div style="position:absolute;left:322.64px;top:667.30px" class="cls_008"><span class="cls_008">transfer versus frozen embryo transfer in in vitro fertilization cycles: a systematic</span></div>
<div style="position:absolute;left:53.35px;top:677.28px" class="cls_008"><span class="cls_008">thawed versus fresh embryos generated through in vitro fertilization treatment:</span></div>
<div style="position:absolute;left:322.64px;top:677.28px" class="cls_008"><span class="cls_008">review and meta-analysis. Fertil Steril 2013;99:156-162.</span></div>
<div style="position:absolute;left:53.35px;top:687.26px" class="cls_008"><span class="cls_008">a systematic review and meta-analysis. Fertil Steril 2012;98:368-337.</span></div>
<div style="position:absolute;left:314.65px;top:687.26px" class="cls_008"><span class="cls_008">Schoolcraft WB, Treff NR, Stevens JM, Ferry K, Katz-Jaffe M, Scott RT Jr. Live birth</span></div>
<div style="position:absolute;left:45.36px;top:697.29px" class="cls_008"><span class="cls_008">Macaldowie  A,  Wang  YA,  Chambers  GM,  Sullivan  EA.  Assisted  Reproductive</span></div>
<div style="position:absolute;left:322.64px;top:697.29px" class="cls_008"><span class="cls_008">outcome  with  trophectoderm  biopsy,  blastocyst  vitrification,  and  single-</span></div>
<div style="position:absolute;left:53.35px;top:707.27px" class="cls_008"><span class="cls_008">Technology in Australia and New Zealand 2010. Sydney, NSW: Australian Institute</span></div>
<div style="position:absolute;left:322.64px;top:707.27px" class="cls_008"><span class="cls_008">nucleotide  polymorphism  microarray-based  comprehensive  chromosome</span></div>
<div style="position:absolute;left:53.35px;top:717.30px" class="cls_008"><span class="cls_008">of Health and Welfare, 2012.</span></div>
<div style="position:absolute;left:322.64px;top:717.30px" class="cls_008"><span class="cls_008">screening in infertile patients. Fertil Steril 2011;96:638-640.</span></div>
</div>
<div style="position:absolute;left:50%;margin-left:-306px;top:12622px;width:612px;height:790px;border-style:outset;overflow:hidden">
<div style="position:absolute;left:0px;top:0px">
<img src="fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_id_fb5b0bf6-a85c-11eb-8b25-0cc47a792c0a_files/background17.jpg" width=612 height=790></div>
<div style="position:absolute;left:48.19px;top:26.63px" class="cls_014"><span class="cls_014">Slow-freezing versus vitrification in ART</span></div>
<div style="position:absolute;left:550.66px;top:25.13px" class="cls_013"><span class="cls_013">155</span></div>
<div style="position:absolute;left:48.19px;top:57.28px" class="cls_008"><span class="cls_008">Selman HA, El-Danasouri I. Pregnancies derived from vitrified human zygotes. Fertil</span></div>
<div style="position:absolute;left:317.48px;top:57.29px" class="cls_008"><span class="cls_008">Vajta G, Rienzi L, Ubaldi FM. Open versus closed systems for vitrification of human</span></div>
<div style="position:absolute;left:56.18px;top:67.26px" class="cls_008"><span class="cls_008">Steril 2002;77:422-423.</span></div>
<div style="position:absolute;left:325.47px;top:67.26px" class="cls_008"><span class="cls_008">oocytes and embryos. Reprod Biomed Online 2015;30:325-333.</span></div>
<div style="position:absolute;left:48.19px;top:77.30px" class="cls_008"><span class="cls_008">Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C. Freeze-all at the</span></div>
<div style="position:absolute;left:317.48px;top:77.30px" class="cls_008"><span class="cls_008">Van Landuyt L, Van de Velde H, De Vos A, Haentjens P, Blockeel C, Tournaye H,</span></div>
<div style="position:absolute;left:56.18px;top:87.28px" class="cls_008"><span class="cls_008">blastocyst or bipronuclear stage: a randomized clinical trial. Fertil Steril 2015;104:</span></div>
<div style="position:absolute;left:325.47px;top:87.28px" class="cls_008"><span class="cls_008">Verheyen G. Influence of cell loss after vitrification or slow-freezing on further</span></div>
<div style="position:absolute;left:56.18px;top:97.25px" class="cls_008"><span class="cls_008">1138-1144.</span></div>
<div style="position:absolute;left:325.47px;top:97.25px" class="cls_008"><span class="cls_008">in vitro development and implantation of human Day 3 embryos. Hum Reprod</span></div>
<div style="position:absolute;left:48.19px;top:107.29px" class="cls_008"><span class="cls_008">Siano L, Engmann L, Nulsen J, Benadiva C. A prospective pilot study comparing fer-</span></div>
<div style="position:absolute;left:325.47px;top:107.29px" class="cls_008"><span class="cls_008">2013;28:2943-2949.</span></div>
<div style="position:absolute;left:56.18px;top:117.27px" class="cls_008"><span class="cls_008">tilization and embryo development between fresh and vitrified sibling oocytes.</span></div>
<div style="position:absolute;left:317.48px;top:117.27px" class="cls_008"><span class="cls_008">Vanderzwalmen P, Ectors F, Grobet L, Prapas Y, Panagiotidis Y, Vanderzwalmen S,</span></div>
<div style="position:absolute;left:56.18px;top:127.30px" class="cls_008"><span class="cls_008">Conn Med 2013;77:211-217.</span></div>
<div style="position:absolute;left:325.47px;top:127.30px" class="cls_008"><span class="cls_008">Stecher A, Frias P, Liebermann J, Zech NH. Aseptic vitrification of blastocysts</span></div>
<div style="position:absolute;left:48.19px;top:137.28px" class="cls_008"><span class="cls_008">Sifer C, Sermondade N, Dupont C, Poncelet C, Cédrin-Durnerin I, Hugues JN,</span></div>
<div style="position:absolute;left:325.47px;top:137.28px" class="cls_008"><span class="cls_008">from infertile patients, egg donors and after IVM. Reprod Biomed Online 2009;19:</span></div>
<div style="position:absolute;left:56.18px;top:147.26px" class="cls_008"><span class="cls_008">Benzacken B, Levy R. [Outcome of embryo vitrification compared to slow-</span></div>
<div style="position:absolute;left:325.48px;top:147.26px" class="cls_008"><span class="cls_008">700-707.</span></div>
<div style="position:absolute;left:56.18px;top:157.29px" class="cls_008"><span class="cls_008">freezing process at earlycleavage stages. Report of the first French birth]. Gynecol</span></div>
<div style="position:absolute;left:317.48px;top:157.29px" class="cls_008"><span class="cls_008">Veeck LL, Bodine R, Clarke RN, Berrios R, Libraro J, Moschini RM, Zaninovic N,</span></div>
<div style="position:absolute;left:56.18px;top:167.27px" class="cls_008"><span class="cls_008">Obstet Fertil 2012;40:158-161.</span></div>
<div style="position:absolute;left:325.48px;top:167.27px" class="cls_008"><span class="cls_008">Rosenwaks Z. High pregnancy rates can be achieved after freezing and thawing</span></div>
<div style="position:absolute;left:48.19px;top:177.30px" class="cls_008"><span class="cls_008">Smith GD, Serafini PC, Fioravanti J, Yadid I, Coslovsky M, Hassun P, Alegretti JR,</span></div>
<div style="position:absolute;left:325.48px;top:177.30px" class="cls_008"><span class="cls_008">human blastocysts. Fertil Steril 2004;82:1418-1427.</span></div>
<div style="position:absolute;left:56.18px;top:187.28px" class="cls_008"><span class="cls_008">Motta EL. Prospective randomized comparison of human oocyte cryopreserva-</span></div>
<div style="position:absolute;left:317.48px;top:187.28px" class="cls_008"><span class="cls_008">Virant-Klun I, Bacer-Kermavner L, Tomazevic T, Vrtacnik-Bokal E. Slow oocyte</span></div>
<div style="position:absolute;left:56.18px;top:197.26px" class="cls_008"><span class="cls_008">tion with slow-rate freezing or vitrification. Fertil Steril 2010;94:2088-2095.</span></div>
<div style="position:absolute;left:325.48px;top:197.26px" class="cls_008"><span class="cls_008">freezing and thawing in couples with no sperm or an insufficient number of</span></div>
<div style="position:absolute;left:48.19px;top:207.29px" class="cls_008"><span class="cls_008">Sole M, Santalo J, Boada M, Clua E, Rodriguez I, Martinez F, Coroleu B, Barri PN,</span></div>
<div style="position:absolute;left:325.48px;top:207.29px" class="cls_008"><span class="cls_008">sperm on the day of in vitro fertilization. Reprod Biol Endocrinol 2011;9:19.</span></div>
<div style="position:absolute;left:56.18px;top:217.27px" class="cls_008"><span class="cls_008">Veiga A. How does vitrification affect oocyte viability in oocyte donation cycles?</span></div>
<div style="position:absolute;left:317.48px;top:217.27px" class="cls_008"><span class="cls_008">Wang YA, Sullivan EA, Black D, Dean J, Bryant J, Chapman M. Preterm birth and</span></div>
<div style="position:absolute;left:56.18px;top:227.31px" class="cls_008"><span class="cls_008">A prospective study to compare outcomes achieved with fresh versus vitrified</span></div>
<div style="position:absolute;left:325.48px;top:227.31px" class="cls_008"><span class="cls_008">low birth weight after assisted reproductive technology-related pregnancy in</span></div>
<div style="position:absolute;left:56.18px;top:237.29px" class="cls_008"><span class="cls_008">sibling oocytes. Hum Reprod 2013;28:2087-2092.</span></div>
<div style="position:absolute;left:325.48px;top:237.29px" class="cls_008"><span class="cls_008">Australia between 1996 and 2000. Fertil Steril 2005;83:1650-1165.</span></div>
<div style="position:absolute;left:48.19px;top:247.26px" class="cls_008"><span class="cls_008">Stehlik E, Stehlik J, Katayama KP, Kuwayama M, Jambor V, Brohammer R, Kato O.</span></div>
<div style="position:absolute;left:317.48px;top:247.26px" class="cls_008"><span class="cls_008">Wang XL, Zhang X, Qin YQ, Hao DY, Shi HR. Outcomes of day 3 embryo trans-</span></div>
<div style="position:absolute;left:56.18px;top:257.30px" class="cls_008"><span class="cls_008">Vitrification demonstrates significant improvement versus slow-freezing of human</span></div>
<div style="position:absolute;left:325.48px;top:257.30px" class="cls_008"><span class="cls_008">fer with vitrification using Cryoleaf: a</span></div>
<div style="position:absolute;left:446.74px;top:257.30px" class="cls_008"><span class="cls_008">3-year follow-up study. J Assist Reprod</span></div>
<div style="position:absolute;left:56.18px;top:267.28px" class="cls_008"><span class="cls_008">blastocysts. Reprod Biomed Online 2005;11:53-57.</span></div>
<div style="position:absolute;left:325.48px;top:267.28px" class="cls_008"><span class="cls_008">Genet 2012;29:883-889.</span></div>
<div style="position:absolute;left:48.19px;top:277.25px" class="cls_008"><span class="cls_008">Stoop D, Nekkebroeck J, Devroey P. A survey on the intentions and attitudes</span></div>
<div style="position:absolute;left:317.48px;top:277.25px" class="cls_008"><span class="cls_008">Wennerholm UB, Söderström-Anttila V, Bergh C, Aittomäki K, Hazekamp J, Nygren</span></div>
<div style="position:absolute;left:56.18px;top:287.29px" class="cls_008"><span class="cls_008">towards oocyte cryopreservation for non-medical reasons among women of</span></div>
<div style="position:absolute;left:325.48px;top:287.29px" class="cls_008"><span class="cls_008">KG, Selbing A, Loft A. Children born after cryopreservation of embryos or</span></div>
<div style="position:absolute;left:56.18px;top:297.27px" class="cls_008"><span class="cls_008">reproductive age. Hum Reprod 2011;3:655-661.</span></div>
<div style="position:absolute;left:325.48px;top:297.27px" class="cls_008"><span class="cls_008">oocytes: a systematic review of outcome data. Hum Reprod 2009;24:2158-2172.</span></div>
<div style="position:absolute;left:48.19px;top:307.30px" class="cls_008"><span class="cls_008">Stoop D, Cobo A, Silber S. Fertility preservation for age-related fertility decline.</span></div>
<div style="position:absolute;left:317.48px;top:307.30px" class="cls_008"><span class="cls_008">Whittingham DG, Leibo SP, Mazur P. Survival of mouse embryos frozen to −196</span></div>
<div style="position:absolute;left:56.18px;top:317.28px" class="cls_008"><span class="cls_008">Lancet 2014;384:1311-1319.</span></div>
<div style="position:absolute;left:325.48px;top:317.28px" class="cls_008"><span class="cls_008">degrees and −269 degrees C. Science 1972;178:411-414.</span></div>
<div style="position:absolute;left:48.19px;top:327.26px" class="cls_008"><span class="cls_008">Summers D, Check JH, Choe JK. A prospective comparison of outcome following</span></div>
<div style="position:absolute;left:317.48px;top:327.26px" class="cls_008"><span class="cls_008">WHO Handbook for Guideline Development, 2nd edn. Geneva: WHO Press, World</span></div>
<div style="position:absolute;left:56.19px;top:337.29px" class="cls_008"><span class="cls_008">cryopreservation using vitrification versus a modified slow-freeze protocol of 2</span></div>
<div style="position:absolute;left:325.48px;top:337.29px" class="cls_008"><span class="cls_008">Health  Organization,</span></div>
<div style="position:absolute;left:399.46px;top:337.29px" class="cls_008"><span class="cls_008">2012.  Available:</span><span class="cls_026">  <A HREF="http://apps.who.int/iris/bitstream/10665/75146/1/9789241548441_eng.pdf">http://apps.who.int/iris/bitstream/</A> </span></div>
<div style="position:absolute;left:56.18px;top:347.27px" class="cls_008"><span class="cls_008">pronuclear (2PN) and day 3 multi-cell embryos. Clin Exp Obstet Gynecol 2016;</span></div>
<div style="position:absolute;left:325.47px;top:347.27px" class="cls_026"><span class="cls_026"> </span><A HREF="http://apps.who.int/iris/bitstream/10665/75146/1/9789241548441_eng.pdf">10665/75146/1/9789241548441_eng.pdf</A> <span class="cls_008">.</span></div>
<div style="position:absolute;left:56.18px;top:357.30px" class="cls_008"><span class="cls_008">43:330-331.</span></div>
<div style="position:absolute;left:317.48px;top:357.30px" class="cls_008"><span class="cls_008">Wilding MG, Capobianco C, Montanaro N, Kabili G, Di Matteo L, Fusco E, Dale B.</span></div>
<div style="position:absolute;left:48.19px;top:367.28px" class="cls_008"><span class="cls_008">Testart J, Lassalle B, Belaisch-Allart J, Hazout A, Forman R, Rainhorn JD, Frydman R.</span></div>
<div style="position:absolute;left:325.47px;top:367.28px" class="cls_008"><span class="cls_008">Human cleavage-stage embryo vitrification is comparable to slow-rate cryo-</span></div>
<div style="position:absolute;left:56.18px;top:377.26px" class="cls_008"><span class="cls_008">High pregnancy rate after early human embryo freezing. Fertil Steril 1986;46:268-272.</span></div>
<div style="position:absolute;left:325.47px;top:377.26px" class="cls_008"><span class="cls_008">preservation in cycles of assisted reproduction. J Assist Reprod Genet 2010;27:</span></div>
<div style="position:absolute;left:48.19px;top:387.29px" class="cls_008"><span class="cls_008">Tiitinen A, Halttunen M, Härkki P, Vuoristo P, Hyden-Granskog C. Elective single</span></div>
<div style="position:absolute;left:325.47px;top:387.29px" class="cls_008"><span class="cls_008">549-554.</span></div>
<div style="position:absolute;left:56.18px;top:397.27px" class="cls_008"><span class="cls_008">embryo transfer: the value of cryopreservation. Hum Reprod 2001;6:1140-1144.</span></div>
<div style="position:absolute;left:317.48px;top:397.27px" class="cls_008"><span class="cls_008">Willadsen SM Factors affecting the survival of sheep embryos during deep freezing</span></div>
<div style="position:absolute;left:48.19px;top:407.31px" class="cls_008"><span class="cls_008">Trokoudes KM, Pavlides C, Zhang X. Comparison outcome of fresh and vitrified</span></div>
<div style="position:absolute;left:325.47px;top:407.31px" class="cls_008"><span class="cls_008">and thawing. In: Elliott K, Whelan L (eds). The Freezing of Mammalian Embryos,</span></div>
<div style="position:absolute;left:56.18px;top:417.28px" class="cls_008"><span class="cls_008">donor oocytes in an egg-sharing donation program. Fertil Steril 2011;95:1996-2000.</span></div>
<div style="position:absolute;left:325.47px;top:417.28px" class="cls_008"><span class="cls_008">Ciba Foundation Symposium 52. Amsterdam: Elsevier, 1977;175-194.</span></div>
<div style="position:absolute;left:48.19px;top:427.26px" class="cls_008"><span class="cls_008">Trounson A, Mohr L. Human pregnancy following cryopreservation, thawing and</span></div>
<div style="position:absolute;left:317.48px;top:427.26px" class="cls_008"><span class="cls_008">Youssef MA, Van der Veen F, Al-Inany HG, Mochtar MH, Griesinger G, Nagi</span></div>
<div style="position:absolute;left:56.18px;top:437.30px" class="cls_008"><span class="cls_008">transfer of an eight-cell embryo. Nature 1983;305:707-709.</span></div>
<div style="position:absolute;left:325.47px;top:437.30px" class="cls_008"><span class="cls_008">Mohesen M, Aboulfoutouh I, van Wely M. Gonadotropin-releasing hormone</span></div>
<div style="position:absolute;left:48.19px;top:447.28px" class="cls_008"><span class="cls_008">Ubaldi F, Anniballo R, Romano S, Baroni E, Albricci L, Colamaria S, Capalbo A,</span></div>
<div style="position:absolute;left:325.47px;top:447.28px" class="cls_008"><span class="cls_008">agonist versus HCG for oocyte triggering in antagonist-assisted reproductive</span></div>
<div style="position:absolute;left:56.18px;top:457.31px" class="cls_008"><span class="cls_008">Sapienza F, Vajta G, Rienzi L. Cumulative ongoing pregnancy rate achieved with</span></div>
<div style="position:absolute;left:325.47px;top:457.31px" class="cls_008"><span class="cls_008">technology. Cochrane Database Syst Rev 2014;10:CD008046.</span></div>
<div style="position:absolute;left:56.18px;top:467.29px" class="cls_008"><span class="cls_008">oocyte vitrification and cleavage stage transfer without embryo selection in a</span></div>
<div style="position:absolute;left:317.48px;top:467.29px" class="cls_008"><span class="cls_008">Zhang X, Trokoudes KM, Pavlides C. Vitrification of biopsied embryos at cleavage,</span></div>
<div style="position:absolute;left:56.18px;top:477.27px" class="cls_008"><span class="cls_008">standard infertility program. Hum Reprod 2010;25:1199-1205.</span></div>
<div style="position:absolute;left:325.47px;top:477.27px" class="cls_008"><span class="cls_008">morula and blastocyst stage. Reprod Biomed Online 2009;19:526-531.</span></div>
<div style="position:absolute;left:48.19px;top:487.30px" class="cls_008"><span class="cls_008">Ubaldi FM, Capalbo A, Colamaria S, Ferrero S, Maggiulli R, Vajta G, Sapienza F,</span></div>
<div style="position:absolute;left:317.48px;top:487.30px" class="cls_008"><span class="cls_008">Zheng WT, Zhuang GL, Zhou CQ et al. Comparison of the survival of human</span></div>
<div style="position:absolute;left:56.18px;top:497.28px" class="cls_008"><span class="cls_008">Cimadomo D, Giuliani M, Gravotta E et al. Reduction of multiple pregnancies in</span></div>
<div style="position:absolute;left:325.47px;top:497.28px" class="cls_008"><span class="cls_008">biopsied embryos after cryopreservation with four different methods using non-</span></div>
<div style="position:absolute;left:56.18px;top:507.26px" class="cls_008"><span class="cls_008">the advanced maternal age population after implementation of an elective single</span></div>
<div style="position:absolute;left:325.47px;top:507.26px" class="cls_008"><span class="cls_008">transferable embryos. Hum Reprod 2005;20:1615-1618.</span></div>
<div style="position:absolute;left:56.18px;top:517.29px" class="cls_008"><span class="cls_008">embryo transfer policy coupled with enhanced embryo selection: pre- and post-</span></div>
<div style="position:absolute;left:317.48px;top:517.29px" class="cls_008"><span class="cls_008">Zhu HY, Xue YM, Yang LY, Jiang LY, Ling C, Tong XM, Zhang SY. Slow freezing</span></div>
<div style="position:absolute;left:56.18px;top:527.27px" class="cls_008"><span class="cls_008">intervention study. Hum Reprod 2015;30:2097-2106.</span></div>
<div style="position:absolute;left:325.47px;top:527.27px" class="cls_008"><span class="cls_008">should not be totally substituted by vitrification when applied to day 3 embryo</span></div>
<div style="position:absolute;left:48.19px;top:537.30px" class="cls_008"><span class="cls_008">Vajta G, Holm P, Kuwayama M, Booth PJ, Jacobsen H, Greve T, Callesen H. Open</span></div>
<div style="position:absolute;left:325.47px;top:537.30px" class="cls_008"><span class="cls_008">cryopreservation: an analysis of 5613 frozen cycles. J Assist Reprod Genet 2015;</span></div>
<div style="position:absolute;left:56.18px;top:547.28px" class="cls_008"><span class="cls_008">Pulled Straw (OPS) vitrification: a new way to reduce cryoinjuries of bovine ova</span></div>
<div style="position:absolute;left:325.47px;top:547.28px" class="cls_008"><span class="cls_008">32:1371-1377.</span></div>
<div style="position:absolute;left:56.18px;top:557.26px" class="cls_008"><span class="cls_008">and embryos. Mol Reprod Dev 1998;51:53-58.</span></div>
<div style="position:absolute;left:317.48px;top:557.26px" class="cls_008"><span class="cls_008">Zeilmaker GH, Alberda AT, van Gent I, Rijkmans CM, Drogendijk AC. Two preg-</span></div>
<div style="position:absolute;left:48.19px;top:567.29px" class="cls_008"><span class="cls_008">Vajta G, Nagy ZP. Are programmable freezers still needed in the embryo labora-</span></div>
<div style="position:absolute;left:325.47px;top:567.29px" class="cls_008"><span class="cls_008">nancies following transfer of intact frozen-thawed embryos. Fertil Steril 1984;42:</span></div>
<div style="position:absolute;left:56.18px;top:577.27px" class="cls_008"><span class="cls_008">tory? Review on vitrification. Reprod Biomed Online 2006;12:779-796.</span></div>
<div style="position:absolute;left:325.47px;top:577.27px" class="cls_008"><span class="cls_008">293-296.</span></div>
</div>

</body>
</html>
